JP5670731B2 - ある種の化学物質、組成物、および方法 - Google Patents
ある種の化学物質、組成物、および方法 Download PDFInfo
- Publication number
- JP5670731B2 JP5670731B2 JP2010521009A JP2010521009A JP5670731B2 JP 5670731 B2 JP5670731 B2 JP 5670731B2 JP 2010521009 A JP2010521009 A JP 2010521009A JP 2010521009 A JP2010521009 A JP 2010521009A JP 5670731 B2 JP5670731 B2 JP 5670731B2
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- amino
- carbamoyloxy
- chloro
- fluorophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims description 300
- 238000000034 method Methods 0.000 title claims description 43
- 239000000126 substance Substances 0.000 title description 64
- -1 pyridino [4,3-d] pyridinyl Chemical group 0.000 claims description 672
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 274
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 186
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 113
- 125000000217 alkyl group Chemical group 0.000 claims description 110
- 150000001875 compounds Chemical class 0.000 claims description 103
- 239000001257 hydrogen Substances 0.000 claims description 100
- 229910052739 hydrogen Inorganic materials 0.000 claims description 100
- 125000001072 heteroaryl group Chemical group 0.000 claims description 91
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 87
- 102000003505 Myosin Human genes 0.000 claims description 62
- 108060008487 Myosin Proteins 0.000 claims description 61
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 55
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 52
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 50
- 125000003107 substituted aryl group Chemical group 0.000 claims description 49
- 125000003118 aryl group Chemical group 0.000 claims description 48
- 125000005843 halogen group Chemical group 0.000 claims description 45
- 150000002431 hydrogen Chemical class 0.000 claims description 43
- 229910019142 PO4 Inorganic materials 0.000 claims description 42
- 239000010452 phosphate Substances 0.000 claims description 41
- 150000003839 salts Chemical class 0.000 claims description 38
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 38
- 210000002460 smooth muscle Anatomy 0.000 claims description 34
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims description 27
- 125000005017 substituted alkenyl group Chemical group 0.000 claims description 27
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 27
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 27
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 25
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 25
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 25
- 239000000725 suspension Substances 0.000 claims description 24
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 22
- 201000010099 disease Diseases 0.000 claims description 22
- 125000005415 substituted alkoxy group Chemical group 0.000 claims description 22
- 125000002252 acyl group Chemical group 0.000 claims description 20
- 210000003205 muscle Anatomy 0.000 claims description 20
- 229910052799 carbon Inorganic materials 0.000 claims description 17
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 17
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 17
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 17
- 239000008194 pharmaceutical composition Substances 0.000 claims description 17
- 125000004426 substituted alkynyl group Chemical group 0.000 claims description 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 15
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 15
- RFIOZSIHFNEKFF-UHFFFAOYSA-M piperazine-1-carboxylate Chemical compound [O-]C(=O)N1CCNCC1 RFIOZSIHFNEKFF-UHFFFAOYSA-M 0.000 claims description 15
- 125000004429 atom Chemical group 0.000 claims description 14
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 14
- 125000004104 aryloxy group Chemical group 0.000 claims description 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 13
- 125000004499 isoxazol-5-yl group Chemical group O1N=CC=C1* 0.000 claims description 13
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 12
- 241000124008 Mammalia Species 0.000 claims description 12
- 125000004284 isoxazol-3-yl group Chemical group [H]C1=C([H])C(*)=NO1 0.000 claims description 12
- 125000004521 1,3,4-thiadiazol-2-yl group Chemical group S1C(=NN=C1)* 0.000 claims description 11
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 11
- 125000004551 isoquinolin-3-yl group Chemical group C1=NC(=CC2=CC=CC=C12)* 0.000 claims description 11
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims description 11
- 125000004076 pyridyl group Chemical group 0.000 claims description 11
- 125000005553 heteroaryloxy group Chemical group 0.000 claims description 9
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 8
- 206010020772 Hypertension Diseases 0.000 claims description 8
- 125000000304 alkynyl group Chemical group 0.000 claims description 8
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 8
- 150000001540 azides Chemical class 0.000 claims description 8
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims description 8
- 125000003342 alkenyl group Chemical group 0.000 claims description 7
- 208000006673 asthma Diseases 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 125000000335 thiazolyl group Chemical group 0.000 claims description 7
- 125000001544 thienyl group Chemical group 0.000 claims description 7
- 208000006011 Stroke Diseases 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 125000004423 acyloxy group Chemical group 0.000 claims description 6
- 125000005194 alkoxycarbonyloxy group Chemical group 0.000 claims description 6
- 125000001153 fluoro group Chemical group F* 0.000 claims description 6
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 6
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 5
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 5
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 5
- 208000010412 Glaucoma Diseases 0.000 claims description 5
- XHRUTYOGFDLXAI-OYKVQYDMSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(O)CO)C(=O)NCC1=CC=CC(F)=C1Cl XHRUTYOGFDLXAI-OYKVQYDMSA-N 0.000 claims description 5
- 125000005873 benzo[d]thiazolyl group Chemical group 0.000 claims description 5
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 5
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 claims description 5
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 claims description 4
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 claims description 4
- 206010006482 Bronchospasm Diseases 0.000 claims description 4
- 208000010228 Erectile Dysfunction Diseases 0.000 claims description 4
- 206010021639 Incontinence Diseases 0.000 claims description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims description 4
- KTCPZIDFBSASSE-IBGZPJMESA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-5-hydroxypentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1F KTCPZIDFBSASSE-IBGZPJMESA-N 0.000 claims description 4
- TZTONEYVSXOKEE-IBGZPJMESA-N [(2s)-5-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCN)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl TZTONEYVSXOKEE-IBGZPJMESA-N 0.000 claims description 4
- RRABPIMPBONLHI-HNNXBMFYSA-N [(2s)-5-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pentyl] n-[5-(trifluoromethyl)pyridin-2-yl]carbamate Chemical compound C([C@H](CCCN)N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)OC(=O)NC1=CC=C(C(F)(F)F)C=N1 RRABPIMPBONLHI-HNNXBMFYSA-N 0.000 claims description 4
- 239000000443 aerosol Substances 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 201000001881 impotence Diseases 0.000 claims description 4
- 208000002551 irritable bowel syndrome Diseases 0.000 claims description 4
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 4
- 125000003386 piperidinyl group Chemical group 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 125000004944 pyrazin-3-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 claims description 4
- 238000007634 remodeling Methods 0.000 claims description 4
- 208000033045 Premenstrual cramps Diseases 0.000 claims description 3
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 claims description 3
- RZLPMYQABUWAMG-IBGZPJMESA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]pent-4-enyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC=C)C(=O)NCC1=CC=CC(F)=C1F RZLPMYQABUWAMG-IBGZPJMESA-N 0.000 claims description 3
- PSAOTDWEWWYFDA-QFIPXVFZSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-oxo-5-piperazin-1-ylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(=O)N1CCNCC1 PSAOTDWEWWYFDA-QFIPXVFZSA-N 0.000 claims description 3
- POQOKRRETJRPHT-OALUTQOASA-N [(2s,4s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)C[C@H](O)CO)C(=O)NCC1=CC=CC(F)=C1F POQOKRRETJRPHT-OALUTQOASA-N 0.000 claims description 3
- XHRUTYOGFDLXAI-OALUTQOASA-N [(2s,4s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C[C@H](O)CO)C(=O)NCC1=CC=CC(F)=C1Cl XHRUTYOGFDLXAI-OALUTQOASA-N 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- 230000007885 bronchoconstriction Effects 0.000 claims description 3
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 3
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 claims description 2
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims description 2
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 claims description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 2
- 208000006399 Premature Obstetric Labor Diseases 0.000 claims description 2
- SKQVRKWBGPCXIS-QFIPXVFZSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-oxo-5-piperazin-1-ylpentyl] N-[3-(3-fluorophenyl)-1,2-oxazol-5-yl]carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC1=CC(=NO1)C1=CC(=CC=C1)F)CCC(N1CCNCC1)=O SKQVRKWBGPCXIS-QFIPXVFZSA-N 0.000 claims description 2
- PSEANGVMDQTEPX-QFIPXVFZSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-oxo-5-piperazin-1-ylpentyl] N-[5-(3-fluorophenyl)-1,2-oxazol-3-yl]carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC1=NOC(=C1)C1=CC(=CC=C1)F)CCC(N1CCNCC1)=O PSEANGVMDQTEPX-QFIPXVFZSA-N 0.000 claims description 2
- QNHVVKICMVUVOS-QHCPKHFHSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-oxo-5-piperazin-1-ylpentyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)CCC(N1CCNCC1)=O QNHVVKICMVUVOS-QHCPKHFHSA-N 0.000 claims description 2
- WUJONBMBDGEVKC-VQTJNVASSA-N [(2S,4R)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4,5-dihydroxypentyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)C[C@H](CO)O WUJONBMBDGEVKC-VQTJNVASSA-N 0.000 claims description 2
- WUJONBMBDGEVKC-PMACEKPBSA-N [(2S,4S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4,5-dihydroxypentyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)C[C@@H](CO)O WUJONBMBDGEVKC-PMACEKPBSA-N 0.000 claims description 2
- YIHURIMTSNNPER-FQEVSTJZSA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-6-hydroxyhexyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCCO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1F YIHURIMTSNNPER-FQEVSTJZSA-N 0.000 claims description 2
- TYCQFLDGDRUVIS-QHCPKHFHSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(2-methyl-3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl)-5-oxopentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCC(=O)N1CC=2N=C(C)NC=2CC1)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl TYCQFLDGDRUVIS-QHCPKHFHSA-N 0.000 claims description 2
- UILNXSFBKLMMHZ-QFIPXVFZSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(2-oxopiperazin-1-yl)pentyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCN1CCNCC1=O UILNXSFBKLMMHZ-QFIPXVFZSA-N 0.000 claims description 2
- MWQAFBYGNSHPMQ-DEOSSOPVSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(4-methylpiperazin-1-yl)pentyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCN1CCN(C)CC1 MWQAFBYGNSHPMQ-DEOSSOPVSA-N 0.000 claims description 2
- HNYXHRONVORMHS-QHCPKHFHSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(6,8-dihydro-5h-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)pentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCN1CC2=NN=CN2CC1)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl HNYXHRONVORMHS-QHCPKHFHSA-N 0.000 claims description 2
- ZDXQWEZWCIQXNR-NRFANRHFSA-N [(2s)-2-[(2-chloro-4-fluorophenyl)methylcarbamoyl-methylamino]-6-hydroxyhexyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCCO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=C(F)C=C1Cl ZDXQWEZWCIQXNR-NRFANRHFSA-N 0.000 claims description 2
- DHSPIHMAHAFAEY-SFHVURJKSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-(2,2-difluoroethylamino)propyl] n-[3-(3-fluorophenyl)-1,2-oxazol-5-yl]carbamate Chemical compound CC(=O)N([C@@H](CNCC(F)F)COC(=O)NC=1ON=C(C=1)C=1C=C(F)C=CC=1)NCC1=CC=CC(F)=C1Cl DHSPIHMAHAFAEY-SFHVURJKSA-N 0.000 claims description 2
- VQGVPNKQIIOIOO-XJDOXCRVSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-hydroxy-5-phosphonooxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(O)COP(O)(O)=O)NCC1=CC=CC(F)=C1Cl VQGVPNKQIIOIOO-XJDOXCRVSA-N 0.000 claims description 2
- MSVHAZSESGCPOQ-NRFANRHFSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[(2-aminoacetyl)amino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CCCNC(=O)CN)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl MSVHAZSESGCPOQ-NRFANRHFSA-N 0.000 claims description 2
- FGKXUGHKJLGVFL-IBGZPJMESA-N [(2s)-5-[[amino-(carbamoylamino)methylidene]amino]-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCN\C(N)=N\C(N)=O)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl FGKXUGHKJLGVFL-IBGZPJMESA-N 0.000 claims description 2
- BGAUYBRSCZLHNB-SFHVURJKSA-N [(2s)-5-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,4-difluoropentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(F)(F)CN)C(=O)NCC1=CC=CC(F)=C1Cl BGAUYBRSCZLHNB-SFHVURJKSA-N 0.000 claims description 2
- LNRNJPXEXQOOKV-KRWDZBQOSA-N [(2s)-5-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,4-difluoropentyl] n-[3-(3-fluorophenyl)-1,2-oxazol-5-yl]carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)CC(F)(F)CN)OC(=O)NC(ON=1)=CC=1C1=CC=CC(F)=C1 LNRNJPXEXQOOKV-KRWDZBQOSA-N 0.000 claims description 2
- WMTXVQUFOCIMHC-ZWKOTPCHSA-N [(2s,4r)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-(3-phenyl-1,2-oxazol-5-yl)carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)C[C@@H](O)CO)OC(=O)NC(ON=1)=CC=1C1=CC=CC=C1 WMTXVQUFOCIMHC-ZWKOTPCHSA-N 0.000 claims description 2
- XHRUTYOGFDLXAI-RBUKOAKNSA-N [(2s,4r)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C[C@@H](O)CO)C(=O)NCC1=CC=CC(F)=C1Cl XHRUTYOGFDLXAI-RBUKOAKNSA-N 0.000 claims description 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims description 2
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims description 2
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 150000007942 carboxylates Chemical class 0.000 claims description 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 2
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims description 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims description 2
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 2
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims description 2
- 125000001113 thiadiazolyl group Chemical group 0.000 claims description 2
- 150000003857 carboxamides Chemical class 0.000 claims 25
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 23
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 16
- HNGXTXJLCUFYQL-UHFFFAOYSA-N 1-[(2-chloro-3-fluorophenyl)methyl]-3-methylurea Chemical compound CNC(=O)NCC1=CC=CC(F)=C1Cl HNGXTXJLCUFYQL-UHFFFAOYSA-N 0.000 claims 15
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 14
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 12
- NUKZAGXMHTUAFE-UHFFFAOYSA-N hexanoic acid methyl ester Natural products CCCCCC(=O)OC NUKZAGXMHTUAFE-UHFFFAOYSA-N 0.000 claims 9
- HNBDRPTVWVGKBR-UHFFFAOYSA-N n-pentanoic acid methyl ester Natural products CCCCC(=O)OC HNBDRPTVWVGKBR-UHFFFAOYSA-N 0.000 claims 7
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims 5
- ZJXZSIYSNXKHEA-UHFFFAOYSA-N ethyl dihydrogen phosphate Chemical compound CCOP(O)(O)=O ZJXZSIYSNXKHEA-UHFFFAOYSA-N 0.000 claims 5
- 125000004193 piperazinyl group Chemical group 0.000 claims 5
- AKOOLKBOVMJJML-UHFFFAOYSA-N 1-[(2,3-difluorophenyl)methyl]-3-methylurea Chemical compound CNC(=O)NCC1=CC=CC(F)=C1F AKOOLKBOVMJJML-UHFFFAOYSA-N 0.000 claims 4
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims 3
- JQVXMIPNQMYRPE-UHFFFAOYSA-N ethyl dimethyl phosphate Chemical compound CCOP(=O)(OC)OC JQVXMIPNQMYRPE-UHFFFAOYSA-N 0.000 claims 3
- IPWFJLQDVFKJDU-UHFFFAOYSA-N pentanamide Chemical compound CCCCC(N)=O IPWFJLQDVFKJDU-UHFFFAOYSA-N 0.000 claims 3
- HNVBNDIMWOYRFU-DHLKQENFSA-N tert-butyl n-[(2s)-1-[[(4s)-4-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-(1,7-naphthyridin-6-ylcarbamoyloxy)pentyl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamate Chemical compound CC(=O)N([C@@H](CCCNC(=O)[C@H](CO)NC(=O)OC(C)(C)C)COC(=O)NC=1N=CC2=NC=CC=C2C=1)NCC1=CC=CC(F)=C1Cl HNVBNDIMWOYRFU-DHLKQENFSA-N 0.000 claims 3
- KRZJRNZICWNMOA-GXSJLCMTSA-N (3s,4r)-4,8-dihydroxy-3-methoxy-3,4-dihydro-2h-naphthalen-1-one Chemical compound C1=CC=C2[C@@H](O)[C@@H](OC)CC(=O)C2=C1O KRZJRNZICWNMOA-GXSJLCMTSA-N 0.000 claims 2
- GFYZBSDGENFVCY-HNNXBMFYSA-N (4s)-4-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-(1,3-benzothiazol-2-ylcarbamoyloxy)pentanoic acid Chemical compound CC(=O)N([C@@H](CCC(O)=O)COC(=O)NC=1SC2=CC=CC=C2N=1)NCC1=CC=CC(F)=C1Cl GFYZBSDGENFVCY-HNNXBMFYSA-N 0.000 claims 2
- VSPMAHXVUGOFMD-UHFFFAOYSA-N 4-benzoylbenzamide Chemical compound C1=CC(C(=O)N)=CC=C1C(=O)C1=CC=CC=C1 VSPMAHXVUGOFMD-UHFFFAOYSA-N 0.000 claims 2
- 229930195711 D-Serine Natural products 0.000 claims 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Natural products COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 claims 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 2
- XFWKFGDFHGECLY-IJBYHRAESA-N [(2s)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]-4-hydroxy-3,4-dimethylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(C)C(C)(C)O)NCC1=CC=CC=C1Cl XFWKFGDFHGECLY-IJBYHRAESA-N 0.000 claims 2
- 229940095102 methyl benzoate Drugs 0.000 claims 2
- NVTPMUHPCAUGCB-UHFFFAOYSA-N pentyl dihydrogen phosphate Chemical compound CCCCCOP(O)(O)=O NVTPMUHPCAUGCB-UHFFFAOYSA-N 0.000 claims 2
- 229910052698 phosphorus Inorganic materials 0.000 claims 2
- 239000011574 phosphorus Substances 0.000 claims 2
- DNUTZBZXLPWRJG-UHFFFAOYSA-M piperidine-1-carboxylate Chemical compound [O-]C(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-M 0.000 claims 2
- PSPXARYONNFEBB-SFHVURJKSA-N (3s)-3-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]butanoic acid Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(O)=O)NCC1=CC=CC(F)=C1Cl PSPXARYONNFEBB-SFHVURJKSA-N 0.000 claims 1
- KWUBYCCZXAYOSX-IBGZPJMESA-N (4s)-4-[acetyl-[(2,3-difluorophenyl)methylamino]amino]-5-(isoquinolin-3-ylcarbamoyloxy)pentanoic acid Chemical compound CC(=O)N([C@@H](CCC(O)=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC(F)=C1F KWUBYCCZXAYOSX-IBGZPJMESA-N 0.000 claims 1
- CNUOKKKCWGIDQS-IBGZPJMESA-N (4s)-4-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-(isoquinolin-3-ylcarbamoyloxy)pentanoic acid Chemical compound CC(=O)N([C@@H](CCC(O)=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC(F)=C1Cl CNUOKKKCWGIDQS-IBGZPJMESA-N 0.000 claims 1
- FFNVIWGRJFGSKY-IBGZPJMESA-N (4s)-4-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]pentanoic acid Chemical compound CC(=O)N([C@@H](CCC(O)=O)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl FFNVIWGRJFGSKY-IBGZPJMESA-N 0.000 claims 1
- MFVREXSIOFPYNE-IBGZPJMESA-N (5s)-5-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-6-(2,6-naphthyridin-3-ylcarbamoyloxy)hexanoic acid Chemical compound CC(=O)N([C@@H](CCCC(O)=O)COC(=O)NC=1N=CC2=CC=NC=C2C=1)NCC1=CC=CC(F)=C1Cl MFVREXSIOFPYNE-IBGZPJMESA-N 0.000 claims 1
- GPUINJLFSODRFL-NRFANRHFSA-N (5s)-5-[acetyl-[(2-chlorophenyl)methylamino]amino]-6-(isoquinolin-3-ylcarbamoyloxy)hexanoic acid Chemical compound CC(=O)N([C@@H](CCCC(O)=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC=C1Cl GPUINJLFSODRFL-NRFANRHFSA-N 0.000 claims 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 claims 1
- VCDGOBCNQULOOV-UHFFFAOYSA-N 1-[(2-bromophenyl)methyl]-3-methylurea Chemical compound CNC(=O)NCC1=CC=CC=C1Br VCDGOBCNQULOOV-UHFFFAOYSA-N 0.000 claims 1
- IROXYQACBUQVKM-UHFFFAOYSA-N 1-[(3-chloro-2-fluorophenyl)methyl]-3-methylurea Chemical compound ClC=1C(=C(C=CC=1)CNC(=O)NC)F IROXYQACBUQVKM-UHFFFAOYSA-N 0.000 claims 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims 1
- OFVIQOGKUSMRFT-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-(2,2,2-trifluoroethyl)amino]ethyl n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCN(CC(F)(F)F)C(=O)NCC1=CC=CC(F)=C1Cl OFVIQOGKUSMRFT-UHFFFAOYSA-N 0.000 claims 1
- MNLOJRCFBDMBJW-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-(2,2-difluoroethyl)amino]ethyl n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCN(CC(F)F)C(=O)NCC1=CC=CC(F)=C1Cl MNLOJRCFBDMBJW-UHFFFAOYSA-N 0.000 claims 1
- OBXPJVBBYATXKQ-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-(2-hydroxy-2-methylpropyl)amino]ethyl n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCN(CC(C)(O)C)C(=O)NCC1=CC=CC(F)=C1Cl OBXPJVBBYATXKQ-UHFFFAOYSA-N 0.000 claims 1
- AOYRKCWAGAPRQS-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-(3,3,3-trifluoropropyl)amino]ethyl n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCN(CCC(F)(F)F)C(=O)NCC1=CC=CC(F)=C1Cl AOYRKCWAGAPRQS-UHFFFAOYSA-N 0.000 claims 1
- VTQDQNWRGZTFJE-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-ethylamino]ethyl n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCN(CC)C(=O)NCC1=CC=CC(F)=C1Cl VTQDQNWRGZTFJE-UHFFFAOYSA-N 0.000 claims 1
- JKNIOOOCZGNJAD-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-(1,6-naphthyridin-7-yl)carbamate Chemical compound C=1C2=NC=CC=C2C=NC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC(F)=C1Cl JKNIOOOCZGNJAD-UHFFFAOYSA-N 0.000 claims 1
- DJMTWSGPMXHLQY-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-(1,7-naphthyridin-6-yl)carbamate Chemical compound C=1C2=CC=CN=C2C=NC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC(F)=C1Cl DJMTWSGPMXHLQY-UHFFFAOYSA-N 0.000 claims 1
- VISAHVFMOFGYKW-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-(2,6-naphthyridin-3-yl)carbamate Chemical compound C=1C2=CN=CC=C2C=NC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC(F)=C1Cl VISAHVFMOFGYKW-UHFFFAOYSA-N 0.000 claims 1
- ZVSUIHDNCDNWDS-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-(5-acetylisoquinolin-3-yl)carbamate Chemical compound C=1C2=C(C(C)=O)C=CC=C2C=NC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC(F)=C1Cl ZVSUIHDNCDNWDS-UHFFFAOYSA-N 0.000 claims 1
- LPXBGBBHLSJKJO-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-(5-bromo-4-methylpyridin-2-yl)carbamate Chemical compound C=1C=CC(F)=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=CC(C)=C(Br)C=N1 LPXBGBBHLSJKJO-UHFFFAOYSA-N 0.000 claims 1
- DABCKRNRDYPSPG-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-(5-bromoisoquinolin-3-yl)carbamate Chemical compound C=1C2=C(Br)C=CC=C2C=NC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC(F)=C1Cl DABCKRNRDYPSPG-UHFFFAOYSA-N 0.000 claims 1
- NLVWKHNOTNRVEB-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-(5-cyano-4-methylpyridin-2-yl)carbamate Chemical compound C=1C=CC(F)=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=CC(C)=C(C#N)C=N1 NLVWKHNOTNRVEB-UHFFFAOYSA-N 0.000 claims 1
- NNESOHZXMXRVLZ-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-(5-fluoro-4-methylpyridin-2-yl)carbamate Chemical compound C=1C=CC(F)=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=CC(C)=C(F)C=N1 NNESOHZXMXRVLZ-UHFFFAOYSA-N 0.000 claims 1
- KUSSMADLSYHNFM-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-(8-bromoisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC=CC(Br)=C2C=NC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC(F)=C1Cl KUSSMADLSYHNFM-UHFFFAOYSA-N 0.000 claims 1
- STYXSVNLTMIGOU-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-(8-cyanoisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC=CC(C#N)=C2C=NC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC(F)=C1Cl STYXSVNLTMIGOU-UHFFFAOYSA-N 0.000 claims 1
- BPFOQZPBLGYXKV-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-[5-(hydroxymethyl)isoquinolin-3-yl]carbamate Chemical compound C=1C2=C(CO)C=CC=C2C=NC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC(F)=C1Cl BPFOQZPBLGYXKV-UHFFFAOYSA-N 0.000 claims 1
- YYCPIWWEZBROGY-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-[6-(hydroxymethyl)isoquinolin-3-yl]carbamate Chemical compound C=1C2=CC(CO)=CC=C2C=NC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC(F)=C1Cl YYCPIWWEZBROGY-UHFFFAOYSA-N 0.000 claims 1
- ALYAAUZNCGQVQQ-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-[7-(hydroxymethyl)isoquinolin-3-yl]carbamate Chemical compound C=1C2=CC=C(CO)C=C2C=NC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC(F)=C1Cl ALYAAUZNCGQVQQ-UHFFFAOYSA-N 0.000 claims 1
- CZNHDHIYKHYNRZ-UHFFFAOYSA-N 2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-isoquinolin-3-ylcarbamate Chemical compound C=1C2=CC=CC=C2C=NC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC(F)=C1Cl CZNHDHIYKHYNRZ-UHFFFAOYSA-N 0.000 claims 1
- IXEOPCWHCZNSOL-UHFFFAOYSA-N 2-[(2-chloro-3-hydroxyphenyl)methylcarbamoyl-methylamino]ethyl n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC(O)=C1Cl IXEOPCWHCZNSOL-UHFFFAOYSA-N 0.000 claims 1
- SYSGMEGVUJPITH-UHFFFAOYSA-N 2-[(2-chloro-3-methoxyphenyl)methylcarbamoyl-methylamino]ethyl n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound COC1=CC=CC(CNC(=O)N(C)CCOC(=O)NC=2N=CC3=CC=C(F)C=C3C=2)=C1Cl SYSGMEGVUJPITH-UHFFFAOYSA-N 0.000 claims 1
- ZWVMYTLYDHJQQJ-UHFFFAOYSA-N 2-[(2-chloro-4-fluorophenyl)methylcarbamoyl-propan-2-ylamino]ethyl n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCN(C(C)C)C(=O)NCC1=CC=C(F)C=C1Cl ZWVMYTLYDHJQQJ-UHFFFAOYSA-N 0.000 claims 1
- ZWLPFXUISIYLBP-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-[2-[2-(methylamino)ethoxy]ethyl]amino]ethyl n-isoquinolin-3-ylcarbamate Chemical compound C=1C2=CC=CC=C2C=NC=1NC(=O)OCCN(CCOCCNC)C(=O)NCC1=CC=CC=C1Cl ZWLPFXUISIYLBP-UHFFFAOYSA-N 0.000 claims 1
- BSDSQHNXOUNOFO-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-(1,3-benzothiazol-2-yl)carbamate Chemical compound N=1C2=CC=CC=C2SC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC=C1Cl BSDSQHNXOUNOFO-UHFFFAOYSA-N 0.000 claims 1
- AOTAZZXZPBIYRK-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-(1,3-benzothiazol-6-yl)carbamate Chemical compound C=1C=C2N=CSC2=CC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC=C1Cl AOTAZZXZPBIYRK-UHFFFAOYSA-N 0.000 claims 1
- CCAHKADHVLDACM-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-(1-phenylpyrazol-3-yl)carbamate Chemical compound C=1C=CC=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC(=N1)C=CN1C1=CC=CC=C1 CCAHKADHVLDACM-UHFFFAOYSA-N 0.000 claims 1
- UFCSYLDSXDMCIX-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-(4,5-dimethylpyridin-2-yl)carbamate Chemical compound C=1C=CC=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=CC(C)=C(C)C=N1 UFCSYLDSXDMCIX-UHFFFAOYSA-N 0.000 claims 1
- JACDDCSEGQPKIZ-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-(4-methyl-1,3-benzothiazol-2-yl)carbamate Chemical compound N=1C2=C(C)C=CC=C2SC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC=C1Cl JACDDCSEGQPKIZ-UHFFFAOYSA-N 0.000 claims 1
- XTKDXRVHYHUSJV-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-(5-acetylpyridin-2-yl)carbamate Chemical compound C=1C=CC=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=CC=C(C(C)=O)C=N1 XTKDXRVHYHUSJV-UHFFFAOYSA-N 0.000 claims 1
- RUYSFGZOPLHFFD-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-(5-bromopyrazin-2-yl)carbamate Chemical compound C=1C=CC=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=CN=C(Br)C=N1 RUYSFGZOPLHFFD-UHFFFAOYSA-N 0.000 claims 1
- NMZNJOPWYFQSPO-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-(5-bromopyrimidin-2-yl)carbamate Chemical compound C=1C=CC=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=NC=C(Br)C=N1 NMZNJOPWYFQSPO-UHFFFAOYSA-N 0.000 claims 1
- IWYPQWOMLOSOLQ-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-(5-chloropyridin-2-yl)carbamate Chemical compound C=1C=CC=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=CC=C(Cl)C=N1 IWYPQWOMLOSOLQ-UHFFFAOYSA-N 0.000 claims 1
- ZUBOHQLVYOIWTE-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-(5-methylpyrazin-2-yl)carbamate Chemical compound C=1C=CC=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=CN=C(C)C=N1 ZUBOHQLVYOIWTE-UHFFFAOYSA-N 0.000 claims 1
- CQCSBLBTEKVHFH-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-(6-methyl-1,3-benzothiazol-2-yl)carbamate Chemical compound N=1C2=CC=C(C)C=C2SC=1NC(=O)OCCN(C)C(=O)NCC1=CC=CC=C1Cl CQCSBLBTEKVHFH-UHFFFAOYSA-N 0.000 claims 1
- TYZXRTQAFDLBGX-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-(6-methylpyridin-3-yl)carbamate Chemical compound C=1C=CC=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=CC=C(C)N=C1 TYZXRTQAFDLBGX-UHFFFAOYSA-N 0.000 claims 1
- FVVYHQQKJRFURB-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-[5-(2-hydroxyethyl)pyridin-2-yl]carbamate Chemical compound C=1C=CC=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=CC=C(CCO)C=N1 FVVYHQQKJRFURB-UHFFFAOYSA-N 0.000 claims 1
- SAOWFHFHEFXMAY-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-[5-(2-hydroxypropan-2-yl)pyridin-2-yl]carbamate Chemical compound C=1C=CC=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=CC=C(C(C)(C)O)C=N1 SAOWFHFHEFXMAY-UHFFFAOYSA-N 0.000 claims 1
- QQDLKSUPWDSHSA-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-[5-(hydroxymethyl)pyridin-2-yl]carbamate Chemical compound C=1C=CC=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=CC=C(CO)C=N1 QQDLKSUPWDSHSA-UHFFFAOYSA-N 0.000 claims 1
- UBEILMZSWSACTD-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]carbamate Chemical compound C=1C=CC=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=NN=C(C(F)(F)F)S1 UBEILMZSWSACTD-UHFFFAOYSA-N 0.000 claims 1
- OWNNXHSYYMNOIQ-UHFFFAOYSA-N 2-[(2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-[6-(trifluoromethyl)pyridin-3-yl]carbamate Chemical compound C=1C=CC=C(Cl)C=1CNC(=O)N(C)CCOC(=O)NC1=CC=C(C(F)(F)F)N=C1 OWNNXHSYYMNOIQ-UHFFFAOYSA-N 0.000 claims 1
- GOLMZVDRXLPEGZ-UHFFFAOYSA-N 2-[(5-bromo-2-chlorophenyl)methylcarbamoyl-methylamino]ethyl n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCN(C)C(=O)NCC1=CC(Br)=CC=C1Cl GOLMZVDRXLPEGZ-UHFFFAOYSA-N 0.000 claims 1
- CGBPJTZAJVOEON-UHFFFAOYSA-N 2-[(5-chloro-2-fluorophenyl)methylcarbamoyl-methylamino]ethyl n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCN(C)C(=O)NCC1=CC(Cl)=CC=C1F CGBPJTZAJVOEON-UHFFFAOYSA-N 0.000 claims 1
- JQMYCUOWRQPMPH-UHFFFAOYSA-N 2-[2-(2-aminoethoxy)ethyl-[(2-chlorophenyl)methylcarbamoyl]amino]ethyl n-isoquinolin-3-ylcarbamate Chemical compound C=1C2=CC=CC=C2C=NC=1NC(=O)OCCN(CCOCCN)C(=O)NCC1=CC=CC=C1Cl JQMYCUOWRQPMPH-UHFFFAOYSA-N 0.000 claims 1
- BCHWIDPEUDEBBM-UHFFFAOYSA-N 2-[[(2-chlorophenyl)methyl-methylcarbamoyl]-methylamino]ethyl n-isoquinolin-3-ylcarbamate Chemical compound C=1C2=CC=CC=C2C=NC=1NC(=O)OCCN(C)C(=O)N(C)CC1=CC=CC=C1Cl BCHWIDPEUDEBBM-UHFFFAOYSA-N 0.000 claims 1
- CXEWHLZCJXBRHL-LJQANCHMSA-N 2-[[(2R)-2-amino-3-hydroxypropyl]-[(2-chlorophenyl)methylcarbamoyl]amino]ethyl N-isoquinolin-3-ylcarbamate Chemical compound C=1C2=CC=CC=C2C=NC=1NC(=O)OCCN(C[C@H](CO)N)C(=O)NCC1=CC=CC=C1Cl CXEWHLZCJXBRHL-LJQANCHMSA-N 0.000 claims 1
- JNDVNIPVVSXACP-UHFFFAOYSA-N 2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]ethyl N-[1-(trifluoromethyl)isoquinolin-3-yl]carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)CCOC(=O)NC=1N=C(C2=CC=CC=C2C1)C(F)(F)F JNDVNIPVVSXACP-UHFFFAOYSA-N 0.000 claims 1
- QPQVTEGRYLVQGM-UHFFFAOYSA-N 2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]ethyl n-(6-bromoisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(Br)=CC=C2C=NC=1NC(=O)OCCN(C(=O)C)NCC1=CC=CC(F)=C1Cl QPQVTEGRYLVQGM-UHFFFAOYSA-N 0.000 claims 1
- MROZTJKFNSEYDT-UHFFFAOYSA-N 2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]ethyl n-(7-bromoisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC=C(Br)C=C2C=NC=1NC(=O)OCCN(C(=O)C)NCC1=CC=CC(F)=C1Cl MROZTJKFNSEYDT-UHFFFAOYSA-N 0.000 claims 1
- JCMNWIHKBZFPLB-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl N-(2,7-naphthyridin-3-yl)carbamate Chemical compound C=1C2=CC=NC=C2C=NC=1NC(=O)OCCN(C(=O)C)NCC1=CC=CC=C1Cl JCMNWIHKBZFPLB-UHFFFAOYSA-N 0.000 claims 1
- IPOHMPUJMOUBAG-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1)CNN(C(=O)C)CCOC(=O)NC=1SC2=C(N1)CCCC2 IPOHMPUJMOUBAG-UHFFFAOYSA-N 0.000 claims 1
- BGSAVRBJQHOUCU-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl N-(4-methylpyridin-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1)CNN(C(=O)C)CCOC(=O)NC1=NC=CC(=C1)C BGSAVRBJQHOUCU-UHFFFAOYSA-N 0.000 claims 1
- IBHSBZOFXCGNNV-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl N-(5-cyanopyridin-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1)CNN(C(=O)C)CCOC(=O)NC1=NC=C(C=C1)C#N IBHSBZOFXCGNNV-UHFFFAOYSA-N 0.000 claims 1
- ILAIHYMDTSBMQL-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl N-(5-ethenylpyridin-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1)CNN(C(=O)C)CCOC(=O)NC1=NC=C(C=C1)C=C ILAIHYMDTSBMQL-UHFFFAOYSA-N 0.000 claims 1
- UIZUJUNHBCQFRE-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl N-(5-methyl-1,3-thiazol-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1)CNN(C(=O)C)CCOC(=O)NC=1SC(=CN1)C UIZUJUNHBCQFRE-UHFFFAOYSA-N 0.000 claims 1
- ZABHUZHVZNDIHH-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl N-(5-methylpyridin-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1)CNN(C(=O)C)CCOC(=O)NC1=NC=C(C=C1)C ZABHUZHVZNDIHH-UHFFFAOYSA-N 0.000 claims 1
- AAXWNZIXHJYIGG-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl N-(6-methylsulfonyl-1,3-benzothiazol-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1)CNN(C(=O)C)CCOC(=O)NC=1SC2=C(N1)C=CC(=C2)S(=O)(=O)C AAXWNZIXHJYIGG-UHFFFAOYSA-N 0.000 claims 1
- RAQSOCQBDWZSBT-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl N-([1,3]thiazolo[5,4-b]pyridin-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1)CNN(C(=O)C)CCOC(=O)NC=1SC2=NC=CC=C2N1 RAQSOCQBDWZSBT-UHFFFAOYSA-N 0.000 claims 1
- PQRJTKYUAMGXBI-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1)CNN(C(=O)C)CCOC(=O)NC=1N=CC2=CC=CC=C2C1 PQRJTKYUAMGXBI-UHFFFAOYSA-N 0.000 claims 1
- SYEFEJQWRLNBOO-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl N-pyridin-2-ylcarbamate Chemical compound ClC1=C(C=CC=C1)CNN(C(=O)C)CCOC(=O)NC1=NC=CC=C1 SYEFEJQWRLNBOO-UHFFFAOYSA-N 0.000 claims 1
- XDAZMGXHTMRZAZ-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl N-quinoxalin-2-ylcarbamate Chemical compound ClC1=C(C=CC=C1)CNN(C(=O)C)CCOC(=O)NC1=NC2=CC=CC=C2N=C1 XDAZMGXHTMRZAZ-UHFFFAOYSA-N 0.000 claims 1
- DWSVXZFPAQNSNO-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl n-(4,5-dimethyl-1,3-thiazol-2-yl)carbamate Chemical compound C=1C=CC=C(Cl)C=1CNN(C(=O)C)CCOC(=O)NC1=NC(C)=C(C)S1 DWSVXZFPAQNSNO-UHFFFAOYSA-N 0.000 claims 1
- LRXFNFCEPWHJGJ-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl n-(5,6-dichloro-1,3-benzothiazol-2-yl)carbamate Chemical compound N=1C2=CC(Cl)=C(Cl)C=C2SC=1NC(=O)OCCN(C(=O)C)NCC1=CC=CC=C1Cl LRXFNFCEPWHJGJ-UHFFFAOYSA-N 0.000 claims 1
- CSYJJKHUAIXNNG-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl n-(5,6-difluoro-1,3-benzothiazol-2-yl)carbamate Chemical compound N=1C2=CC(F)=C(F)C=C2SC=1NC(=O)OCCN(C(=O)C)NCC1=CC=CC=C1Cl CSYJJKHUAIXNNG-UHFFFAOYSA-N 0.000 claims 1
- BVODPUOLBPZVHI-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl n-(5,6-dimethyl-1,3-benzothiazol-2-yl)carbamate Chemical compound N=1C2=CC(C)=C(C)C=C2SC=1NC(=O)OCCN(C(=O)C)NCC1=CC=CC=C1Cl BVODPUOLBPZVHI-UHFFFAOYSA-N 0.000 claims 1
- RGTOZODPNZJOBM-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl n-(5-bromopyridin-2-yl)carbamate Chemical compound C=1C=CC=C(Cl)C=1CNN(C(=O)C)CCOC(=O)NC1=CC=C(Br)C=N1 RGTOZODPNZJOBM-UHFFFAOYSA-N 0.000 claims 1
- DNNMTDMQPAUFRX-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl n-(5-ethylpyridin-2-yl)carbamate Chemical compound N1=CC(CC)=CC=C1NC(=O)OCCN(C(C)=O)NCC1=CC=CC=C1Cl DNNMTDMQPAUFRX-UHFFFAOYSA-N 0.000 claims 1
- UJFWHOZEPGZTMK-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl n-(5-phenyl-1,3,4-oxadiazol-2-yl)carbamate Chemical compound C=1C=CC=C(Cl)C=1CNN(C(=O)C)CCOC(=O)NC(O1)=NN=C1C1=CC=CC=C1 UJFWHOZEPGZTMK-UHFFFAOYSA-N 0.000 claims 1
- NVTFOYISZNYQGQ-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl n-(6-methoxy-1,3-benzothiazol-2-yl)carbamate Chemical compound S1C2=CC(OC)=CC=C2N=C1NC(=O)OCCN(C(C)=O)NCC1=CC=CC=C1Cl NVTFOYISZNYQGQ-UHFFFAOYSA-N 0.000 claims 1
- RRGXRSPQKJGJCE-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl n-[5-(trifluoromethyl)pyridin-2-yl]carbamate Chemical compound C=1C=CC=C(Cl)C=1CNN(C(=O)C)CCOC(=O)NC1=CC=C(C(F)(F)F)C=N1 RRGXRSPQKJGJCE-UHFFFAOYSA-N 0.000 claims 1
- KCOKGNZYUPVSOQ-UHFFFAOYSA-N 2-[acetyl-[(2-chlorophenyl)methylamino]amino]ethyl n-[6-(trifluoromethyl)-1,3-benzothiazol-2-yl]carbamate Chemical compound N=1C2=CC=C(C(F)(F)F)C=C2SC=1NC(=O)OCCN(C(=O)C)NCC1=CC=CC=C1Cl KCOKGNZYUPVSOQ-UHFFFAOYSA-N 0.000 claims 1
- GWQNUDJPKHTJQD-UHFFFAOYSA-N 2-[benzylcarbamoyl(methyl)amino]ethyl n-(5-ethylpyridin-2-yl)carbamate Chemical compound N1=CC(CC)=CC=C1NC(=O)OCCN(C)C(=O)NCC1=CC=CC=C1 GWQNUDJPKHTJQD-UHFFFAOYSA-N 0.000 claims 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims 1
- ULPUWBNARFWSSQ-UHFFFAOYSA-N 2-methylpentyl dihydrogen phosphate Chemical compound CCCC(C)COP(O)(O)=O ULPUWBNARFWSSQ-UHFFFAOYSA-N 0.000 claims 1
- DTBDAFLSBDGPEA-UHFFFAOYSA-N 3-Methylquinoline Natural products C1=CC=CC2=CC(C)=CN=C21 DTBDAFLSBDGPEA-UHFFFAOYSA-N 0.000 claims 1
- NPNCDCLUYRJANH-UHFFFAOYSA-N 3-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]butan-2-yl n-isoquinolin-3-ylcarbamate Chemical compound C=1C2=CC=CC=C2C=NC=1NC(=O)OC(C)C(C)N(C)C(=O)NCC1=CC=CC(F)=C1Cl NPNCDCLUYRJANH-UHFFFAOYSA-N 0.000 claims 1
- FYJUZWSEPGGAOS-UHFFFAOYSA-N 3-benzoylbenzamide Chemical compound NC(=O)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 FYJUZWSEPGGAOS-UHFFFAOYSA-N 0.000 claims 1
- FZAXBPZVVJOFKX-UHFFFAOYSA-N 3-methyl-1,2,4-oxadiazole Chemical compound CC=1N=CON=1 FZAXBPZVVJOFKX-UHFFFAOYSA-N 0.000 claims 1
- ZBRDJMFLJXFIGJ-UHFFFAOYSA-N 3-phenyl-1,2-oxazole Chemical compound O1C=CC(C=2C=CC=CC=2)=N1 ZBRDJMFLJXFIGJ-UHFFFAOYSA-N 0.000 claims 1
- JLAKCHGEEBPDQI-UHFFFAOYSA-N 4-(4-fluorobenzyl)piperidine Chemical compound C1=CC(F)=CC=C1CC1CCNCC1 JLAKCHGEEBPDQI-UHFFFAOYSA-N 0.000 claims 1
- JQRDUBYISJYKBW-QHCPKHFHSA-N 4-[(5s)-5-[acetyl-[(2,3-difluorophenyl)methylamino]amino]-6-(isoquinolin-3-ylcarbamoyloxy)hexoxy]-4-oxobutanoic acid Chemical compound CC(=O)N([C@@H](CCCCOC(=O)CCC(O)=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC(F)=C1F JQRDUBYISJYKBW-QHCPKHFHSA-N 0.000 claims 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- PWFLAHNAMVDOQT-UHFFFAOYSA-N 6,8-dihydro-5h-imidazo[1,5-a]pyrazine-7-carboxylic acid Chemical compound C1N(C(=O)O)CCN2C=NC=C21 PWFLAHNAMVDOQT-UHFFFAOYSA-N 0.000 claims 1
- 208000030644 Esophageal Motility disease Diseases 0.000 claims 1
- 241001024304 Mino Species 0.000 claims 1
- 239000004727 Noryl Substances 0.000 claims 1
- 229920001207 Noryl Polymers 0.000 claims 1
- 208000014934 Oesophageal motility disease Diseases 0.000 claims 1
- LIEXWVDNCVCNAK-WOJBJXKFSA-N [(2R)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-[(4R)-2-oxo-1,3-dioxolan-4-yl]propyl] N-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound O=C1OC[C@H](O1)C[C@H](COC(=O)NC=1N=CC2=CC=C(C=C2C1)F)N(C(=O)C)NCC1=C(C(=CC=C1)F)Cl LIEXWVDNCVCNAK-WOJBJXKFSA-N 0.000 claims 1
- QNHVVKICMVUVOS-HSZRJFAPSA-N [(2R)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-oxo-5-piperazin-1-ylpentyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)CCC(N1CCNCC1)=O QNHVVKICMVUVOS-HSZRJFAPSA-N 0.000 claims 1
- WUJONBMBDGEVKC-WOJBJXKFSA-N [(2R,4R)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4,5-dihydroxypentyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)C[C@H](CO)O WUJONBMBDGEVKC-WOJBJXKFSA-N 0.000 claims 1
- MJWNPJADQKOYEX-IBGZPJMESA-N [(2S)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,4-difluoro-5-isocyanatopentyl] N-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNC(=O)N(C)[C@@H](CC(CN=C=O)(F)F)COC(NC=1N=CC2=CC=C(C=C2C=1)F)=O MJWNPJADQKOYEX-IBGZPJMESA-N 0.000 claims 1
- DVHIZTWVDZBSSB-QFIPXVFZSA-N [(2S)-2-[acetyl-[(2,3-difluorophenyl)methylamino]amino]-4-oxo-4-piperazin-1-ylbutyl] N-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound FC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=C(C=C2C1)F)CC(N1CCNCC1)=O DVHIZTWVDZBSSB-QFIPXVFZSA-N 0.000 claims 1
- ACKBWIKQKXBRMZ-QFIPXVFZSA-N [(2S)-2-[acetyl-[(2,3-difluorophenyl)methylamino]amino]-4-oxo-4-piperazin-1-ylbutyl] N-isoquinolin-3-ylcarbamate Chemical compound FC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC(N1CCNCC1)=O ACKBWIKQKXBRMZ-QFIPXVFZSA-N 0.000 claims 1
- GRCPZCPJLWJTIB-QFIPXVFZSA-N [(2S)-2-[acetyl-[(2,3-difluorophenyl)methylamino]amino]-5-oxo-5-piperazin-1-ylpentyl] N-(3-phenyl-1,2-oxazol-5-yl)carbamate Chemical compound FC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC1=CC(=NO1)C1=CC=CC=C1)CCC(N1CCNCC1)=O GRCPZCPJLWJTIB-QFIPXVFZSA-N 0.000 claims 1
- RBTYAHJPVMRMDJ-NRFANRHFSA-N [(2S)-2-[acetyl-[(2,3-difluorophenyl)methylamino]amino]-6-hydroxyhexyl] N-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound FC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=C(C=C2C1)F)CCCCO RBTYAHJPVMRMDJ-NRFANRHFSA-N 0.000 claims 1
- MFHNHXGTAAARLF-QFIPXVFZSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-(1-methylimidazol-4-yl)propyl] N-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=C(C=C2C1)F)CC=1N=CN(C1)C MFHNHXGTAAARLF-QFIPXVFZSA-N 0.000 claims 1
- NLHYBUWVSPNJIB-IBGZPJMESA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-(2,2,2-trifluoroethylamino)propyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)CNCC(F)(F)F NLHYBUWVSPNJIB-IBGZPJMESA-N 0.000 claims 1
- XXSGOQATBGMCSA-FQEVSTJZSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-(2-fluoroethylamino)propyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)CNCCF XXSGOQATBGMCSA-FQEVSTJZSA-N 0.000 claims 1
- UESZZPMVDWUWSO-FQEVSTJZSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-(2-hydroxyethylamino)propyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)CNCCO UESZZPMVDWUWSO-FQEVSTJZSA-N 0.000 claims 1
- JMGOXNADEVCJDS-NRFANRHFSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-[(2-hydroxy-2-methylpropyl)amino]propyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)CNCC(C)(C)O JMGOXNADEVCJDS-NRFANRHFSA-N 0.000 claims 1
- PHMYILWCAYIFRF-KRWDZBQOSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-aminopropyl] N-(5-phenyl-1,2-oxazol-3-yl)carbamate Chemical compound NC[C@@H](COC(=O)NC1=NOC(=C1)C1=CC=CC=C1)N(C(=O)C)NCC1=C(C(=CC=C1)F)Cl PHMYILWCAYIFRF-KRWDZBQOSA-N 0.000 claims 1
- IROGWHDRXMQNPU-FQEVSTJZSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4,4-difluoro-5-hydroxy-5-methylhexyl] N-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=C(C=C2C1)F)CC(C(C)(C)O)(F)F IROGWHDRXMQNPU-FQEVSTJZSA-N 0.000 claims 1
- DDHMQNOGYUZPSA-IBGZPJMESA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-aminobutyl] N-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound NCC[C@@H](COC(=O)NC=1N=CC2=CC=C(C=C2C1)F)N(C(=O)C)NCC1=C(C(=CC=C1)F)Cl DDHMQNOGYUZPSA-IBGZPJMESA-N 0.000 claims 1
- GCOJLUYIYYULQR-SFHVURJKSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-hydroxy-4-methylpentyl] N-(5-fluoroisoquinolin-3-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC(=C2C1)F)CC(C)(C)O GCOJLUYIYYULQR-SFHVURJKSA-N 0.000 claims 1
- FOHCSOSWYQKOOM-FQEVSTJZSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-hydroxy-4-methylpentyl] N-(7-fluoroisoquinolin-3-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC(=CC=C2C1)F)CC(C)(C)O FOHCSOSWYQKOOM-FQEVSTJZSA-N 0.000 claims 1
- IAJBSNBKGBOYAJ-QFIPXVFZSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-oxo-4-piperazin-1-ylbutyl] N-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=C(C=C2C1)F)CC(N1CCNCC1)=O IAJBSNBKGBOYAJ-QFIPXVFZSA-N 0.000 claims 1
- UBZITVFUAZZSSO-QFIPXVFZSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-(2-hydroxyethylcarbamoylamino)pentyl] N-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CCCNC(=O)NCCO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl UBZITVFUAZZSSO-QFIPXVFZSA-N 0.000 claims 1
- YAYUKKZWZHHBOS-DEOSSOPVSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-(3,3-dimethylpiperazin-1-yl)-5-oxopentyl] N-isoquinolin-3-ylcarbamate Chemical compound CC1(CN(CCN1)C(CC[C@@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)N(C(=O)C)NCC1=C(C(=CC=C1)F)Cl)=O)C YAYUKKZWZHHBOS-DEOSSOPVSA-N 0.000 claims 1
- QFGOCCNJVZVATI-SANMLTNESA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-(4-cyclopropylpiperazin-1-yl)-5-oxopentyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)CCC(=O)N1CCN(CC1)C1CC1 QFGOCCNJVZVATI-SANMLTNESA-N 0.000 claims 1
- NVGRIEPXZLHPSP-QHCPKHFHSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-(6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)-5-oxopentyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)CCC(N1CC=2N(CC1)C=NN2)=O NVGRIEPXZLHPSP-QHCPKHFHSA-N 0.000 claims 1
- QNNMTZMKOJIWBU-DVECYGJZSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[(2R)-2-methylpiperazin-1-yl]-5-oxopentyl] N-isoquinolin-3-ylcarbamate Chemical compound C[C@@H]1CNCCN1C(=O)CC[C@H](N(NCC=1C(=C(F)C=CC=1)Cl)C(C)=O)COC(=O)NC1=CC2=CC=CC=C2C=N1 QNNMTZMKOJIWBU-DVECYGJZSA-N 0.000 claims 1
- QNNMTZMKOJIWBU-CYFREDJKSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[(2S)-2-methylpiperazin-1-yl]-5-oxopentyl] N-isoquinolin-3-ylcarbamate Chemical compound C[C@@H]1N(CCNC1)C(CC[C@@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)N(C(=O)C)NCC1=C(C(=CC=C1)F)Cl)=O QNNMTZMKOJIWBU-CYFREDJKSA-N 0.000 claims 1
- ULUQHAMEOHXUCG-DVECYGJZSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[(3R)-3-methylpiperazin-1-yl]-5-oxopentyl] N-isoquinolin-3-ylcarbamate Chemical compound C[C@@H]1CN(CCN1)C(CC[C@@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)N(C(=O)C)NCC1=C(C(=CC=C1)F)Cl)=O ULUQHAMEOHXUCG-DVECYGJZSA-N 0.000 claims 1
- BKAQVTLKTHGTQD-DFIYOIEZSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5-oxopentyl] N-isoquinolin-3-ylcarbamate Chemical compound C[C@H]1CN(C[C@H](N1)C)C(CC[C@@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)N(C(=O)C)NCC1=C(C(=CC=C1)F)Cl)=O BKAQVTLKTHGTQD-DFIYOIEZSA-N 0.000 claims 1
- ADDHBBGNZUQSJN-VWLOTQADSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[4-(2-hydroxyethyl)piperazin-1-yl]-5-oxopentyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)CCC(=O)N1CCN(CC1)CCO ADDHBBGNZUQSJN-VWLOTQADSA-N 0.000 claims 1
- BNPAOHJNWPHWRJ-FQEVSTJZSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-hydrazinylpentyl] N-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CCCNN)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl BNPAOHJNWPHWRJ-FQEVSTJZSA-N 0.000 claims 1
- HRISXMXRUMHXPF-NRFANRHFSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-hydroxy-4,4-dimethylpentyl] N-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=C(C=C2C1)F)CC(CO)(C)C HRISXMXRUMHXPF-NRFANRHFSA-N 0.000 claims 1
- KKACBKDSHAWVPA-NRFANRHFSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-hydroxy-4,4-dimethylpentyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)CC(CO)(C)C KKACBKDSHAWVPA-NRFANRHFSA-N 0.000 claims 1
- VYGLLGCOLIUZQD-VWLOTQADSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-oxo-5-(4-propan-2-ylpiperazin-1-yl)pentyl] N-(3-phenyl-1,2-oxazol-5-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC1=CC(=NO1)C1=CC=CC=C1)CCC(=O)N1CCN(CC1)C(C)C VYGLLGCOLIUZQD-VWLOTQADSA-N 0.000 claims 1
- QQLVFYQLTWMAJU-VWLOTQADSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-oxo-5-(4-propan-2-ylpiperazin-1-yl)pentyl] N-(5-phenyl-1,2-oxazol-3-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC1=NOC(=C1)C1=CC=CC=C1)CCC(=O)N1CCN(CC1)C(C)C QQLVFYQLTWMAJU-VWLOTQADSA-N 0.000 claims 1
- SINNIMHCRVOPLY-VWLOTQADSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-oxo-5-(4-propan-2-ylpiperazin-1-yl)pentyl] N-[3-(3-fluorophenyl)-1,2-oxazol-5-yl]carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC1=CC(=NO1)C1=CC(=CC=C1)F)CCC(=O)N1CCN(CC1)C(C)C SINNIMHCRVOPLY-VWLOTQADSA-N 0.000 claims 1
- AWWUMJKMFVMAMC-SANMLTNESA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-oxo-5-(4-propan-2-ylpiperazin-1-yl)pentyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)CCC(=O)N1CCN(CC1)C(C)C AWWUMJKMFVMAMC-SANMLTNESA-N 0.000 claims 1
- ICDWVTCJYMLLJC-INIZCTEOSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]pent-4-enyl] N-(5-chloropyridin-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC1=NC=C(C=C1)Cl)CC=C ICDWVTCJYMLLJC-INIZCTEOSA-N 0.000 claims 1
- QYZLTONMERJURR-FQEVSTJZSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]pent-4-enyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)CC=C QYZLTONMERJURR-FQEVSTJZSA-N 0.000 claims 1
- URKPWFMYRUPPDS-IBGZPJMESA-N [(2S)-2-[acetyl-[(2-chloro-4-fluorophenyl)methylamino]amino]-4-hydroxy-4-methylpentyl] N-(5-fluoroisoquinolin-3-yl)carbamate Chemical compound ClC1=C(C=CC(=C1)F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC(=C2C1)F)CC(C)(C)O URKPWFMYRUPPDS-IBGZPJMESA-N 0.000 claims 1
- NTSAOCFTVFLANP-JOCHJYFZSA-N [(2S)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]-3-methylbutyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)C(C)C NTSAOCFTVFLANP-JOCHJYFZSA-N 0.000 claims 1
- YWGLYMABEOVCCH-IBGZPJMESA-N [(2S)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]-4-hydroxy-4-methylpentyl] N-(5-fluoroisoquinolin-3-yl)carbamate Chemical compound ClC1=C(C=CC=C1)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC(=C2C1)F)CC(C)(C)O YWGLYMABEOVCCH-IBGZPJMESA-N 0.000 claims 1
- KNNHWWREMUPKAF-IBGZPJMESA-N [(2S)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]-4-methylpentyl] N-(6-methyl-1,3-benzothiazol-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1)CNN(C(=O)C)[C@H](COC(=O)NC=1SC2=C(N1)C=CC(=C2)C)CC(C)C KNNHWWREMUPKAF-IBGZPJMESA-N 0.000 claims 1
- ZJNJARNMTRCKJF-NRFANRHFSA-N [(2S)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]-5-aminopentyl] N-isoquinolin-3-ylcarbamate Chemical compound NCCC[C@@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)N(C(=O)C)NCC1=C(C=CC=C1)Cl ZJNJARNMTRCKJF-NRFANRHFSA-N 0.000 claims 1
- FVAZQWFNOJTCPG-QFIPXVFZSA-N [(2S)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]-6-[(2-diazo-3,3,3-trifluoropropanoyl)amino]hexyl] N-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N(NCc1ccccc1Cl)[C@@H](CCCCNC(=O)C(=[N+]=[N-])C(F)(F)F)COC(=O)Nc1cc2ccccc2cn1 FVAZQWFNOJTCPG-QFIPXVFZSA-N 0.000 claims 1
- AULLRWXPLFNIFH-FQEVSTJZSA-N [(2S)-2-[acetyl-[(3-fluorophenyl)methylamino]amino]-3-aminopropyl] N-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CN)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1 AULLRWXPLFNIFH-FQEVSTJZSA-N 0.000 claims 1
- NYQPTBDDQQHCOR-HMTLIYDFSA-N [(2S)-2-[acetyl-[(3-fluorophenyl)methylamino]amino]-4,5-dihydroxypentyl] N-isoquinolin-3-ylcarbamate Chemical compound FC=1C=C(C=CC1)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)CC(CO)O NYQPTBDDQQHCOR-HMTLIYDFSA-N 0.000 claims 1
- LWXZREGKVGWIJG-JKSUJKDBSA-N [(2S,4R)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4,5-dihydroxypentyl] N-(1,3-benzothiazol-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1SC2=C(N1)C=CC=C2)C[C@H](CO)O LWXZREGKVGWIJG-JKSUJKDBSA-N 0.000 claims 1
- ZVROFHCWQAMMLR-UONOGXRCSA-N [(2S,4R)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4,5-dihydroxypentyl] N-(5,6-difluoro-1,3-benzothiazol-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1SC2=C(N1)C=C(C(=C2)F)F)C[C@H](CO)O ZVROFHCWQAMMLR-UONOGXRCSA-N 0.000 claims 1
- NLFKCIXQJKSWAW-ZWKOTPCHSA-N [(2S,4R)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4,5-dihydroxypentyl] N-(5,6-dimethyl-1,3-benzothiazol-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1SC2=C(N1)C=C(C(=C2)C)C)C[C@H](CO)O NLFKCIXQJKSWAW-ZWKOTPCHSA-N 0.000 claims 1
- DNGGBLXHIFARSQ-JKSUJKDBSA-N [(2S,4R)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4,5-dihydroxypentyl] N-(6-fluoro-1,3-benzothiazol-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1SC2=C(N1)C=CC(=C2)F)C[C@H](CO)O DNGGBLXHIFARSQ-JKSUJKDBSA-N 0.000 claims 1
- OWWSZDYBDFFHEK-DLBZAZTESA-N [(2S,4R)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4,5-dihydroxypentyl] N-(6-methyl-1,3-benzothiazol-2-yl)carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1SC2=C(N1)C=CC(=C2)C)C[C@H](CO)O OWWSZDYBDFFHEK-DLBZAZTESA-N 0.000 claims 1
- KTCPZIDFBSASSE-LJQANCHMSA-N [(2r)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-5-hydroxypentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](CCCO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1F KTCPZIDFBSASSE-LJQANCHMSA-N 0.000 claims 1
- LMGWOYLAYVVJGR-OAHLLOKOSA-N [(2r)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]propyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)C)NCC1=CC=CC=C1Cl LMGWOYLAYVVJGR-OAHLLOKOSA-N 0.000 claims 1
- VQGVPNKQIIOIOO-WOJBJXKFSA-N [(2r,4r)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-hydroxy-5-phosphonooxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C[C@@H](O)COP(O)(O)=O)NCC1=CC=CC(F)=C1Cl VQGVPNKQIIOIOO-WOJBJXKFSA-N 0.000 claims 1
- OLYRUYIFLZDDBM-DNQXCXABSA-N [(2r,4r)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-diethoxyphosphoryloxy-4-hydroxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C[C@@H](O)COP(=O)(OCC)OCC)NCC1=CC=CC(F)=C1Cl OLYRUYIFLZDDBM-DNQXCXABSA-N 0.000 claims 1
- VQGVPNKQIIOIOO-UXHICEINSA-N [(2r,4s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-hydroxy-5-phosphonooxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C[C@H](O)COP(O)(O)=O)NCC1=CC=CC(F)=C1Cl VQGVPNKQIIOIOO-UXHICEINSA-N 0.000 claims 1
- OLYRUYIFLZDDBM-RPWUZVMVSA-N [(2r,4s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-diethoxyphosphoryloxy-4-hydroxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C[C@H](O)COP(=O)(OCC)OCC)NCC1=CC=CC(F)=C1Cl OLYRUYIFLZDDBM-RPWUZVMVSA-N 0.000 claims 1
- YCYCIIZNBZOQLM-NRFANRHFSA-N [(2s)-2-[(2,3-dichlorophenyl)methylcarbamoyl-methylamino]-6-hydroxy-6-methylheptyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCC(C)(C)O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(Cl)=C1Cl YCYCIIZNBZOQLM-NRFANRHFSA-N 0.000 claims 1
- YUXNFSUBCOIOGR-FQEVSTJZSA-N [(2s)-2-[(2,3-dichlorophenyl)methylcarbamoyl-methylamino]-6-hydroxyhexyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCCO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(Cl)=C1Cl YUXNFSUBCOIOGR-FQEVSTJZSA-N 0.000 claims 1
- ITMFPKQIICKDME-PMACEKPBSA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-3-[(2s)-2,3-dihydroxypropoxy]propyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](COC[C@@H](O)CO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1F ITMFPKQIICKDME-PMACEKPBSA-N 0.000 claims 1
- YYXFPQKDUGLWEV-VQTJNVASSA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-3-[(4r)-2,2-dimethyl-1,3-dioxolan-4-yl]propyl] n-(5-phenyl-1,2-oxazol-3-yl)carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)F)C[C@H]1OC(C)(C)OC1)OC(=O)NC(=NO1)C=C1C1=CC=CC=C1 YYXFPQKDUGLWEV-VQTJNVASSA-N 0.000 claims 1
- ROTUDUXNMAFJHG-LEWJYISDSA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-3-[(4r)-2,2-dimethyl-1,3-dioxolan-4-yl]propyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)N(C)C(=O)NCC=1C(=C(F)C=CC=1)F)[C@@H]1COC(C)(C)O1 ROTUDUXNMAFJHG-LEWJYISDSA-N 0.000 claims 1
- POQOKRRETJRPHT-OYKVQYDMSA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC(O)CO)C(=O)NCC1=CC=CC(F)=C1F POQOKRRETJRPHT-OYKVQYDMSA-N 0.000 claims 1
- LCJNNTQWQOIDPX-IBGZPJMESA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-5-hydroxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1F LCJNNTQWQOIDPX-IBGZPJMESA-N 0.000 claims 1
- ULPSRCNZMUWRSA-QFIPXVFZSA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-5-oxo-5-piperazin-1-ylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)F)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(=O)N1CCNCC1 ULPSRCNZMUWRSA-QFIPXVFZSA-N 0.000 claims 1
- GPXLZGYBJVSMSO-NRFANRHFSA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-6-hydroxy-6-methylheptyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCC(C)(C)O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1F GPXLZGYBJVSMSO-NRFANRHFSA-N 0.000 claims 1
- XBRMGMITPOXTQD-IBGZPJMESA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-6-hydroxyhexyl] n-(5-phenyl-1,2-oxazol-3-yl)carbamate Chemical compound C([C@H](CCCCO)N(C)C(=O)NCC=1C(=C(F)C=CC=1)F)OC(=O)NC(=NO1)C=C1C1=CC=CC=C1 XBRMGMITPOXTQD-IBGZPJMESA-N 0.000 claims 1
- DVDJXFLTWGTZON-IBGZPJMESA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-6-hydroxyhexyl] n-[3-(4-bromophenyl)-1,2-oxazol-5-yl]carbamate Chemical compound C([C@H](CCCCO)N(C)C(=O)NCC=1C(=C(F)C=CC=1)F)OC(=O)NC(ON=1)=CC=1C1=CC=C(Br)C=C1 DVDJXFLTWGTZON-IBGZPJMESA-N 0.000 claims 1
- RRLIVPZHHZKSDI-FQEVSTJZSA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-6-hydroxyhexyl] n-[3-(4-cyanophenyl)-1,2-oxazol-5-yl]carbamate Chemical compound C([C@H](CCCCO)N(C)C(=O)NCC=1C(=C(F)C=CC=1)F)OC(=O)NC(ON=1)=CC=1C1=CC=C(C#N)C=C1 RRLIVPZHHZKSDI-FQEVSTJZSA-N 0.000 claims 1
- OYYQWXXFQQNIMO-IBGZPJMESA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-6-hydroxyhexyl] n-[5-(3-chlorophenyl)-1,2-oxazol-3-yl]carbamate Chemical compound C([C@H](CCCCO)N(C)C(=O)NCC=1C(=C(F)C=CC=1)F)OC(=O)NC(=NO1)C=C1C1=CC=CC(Cl)=C1 OYYQWXXFQQNIMO-IBGZPJMESA-N 0.000 claims 1
- ZPYQHRVQJCOZIH-IBGZPJMESA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-6-hydroxyhexyl] n-[5-(3-fluorophenyl)-1,2-oxazol-3-yl]carbamate Chemical compound C([C@H](CCCCO)N(C)C(=O)NCC=1C(=C(F)C=CC=1)F)OC(=O)NC(=NO1)C=C1C1=CC=CC(F)=C1 ZPYQHRVQJCOZIH-IBGZPJMESA-N 0.000 claims 1
- CJMBYNKZUOOONJ-IBGZPJMESA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-6-hydroxyhexyl] n-[5-(4-chlorophenyl)-1,2-oxazol-3-yl]carbamate Chemical compound C([C@H](CCCCO)N(C)C(=O)NCC=1C(=C(F)C=CC=1)F)OC(=O)NC(=NO1)C=C1C1=CC=C(Cl)C=C1 CJMBYNKZUOOONJ-IBGZPJMESA-N 0.000 claims 1
- PGDPLACMERQPQJ-QFIPXVFZSA-N [(2s)-2-[(2,4-dichlorophenyl)methylcarbamoyl-methylamino]-6-hydroxy-6-methylheptyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCC(C)(C)O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=C(Cl)C=C1Cl PGDPLACMERQPQJ-QFIPXVFZSA-N 0.000 claims 1
- GFAOIMMEHCZTKE-QFIPXVFZSA-N [(2s)-2-[(2,4-difluorophenyl)methylcarbamoyl-methylamino]-6-hydroxy-6-methylheptyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCC(C)(C)O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=C(F)C=C1F GFAOIMMEHCZTKE-QFIPXVFZSA-N 0.000 claims 1
- NKTNDADUYGKAKC-IBGZPJMESA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-(2-hydroxyethoxy)propyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](COCCO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl NKTNDADUYGKAKC-IBGZPJMESA-N 0.000 claims 1
- VCVHGVHSGAUBOA-NRFANRHFSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-(3-hydroxy-2,2-dimethylpropoxy)propyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](COCC(C)(C)CO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl VCVHGVHSGAUBOA-NRFANRHFSA-N 0.000 claims 1
- DZRZWOFSMMKYRO-IBGZPJMESA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-(dimethylamino)propyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CN(C)C)C(=O)NCC1=CC=CC(F)=C1Cl DZRZWOFSMMKYRO-IBGZPJMESA-N 0.000 claims 1
- CGQVJQDUUJPIEZ-VQTJNVASSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-[(2r)-2,3-dihydroxypropoxy]propyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](COC[C@H](O)CO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl CGQVJQDUUJPIEZ-VQTJNVASSA-N 0.000 claims 1
- MVHHEGWRUILCBP-PMACEKPBSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-[(2s)-2,3-dihydroxypropoxy]propyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](COC[C@@H](O)CO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl MVHHEGWRUILCBP-PMACEKPBSA-N 0.000 claims 1
- GNRHMRNHRBPFGW-RBUKOAKNSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-[(4r)-2,2-dimethyl-1,3-dioxolan-4-yl]propyl] n-(5-phenyl-1,2,4-oxadiazol-3-yl)carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)C[C@H]1OC(C)(C)OC1)OC(=O)NC(N=1)=NOC=1C1=CC=CC=C1 GNRHMRNHRBPFGW-RBUKOAKNSA-N 0.000 claims 1
- UQXMXVDOEAAZLT-VQTJNVASSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-[(4r)-2,2-dimethyl-1,3-dioxolan-4-yl]propyl] n-(5-phenyl-1,2-oxazol-3-yl)carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)C[C@H]1OC(C)(C)OC1)OC(=O)NC(=NO1)C=C1C1=CC=CC=C1 UQXMXVDOEAAZLT-VQTJNVASSA-N 0.000 claims 1
- XUHDGKBQWCCCQO-VQTJNVASSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-[(4r)-2,2-dimethyl-1,3-dioxolan-4-yl]propyl] n-[5-(3-chlorophenyl)-1,2-oxazol-3-yl]carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)C[C@H]1OC(C)(C)OC1)OC(=O)NC(=NO1)C=C1C1=CC=CC(Cl)=C1 XUHDGKBQWCCCQO-VQTJNVASSA-N 0.000 claims 1
- BOHKVJPARDAZPJ-VQTJNVASSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-[(4r)-2,2-dimethyl-1,3-dioxolan-4-yl]propyl] n-[5-(3-fluorophenyl)-1,2-oxazol-3-yl]carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)C[C@H]1OC(C)(C)OC1)OC(=O)NC(=NO1)C=C1C1=CC=CC(F)=C1 BOHKVJPARDAZPJ-VQTJNVASSA-N 0.000 claims 1
- FUKHYSYRJPMDPD-KRWDZBQOSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,4-difluoro-5-hydroxypentyl] n-(3-phenyl-1,2-oxazol-5-yl)carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)CC(F)(F)CO)OC(=O)NC(ON=1)=CC=1C1=CC=CC=C1 FUKHYSYRJPMDPD-KRWDZBQOSA-N 0.000 claims 1
- CCFSPBBCRNQIMU-SFHVURJKSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,4-difluoro-5-hydroxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(F)(F)CO)C(=O)NCC1=CC=CC(F)=C1Cl CCFSPBBCRNQIMU-SFHVURJKSA-N 0.000 claims 1
- FZPCPVGNAOGFPU-KRWDZBQOSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,4-difluoro-5-hydroxypentyl] n-[3-(3-fluorophenyl)-1,2-oxazol-5-yl]carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)CC(F)(F)CO)OC(=O)NC(ON=1)=CC=1C1=CC=CC(F)=C1 FZPCPVGNAOGFPU-KRWDZBQOSA-N 0.000 claims 1
- IMQKIJZHEAIZSK-KRWDZBQOSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,4-difluoro-5-hydroxypentyl] n-[5-(3-fluorophenyl)-1,2-oxazol-3-yl]carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)CC(F)(F)CO)OC(=O)NC(=NO1)C=C1C1=CC=CC(F)=C1 IMQKIJZHEAIZSK-KRWDZBQOSA-N 0.000 claims 1
- KOMVGXUBOGVICD-ZENAZSQFSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-(2,6-naphthyridin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=NC=C2C=1)CC(O)CO)C(=O)NCC1=CC=CC(F)=C1Cl KOMVGXUBOGVICD-ZENAZSQFSA-N 0.000 claims 1
- UBSNYCLTNCGHFC-QFIPXVFZSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyrazin-3-yl)butyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCC=1N2CCNCC2=CN=1)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl UBSNYCLTNCGHFC-QFIPXVFZSA-N 0.000 claims 1
- JPYFWTXKCQSTGK-ZDUSSCGKSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4-hydroxy-4-methylpentyl] n-(5,6-difluoro-1,3-benzothiazol-2-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1SC2=CC(F)=C(F)C=C2N=1)CC(C)(C)O)C(=O)NCC1=CC=CC(F)=C1Cl JPYFWTXKCQSTGK-ZDUSSCGKSA-N 0.000 claims 1
- MLYFDCNFWJSNHO-IBGZPJMESA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4-hydroxy-4-methylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(C)(C)O)C(=O)NCC1=CC=CC(F)=C1Cl MLYFDCNFWJSNHO-IBGZPJMESA-N 0.000 claims 1
- JZFWQSNJUHWHRI-SFHVURJKSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4-hydroxy-4-methylpentyl] n-[5-(3-fluorophenyl)-1,2-oxazol-3-yl]carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)CC(C)(C)O)OC(=O)NC(=NO1)C=C1C1=CC=CC(F)=C1 JZFWQSNJUHWHRI-SFHVURJKSA-N 0.000 claims 1
- FKTWDPKMRWNNOJ-IBGZPJMESA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4-hydroxy-4-methylpentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC(C)(C)O)C(=O)NCC1=CC=CC(F)=C1Cl FKTWDPKMRWNNOJ-IBGZPJMESA-N 0.000 claims 1
- AQRAUVGSILPNCZ-QHCPKHFHSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(1,3-dioxoisoindol-2-yl)pentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCN1C(C2=CC=CC=C2C1=O)=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl AQRAUVGSILPNCZ-QHCPKHFHSA-N 0.000 claims 1
- XHRKJXVXSVLHNJ-FQEVSTJZSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(2,2,2-trifluoroethylamino)pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCNCC(F)(F)F)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl XHRKJXVXSVLHNJ-FQEVSTJZSA-N 0.000 claims 1
- MMPPBVVHSMDLSZ-FQEVSTJZSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(2,2-difluoroethylamino)pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCNCC(F)F)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl MMPPBVVHSMDLSZ-FQEVSTJZSA-N 0.000 claims 1
- LCBCYNNSCKPZOX-NRFANRHFSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(2-fluoroethylamino)pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCNCCF)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl LCBCYNNSCKPZOX-NRFANRHFSA-N 0.000 claims 1
- IMMXOUCDBPOSTM-NRFANRHFSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(3,3-difluoroazetidin-1-yl)pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CCN1CC(F)(F)C1 IMMXOUCDBPOSTM-NRFANRHFSA-N 0.000 claims 1
- HQBNHMNYQYUNEH-QFIPXVFZSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(3,3-difluoropyrrolidin-1-yl)pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CCN1CCC(F)(F)C1 HQBNHMNYQYUNEH-QFIPXVFZSA-N 0.000 claims 1
- YDVZMJLGPWFTTL-CGAIIQECSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(3-fluoropiperidin-1-yl)pentyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCN1CCCC(F)C1 YDVZMJLGPWFTTL-CGAIIQECSA-N 0.000 claims 1
- PTXMCBHZMJHARD-QHCPKHFHSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(6,8-dihydro-5h-[1,2,4]triazolo[1,5-a]pyrazin-7-yl)pentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCN1CC2=NC=NN2CC1)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl PTXMCBHZMJHARD-QHCPKHFHSA-N 0.000 claims 1
- ZKQVEEVNWDHTIK-IBGZPJMESA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(diaminomethylideneamino)pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCNC(N)=N)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl ZKQVEEVNWDHTIK-IBGZPJMESA-N 0.000 claims 1
- WHWALWOYRJAQAB-NRFANRHFSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(dimethylsulfamoylamino)pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CCCNS(=O)(=O)N(C)C)C(=O)NCC1=CC=CC(F)=C1Cl WHWALWOYRJAQAB-NRFANRHFSA-N 0.000 claims 1
- VSWNYWCCTKMEEP-IBGZPJMESA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(sulfamoylamino)pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCNS(N)(=O)=O)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl VSWNYWCCTKMEEP-IBGZPJMESA-N 0.000 claims 1
- JVACUXXCYZLVAN-QFIPXVFZSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-[(2-hydroxy-2-methylpropyl)amino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCNCC(C)(C)O)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl JVACUXXCYZLVAN-QFIPXVFZSA-N 0.000 claims 1
- LMPDNXCGJHWHIJ-GOTSBHOMSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-[(3s)-3-(hydroxymethyl)piperazin-1-yl]-5-oxopentyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC(=O)N1CCN[C@H](CO)C1 LMPDNXCGJHWHIJ-GOTSBHOMSA-N 0.000 claims 1
- QIUZZHNTDVFWAN-NRFANRHFSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-[(n-cyano-n'-methylcarbamimidoyl)amino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CCCNC(/NC)=N/C#N)C(=O)NCC1=CC=CC(F)=C1Cl QIUZZHNTDVFWAN-NRFANRHFSA-N 0.000 claims 1
- LMPDNXCGJHWHIJ-WCSIJFPASA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-[3-(hydroxymethyl)piperazin-1-yl]-5-oxopentyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC(=O)N1CCNC(CO)C1 LMPDNXCGJHWHIJ-WCSIJFPASA-N 0.000 claims 1
- NALHHAPEAFWOIO-DEOSSOPVSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pentyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCN1CCN(CC(F)(F)F)CC1 NALHHAPEAFWOIO-DEOSSOPVSA-N 0.000 claims 1
- OTSKNHYFYJPTDD-SFHVURJKSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-[[(cyanoamino)-(2-hydroxyethylamino)methylidene]amino]pentyl] n-(1,3-benzothiazol-2-yl)carbamate Chemical compound CN([C@@H](CCCN\C(NCCO)=N/C#N)COC(=O)NC=1SC2=CC=CC=C2N=1)C(=O)NCC1=CC=CC(F)=C1Cl OTSKNHYFYJPTDD-SFHVURJKSA-N 0.000 claims 1
- LQWBFIQFJBYAMS-QFIPXVFZSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-[[(cyanoamino)-(2-hydroxyethylamino)methylidene]amino]pentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCN\C(NCCO)=N/C#N)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl LQWBFIQFJBYAMS-QFIPXVFZSA-N 0.000 claims 1
- OHAUIICTWKRYGV-QFIPXVFZSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-[[(cyanoamino)-(dimethylamino)methylidene]amino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CCCN/C(N(C)C)=N/C#N)C(=O)NCC1=CC=CC(F)=C1Cl OHAUIICTWKRYGV-QFIPXVFZSA-N 0.000 claims 1
- BYMISGXDBYIDQI-IBGZPJMESA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-hydroxy-4,4-dimethylpentyl] n-(3-phenyl-1,2-oxazol-5-yl)carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)CC(C)(C)CO)OC(=O)NC(ON=1)=CC=1C1=CC=CC=C1 BYMISGXDBYIDQI-IBGZPJMESA-N 0.000 claims 1
- BGVWTWFFNOGQGY-IBGZPJMESA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-hydroxy-5-methylhexyl] n-(3-phenyl-1,2-oxazol-5-yl)carbamate Chemical compound C([C@H](CCC(C)(C)O)N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)OC(=O)NC(ON=1)=CC=1C1=CC=CC=C1 BGVWTWFFNOGQGY-IBGZPJMESA-N 0.000 claims 1
- WGZIYXHDUUJMPQ-IBGZPJMESA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-hydroxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl WGZIYXHDUUJMPQ-IBGZPJMESA-N 0.000 claims 1
- IXCJVXGBGFBZOX-QHCPKHFHSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-morpholin-4-ylpentyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCN1CCOCC1 IXCJVXGBGFBZOX-QHCPKHFHSA-N 0.000 claims 1
- DYPUBNZZNFFQOS-NRFANRHFSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-oxo-5-piperazin-1-ylpentyl] n-(3-phenyl-1,2-oxazol-5-yl)carbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1ON=C(C=1)C=1C=CC=CC=1)CC(=O)N1CCNCC1 DYPUBNZZNFFQOS-NRFANRHFSA-N 0.000 claims 1
- KWOCGYDKMLCTTH-NRFANRHFSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-oxo-5-piperazin-1-ylpentyl] n-(5-phenyl-1,2-oxazol-3-yl)carbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC1=NOC(=C1)C=1C=CC=CC=1)CC(=O)N1CCNCC1 KWOCGYDKMLCTTH-NRFANRHFSA-N 0.000 claims 1
- FCEDSFPCEZDAKD-IBGZPJMESA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-6-hydroxyhexyl] n-(2,7-naphthyridin-3-yl)carbamate Chemical compound CN([C@@H](CCCCO)COC(=O)NC=1N=CC2=CN=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl FCEDSFPCEZDAKD-IBGZPJMESA-N 0.000 claims 1
- CHRYDBCEXPPJTI-FQEVSTJZSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-6-hydroxyhexyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCCO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl CHRYDBCEXPPJTI-FQEVSTJZSA-N 0.000 claims 1
- MZJJMMYDKKXLOD-FQEVSTJZSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-6-hydroxyhexyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCCO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl MZJJMMYDKKXLOD-FQEVSTJZSA-N 0.000 claims 1
- OKDUBSWTAWMLOY-SFHVURJKSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pent-4-enyl] n-(2,6-naphthyridin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=NC=C2C=1)CC=C)C(=O)NCC1=CC=CC(F)=C1Cl OKDUBSWTAWMLOY-SFHVURJKSA-N 0.000 claims 1
- FWMBTEOTHACGLA-SFHVURJKSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pent-4-enyl] n-(2,7-naphthyridin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CN=CC=C2C=1)CC=C)C(=O)NCC1=CC=CC(F)=C1Cl FWMBTEOTHACGLA-SFHVURJKSA-N 0.000 claims 1
- XVOKFVSAAOSLLK-IBGZPJMESA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pent-4-enyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC=C)C(=O)NCC1=CC=CC(F)=C1Cl XVOKFVSAAOSLLK-IBGZPJMESA-N 0.000 claims 1
- RHCQXAUPVIICHG-NRFANRHFSA-N [(2s)-2-[(2-chloro-4-fluorophenyl)methylcarbamoyl-ethylamino]-4-hydroxy-4-methylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CCN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(C)(C)O)C(=O)NCC1=CC=C(F)C=C1Cl RHCQXAUPVIICHG-NRFANRHFSA-N 0.000 claims 1
- GEZOGDLXULPGTP-AWEZNQCLSA-N [(2s)-2-[(2-chloro-4-fluorophenyl)methylcarbamoyl-methylamino]-4-hydroxy-4-methylpentyl] n-(5,6-difluoro-1,3-benzothiazol-2-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1SC2=CC(F)=C(F)C=C2N=1)CC(C)(C)O)C(=O)NCC1=CC=C(F)C=C1Cl GEZOGDLXULPGTP-AWEZNQCLSA-N 0.000 claims 1
- YTTZQTBATVLYOE-FQEVSTJZSA-N [(2s)-2-[(2-chloro-4-fluorophenyl)methylcarbamoyl-methylamino]-4-hydroxy-4-methylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(C)(C)O)C(=O)NCC1=CC=C(F)C=C1Cl YTTZQTBATVLYOE-FQEVSTJZSA-N 0.000 claims 1
- UBXVCCXDGQRXDM-FQEVSTJZSA-N [(2s)-2-[(2-chloro-4-fluorophenyl)methylcarbamoyl-methylamino]-4-hydroxy-4-methylpentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC(C)(C)O)C(=O)NCC1=CC=C(F)C=C1Cl UBXVCCXDGQRXDM-FQEVSTJZSA-N 0.000 claims 1
- YDADDAQOLSBHQQ-QFIPXVFZSA-N [(2s)-2-[(2-chloro-4-fluorophenyl)methylcarbamoyl-methylamino]-6-hydroxy-6-methylheptyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCC(C)(C)O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=C(F)C=C1Cl YDADDAQOLSBHQQ-QFIPXVFZSA-N 0.000 claims 1
- UQDRUAKNJQDEIU-NRFANRHFSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-ethylamino]-4-hydroxy-4-methylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CCN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(C)(C)O)C(=O)NCC1=CC=CC=C1Cl UQDRUAKNJQDEIU-NRFANRHFSA-N 0.000 claims 1
- PPXRFXMLXSMDJJ-NRFANRHFSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-3-(3-oxopiperazin-1-yl)propyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C([C@@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)N(C)C(=O)NCC=1C(=CC=CC=1)Cl)N1CCNC(=O)C1 PPXRFXMLXSMDJJ-NRFANRHFSA-N 0.000 claims 1
- CEXAXFPXMXTAOL-SFHVURJKSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-3-hydroxypropyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC=C1Cl CEXAXFPXMXTAOL-SFHVURJKSA-N 0.000 claims 1
- UBXXSGBVJMWLHL-QFIPXVFZSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-3-morpholin-4-ylpropyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)N(C)C(=O)NCC=1C(=CC=CC=1)Cl)N1CCOCC1 UBXXSGBVJMWLHL-QFIPXVFZSA-N 0.000 claims 1
- BCXIHPKVJJVFAY-VWLOTQADSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-3-phenylmethoxypropyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=CC=CC=1)Cl)COC(=O)NC=1N=CC2=CC=CC=C2C=1)OCC1=CC=CC=C1 BCXIHPKVJJVFAY-VWLOTQADSA-N 0.000 claims 1
- COPAYETUSHDQFC-QFIPXVFZSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-4-(3-oxopiperazin-1-yl)butyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=CC=CC=1)Cl)COC(=O)NC=1N=CC2=CC=CC=C2C=1)CN1CCNC(=O)C1 COPAYETUSHDQFC-QFIPXVFZSA-N 0.000 claims 1
- DDMNLQIIEVSUNN-QHCPKHFHSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-4-(4-methyl-3-oxopiperazin-1-yl)butyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=CC=CC=1)Cl)COC(=O)NC=1N=CC2=CC=CC=C2C=1)CN1CCN(C)C(=O)C1 DDMNLQIIEVSUNN-QHCPKHFHSA-N 0.000 claims 1
- NUQGPRNSHNSYAC-DEOSSOPVSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-4-(4-methylsulfonylpiperazin-1-yl)butyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=CC=CC=1)Cl)COC(=O)NC=1N=CC2=CC=CC=C2C=1)CN1CCN(S(C)(=O)=O)CC1 NUQGPRNSHNSYAC-DEOSSOPVSA-N 0.000 claims 1
- NLKFBCMZXPHLBR-FQEVSTJZSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-4-hydroxy-4-methylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(C)(C)O)C(=O)NCC1=CC=CC=C1Cl NLKFBCMZXPHLBR-FQEVSTJZSA-N 0.000 claims 1
- FRKRDQRYBRBUPR-FQEVSTJZSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-4-hydroxy-4-methylpentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC(C)(C)O)C(=O)NCC1=CC=CC=C1Cl FRKRDQRYBRBUPR-FQEVSTJZSA-N 0.000 claims 1
- NEPHNHQRUPMSAH-NRFANRHFSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-5-hydroxy-5-methylhexyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCC(C)(C)O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC=C1Cl NEPHNHQRUPMSAH-NRFANRHFSA-N 0.000 claims 1
- FYFXFSXIISCHGD-QFIPXVFZSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-6-hydroxy-6-methylheptyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCC(C)(C)O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC=C1Cl FYFXFSXIISCHGD-QFIPXVFZSA-N 0.000 claims 1
- YNEZRWOVWRCIAU-YSYXNDDBSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-6-hydroxyheptyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCCC(O)C)C(=O)NCC1=CC=CC=C1Cl YNEZRWOVWRCIAU-YSYXNDDBSA-N 0.000 claims 1
- RJRSBHXVTNMPSK-NRFANRHFSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-6-hydroxyhexyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCCO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC=C1Cl RJRSBHXVTNMPSK-NRFANRHFSA-N 0.000 claims 1
- LJKOJTODDNVCLT-NRFANRHFSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-6-hydroxyhexyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCCO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC=C1Cl LJKOJTODDNVCLT-NRFANRHFSA-N 0.000 claims 1
- FUHWYPDOJNTRPN-QFIPXVFZSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-6-oxoheptyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCC(C)=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC=C1Cl FUHWYPDOJNTRPN-QFIPXVFZSA-N 0.000 claims 1
- NRSGFRUYUYIOOI-QFIPXVFZSA-N [(2s)-2-[(2-chlorophenyl)methylcarbamoyl-propan-2-ylamino]-4-hydroxy-4-methylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(C)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(C)(C)O)C(=O)NCC1=CC=CC=C1Cl NRSGFRUYUYIOOI-QFIPXVFZSA-N 0.000 claims 1
- PGUIGYSGCQGJOO-NRFANRHFSA-N [(2s)-2-[(3-chloro-2-fluorophenyl)methylcarbamoyl-methylamino]-6-hydroxy-6-methylheptyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCC(C)(C)O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(Cl)=C1F PGUIGYSGCQGJOO-NRFANRHFSA-N 0.000 claims 1
- ZIBJPRVJFJJFIW-BGERDNNASA-N [(2s)-2-[(3-fluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(O)CO)C(=O)NCC1=CC=CC(F)=C1 ZIBJPRVJFJJFIW-BGERDNNASA-N 0.000 claims 1
- QPPJEGJPTYAURH-SFTDATJTSA-N [(2s)-2-[acetyl-[(2,3-difluorophenyl)methylamino]amino]-3-[(2s)-2-hydroxy-3-phosphonooxypropoxy]propyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@@H](COC[C@H](O)COP(O)(O)=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC(F)=C1F QPPJEGJPTYAURH-SFTDATJTSA-N 0.000 claims 1
- DMAPQHSNXFBTME-NRFANRHFSA-N [(2s)-2-[acetyl-[(2,3-difluorophenyl)methylamino]amino]-4-(1h-imidazol-2-yl)butyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CCC=1NC=CN=1)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1F DMAPQHSNXFBTME-NRFANRHFSA-N 0.000 claims 1
- ZQHWADKFWSVESG-NRFANRHFSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-(1h-imidazol-5-yl)propyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC=1NC=NC=1)NCC1=CC=CC(F)=C1Cl ZQHWADKFWSVESG-NRFANRHFSA-N 0.000 claims 1
- VUALHMOUTMGKDK-NRFANRHFSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-(1h-imidazol-5-yl)propyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC=1NC=NC=1)NCC1=CC=CC(F)=C1Cl VUALHMOUTMGKDK-NRFANRHFSA-N 0.000 claims 1
- YUAJBSPRRDFWIK-SFHVURJKSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-(2,2-difluoroethylamino)propyl] n-(5-phenyl-1,2-oxazol-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CNCC(F)F)COC(=O)NC1=NOC(=C1)C=1C=CC=CC=1)NCC1=CC=CC(F)=C1Cl YUAJBSPRRDFWIK-SFHVURJKSA-N 0.000 claims 1
- OGWVVEDQURXJRK-IBGZPJMESA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-(2,2-difluoroethylamino)propyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@@H](CNCC(F)F)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC(F)=C1Cl OGWVVEDQURXJRK-IBGZPJMESA-N 0.000 claims 1
- XFOUBJICCFVVHR-QFIPXVFZSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-(2,2-dimethyl-3-phosphonooxypropoxy)propyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](COCC(C)(C)COP(O)(O)=O)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl XFOUBJICCFVVHR-QFIPXVFZSA-N 0.000 claims 1
- HVAAIFIXRXDNCB-IBGZPJMESA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-(methanesulfonamido)propyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@@H](CNS(C)(=O)=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC(F)=C1Cl HVAAIFIXRXDNCB-IBGZPJMESA-N 0.000 claims 1
- LIENKLXCWPGNGE-IBGZPJMESA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-[(2-aminoacetyl)amino]propyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CNC(=O)CN)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl LIENKLXCWPGNGE-IBGZPJMESA-N 0.000 claims 1
- YTDPGLUVPDGFSJ-PMERELPUSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-[(3-benzoylbenzoyl)amino]propyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CNC(=O)C=1C=C(C=CC=1)C(=O)C=1C=CC=CC=1)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl YTDPGLUVPDGFSJ-PMERELPUSA-N 0.000 claims 1
- OHKLEKHBJJKBOV-PZJWPPBQSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-[[(2r)-2-amino-3-hydroxypropanoyl]amino]propyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CNC(=O)[C@H](N)CO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl OHKLEKHBJJKBOV-PZJWPPBQSA-N 0.000 claims 1
- ILFOPYOYXQJDMB-QFIPXVFZSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-[bis(2-hydroxyethyl)amino]propyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CN(CCO)CCO)NCC1=CC=CC(F)=C1Cl ILFOPYOYXQJDMB-QFIPXVFZSA-N 0.000 claims 1
- YGZXJNIDEAQUFE-INIZCTEOSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-aminopropyl] n-(4-iodo-5-phenyl-1,2-oxazol-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CN)COC(=O)NC=1C(=C(ON=1)C=1C=CC=CC=1)I)NCC1=CC=CC(F)=C1Cl YGZXJNIDEAQUFE-INIZCTEOSA-N 0.000 claims 1
- FWOPWIXUNRVUAP-NRFANRHFSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4,4-dimethyl-5-phosphonooxypentyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC(C)(C)COP(O)(O)=O)NCC1=CC=CC(F)=C1Cl FWOPWIXUNRVUAP-NRFANRHFSA-N 0.000 claims 1
- BZYIPCAOYPGRBJ-FQEVSTJZSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-[(2-aminoacetyl)amino]butyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CCNC(=O)CN)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl BZYIPCAOYPGRBJ-FQEVSTJZSA-N 0.000 claims 1
- CTZKVKRXGSGNNT-RBBKRZOGSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-[[(2r)-2-amino-3-hydroxypropanoyl]amino]butyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CCNC(=O)[C@H](N)CO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl CTZKVKRXGSGNNT-RBBKRZOGSA-N 0.000 claims 1
- BVHSHZKDZLZNGZ-BGERDNNASA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-hydroxy-5-[hydroxy(methoxy)phosphoryl]oxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(O)COP(O)(=O)OC)NCC1=CC=CC(F)=C1Cl BVHSHZKDZLZNGZ-BGERDNNASA-N 0.000 claims 1
- LYAPCGMJWHAOLT-XJDOXCRVSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-hydroxy-5-sulfooxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(O)COS(O)(=O)=O)NCC1=CC=CC(F)=C1Cl LYAPCGMJWHAOLT-XJDOXCRVSA-N 0.000 claims 1
- UYTJPQNAAFTZEF-QFIPXVFZSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-morpholin-4-yl-4-oxobutyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(=O)N1CCOCC1)NCC1=CC=CC(F)=C1Cl UYTJPQNAAFTZEF-QFIPXVFZSA-N 0.000 claims 1
- OVNHDWYGZASBKR-BBQAJUCSSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-(2,3-dihydroxypropanoylamino)pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CCCNC(=O)C(O)CO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl OVNHDWYGZASBKR-BBQAJUCSSA-N 0.000 claims 1
- QPPDTLYPCNJQJN-NRFANRHFSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-(2-hydroxyethylcarbamoylamino)pentyl] n-(3-phenyl-1,2-oxazol-5-yl)carbamate Chemical compound CC(=O)N([C@@H](CCCNC(=O)NCCO)COC(=O)NC=1ON=C(C=1)C=1C=CC=CC=1)NCC1=CC=CC(F)=C1Cl QPPDTLYPCNJQJN-NRFANRHFSA-N 0.000 claims 1
- YTSWRESUVYCCGD-QFIPXVFZSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-(2-hydroxyethylcarbamoylamino)pentyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@@H](CCCNC(=O)NCCO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC(F)=C1Cl YTSWRESUVYCCGD-QFIPXVFZSA-N 0.000 claims 1
- VLJFUKLLFJXSDL-QHCPKHFHSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-(3-hydroxypropylcarbamoylamino)pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CCCNC(=O)NCCCO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl VLJFUKLLFJXSDL-QHCPKHFHSA-N 0.000 claims 1
- GQHSYOWSJLXBDA-QHCPKHFHSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-(4-methylpiperazin-1-yl)-5-oxopentyl] n-(5-phenyl-1,2-oxazol-3-yl)carbamate Chemical compound C1CN(C)CCN1C(=O)CC[C@H](N(NCC=1C(=C(F)C=CC=1)Cl)C(C)=O)COC(=O)NC1=NOC(C=2C=CC=CC=2)=C1 GQHSYOWSJLXBDA-QHCPKHFHSA-N 0.000 claims 1
- CLNOTPMHJVGZKC-DEOSSOPVSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-(4-methylpiperazin-1-yl)-5-oxopentyl] n-isoquinolin-3-ylcarbamate Chemical compound C1CN(C)CCN1C(=O)CC[C@H](N(NCC=1C(=C(F)C=CC=1)Cl)C(C)=O)COC(=O)NC1=CC2=CC=CC=C2C=N1 CLNOTPMHJVGZKC-DEOSSOPVSA-N 0.000 claims 1
- GHVIWEYDWAPOLQ-QHCPKHFHSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[(2,2-dimethyl-3-phosphonooxypropyl)amino]-5-oxopentyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@@H](CCC(=O)NCC(C)(C)COP(O)(O)=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC(F)=C1Cl GHVIWEYDWAPOLQ-QHCPKHFHSA-N 0.000 claims 1
- DEMYIAALEDYHTA-NRFANRHFSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[(2-hydroxyacetyl)amino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CCCNC(=O)CO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl DEMYIAALEDYHTA-NRFANRHFSA-N 0.000 claims 1
- SOGIOKDTNALJJX-DEOSSOPVSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[(3-hydroxy-2,2-dimethylpropyl)carbamoylamino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CCCNC(=O)NCC(C)(C)CO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl SOGIOKDTNALJJX-DEOSSOPVSA-N 0.000 claims 1
- URXZSZLCMXMZBU-JTHBVZDNSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[[(2r)-2-amino-3-hydroxypropanoyl]amino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CCCNC(=O)[C@H](N)CO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl URXZSZLCMXMZBU-JTHBVZDNSA-N 0.000 claims 1
- RWYRWAURVXXVBY-JTHBVZDNSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[[(2r)-2-amino-3-hydroxypropanoyl]amino]pentyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@@H](CCCNC(=O)[C@H](N)CO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC(F)=C1Cl RWYRWAURVXXVBY-JTHBVZDNSA-N 0.000 claims 1
- ZDLFELLIWDAXAR-UNMCSNQZSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[[(2s)-2-amino-3-hydroxypropanoyl]amino]pentyl] n-(2,7-naphthyridin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CCCNC(=O)[C@@H](N)CO)COC(=O)NC=1N=CC2=CN=CC=C2C=1)NCC1=CC=CC(F)=C1Cl ZDLFELLIWDAXAR-UNMCSNQZSA-N 0.000 claims 1
- URXZSZLCMXMZBU-GMAHTHKFSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[[(2s)-2-amino-3-hydroxypropanoyl]amino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CCCNC(=O)[C@@H](N)CO)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl URXZSZLCMXMZBU-GMAHTHKFSA-N 0.000 claims 1
- RWYRWAURVXXVBY-GMAHTHKFSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[[(2s)-2-amino-3-hydroxypropanoyl]amino]pentyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@@H](CCCNC(=O)[C@@H](N)CO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC(F)=C1Cl RWYRWAURVXXVBY-GMAHTHKFSA-N 0.000 claims 1
- RUAHTSNCLARDAE-NRFANRHFSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[methoxy(methyl)amino]-5-oxopentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CCC(=O)N(C)OC)NCC1=CC=CC(F)=C1Cl RUAHTSNCLARDAE-NRFANRHFSA-N 0.000 claims 1
- LXIROZUWAYGAKO-WCSIJFPASA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-oxo-5-(pyrrolidin-3-ylamino)pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@@H](CCC(=O)NC1CNCC1)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl LXIROZUWAYGAKO-WCSIJFPASA-N 0.000 claims 1
- IYIPRFRBEKYTTA-UPVQGACJSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-oxo-5-[(2s)-2-(trifluoromethyl)piperazin-1-yl]pentyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@@H](CCC(=O)N1[C@@H](CNCC1)C(F)(F)F)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC(F)=C1Cl IYIPRFRBEKYTTA-UPVQGACJSA-N 0.000 claims 1
- DGIDABLAOUWKQK-NRFANRHFSA-N [(2s)-2-[acetyl-[(2-chloro-4-fluorophenyl)methylamino]amino]-4-hydroxy-4-methylpentyl] n-(7-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC(F)=CC=C2C=1)CC(C)(C)O)NCC1=CC=C(F)C=C1Cl DGIDABLAOUWKQK-NRFANRHFSA-N 0.000 claims 1
- SNQGQUMKVURZQZ-HXUWFJFHSA-N [(2s)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]-3-methylbutyl] n-(6-methyl-1,3-benzothiazol-2-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1SC2=CC(C)=CC=C2N=1)C(C)C)NCC1=CC=CC=C1Cl SNQGQUMKVURZQZ-HXUWFJFHSA-N 0.000 claims 1
- FJEKXRLLDPLTFU-NRFANRHFSA-N [(2s)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]-4-[methoxy(methyl)amino]-4-oxobutyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC(=O)N(C)OC)NCC1=CC=CC=C1Cl FJEKXRLLDPLTFU-NRFANRHFSA-N 0.000 claims 1
- SQPPREGDZHEQMI-NRFANRHFSA-N [(2s)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]-4-hydroxy-4-methylpentyl] n-(7-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC(F)=CC=C2C=1)CC(C)(C)O)NCC1=CC=CC=C1Cl SQPPREGDZHEQMI-NRFANRHFSA-N 0.000 claims 1
- JLYQDMIHKWPLAK-FQEVSTJZSA-N [(2s)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]-4-hydroxybutyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@@H](CCO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC=C1Cl JLYQDMIHKWPLAK-FQEVSTJZSA-N 0.000 claims 1
- QEEMZVIZAGCYNY-NRFANRHFSA-N [(2s)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]-5-hydroxypentyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@@H](CCCO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC=C1Cl QEEMZVIZAGCYNY-NRFANRHFSA-N 0.000 claims 1
- CBWKOHITAFJKPS-KRWDZBQOSA-N [(2s)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]butyl] n-(6-methyl-1,3-benzothiazol-2-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1SC2=CC(C)=CC=C2N=1)CC)NCC1=CC=CC=C1Cl CBWKOHITAFJKPS-KRWDZBQOSA-N 0.000 claims 1
- OGFJHBUKELWHSV-FQEVSTJZSA-N [(2s)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]butyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC)NCC1=CC=CC=C1Cl OGFJHBUKELWHSV-FQEVSTJZSA-N 0.000 claims 1
- LMGWOYLAYVVJGR-HNNXBMFYSA-N [(2s)-2-[acetyl-[(2-chlorophenyl)methylamino]amino]propyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)C)NCC1=CC=CC=C1Cl LMGWOYLAYVVJGR-HNNXBMFYSA-N 0.000 claims 1
- SGZLMSSAFUTARY-ZDUSSCGKSA-N [(2s)-3-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]propyl] n-(5-chloropyridin-2-yl)carbamate Chemical compound C([C@H](CN)N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)OC(=O)NC1=CC=C(Cl)C=N1 SGZLMSSAFUTARY-ZDUSSCGKSA-N 0.000 claims 1
- LWCSGLDZVGJCQR-INIZCTEOSA-N [(2s)-3-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]propyl] n-[3-(3-chlorophenyl)-1,2-oxazol-5-yl]carbamate Chemical compound C([C@H](CN)N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)OC(=O)NC(ON=1)=CC=1C1=CC=CC(Cl)=C1 LWCSGLDZVGJCQR-INIZCTEOSA-N 0.000 claims 1
- FNSZQIKAINWLEP-INIZCTEOSA-N [(2s)-3-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]propyl] n-[5-(3-fluorophenyl)-1,2-oxazol-3-yl]carbamate Chemical compound C([C@H](CN)N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)OC(=O)NC(=NO1)C=C1C1=CC=CC(F)=C1 FNSZQIKAINWLEP-INIZCTEOSA-N 0.000 claims 1
- UREUPJWPNLLFKM-KRWDZBQOSA-N [(2s)-3-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]propyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CN)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl UREUPJWPNLLFKM-KRWDZBQOSA-N 0.000 claims 1
- IRIYODHXEPUMQK-GGYWPGCISA-N [(2s)-4,5-diamino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(N)CN)C(=O)NCC1=CC=CC(F)=C1Cl IRIYODHXEPUMQK-GGYWPGCISA-N 0.000 claims 1
- QQYNVTRTQRBEDC-QFIPXVFZSA-N [(2s)-4-[7-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-6,8-dihydro-5h-imidazo[1,5-a]pyrazin-3-yl]-2-(methylamino)butyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@H](NC)COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC(N1CC2)=NC=C1CN2C(=O)NCC1=CC=CC(F)=C1Cl QQYNVTRTQRBEDC-QFIPXVFZSA-N 0.000 claims 1
- MJUXTYXPOKGETD-NRFANRHFSA-N [(2s)-5-[[(carbamoylamino)-(2-hydroxyethylamino)methylidene]amino]-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCN\C(NCCO)=N/C(N)=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl MJUXTYXPOKGETD-NRFANRHFSA-N 0.000 claims 1
- KWYFDXWKYURCQP-VWLOTQADSA-N [(2s)-5-[bis(2-hydroxy-2-methylpropyl)amino]-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCN(CC(C)(C)O)CC(C)(C)O)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl KWYFDXWKYURCQP-VWLOTQADSA-N 0.000 claims 1
- RVXKGQSVUKHEPB-SFHVURJKSA-N [(2s)-5-amino-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-4,4-difluoropentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC(F)(F)CN)C(=O)NCC1=CC=CC(F)=C1F RVXKGQSVUKHEPB-SFHVURJKSA-N 0.000 claims 1
- RLRGFYHYKNTOKD-SFHVURJKSA-N [(2s)-5-amino-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-5-oxopentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCC(N)=O)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1F RLRGFYHYKNTOKD-SFHVURJKSA-N 0.000 claims 1
- QXUSEWRHWGONFZ-HNNXBMFYSA-N [(2s)-5-amino-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]pentyl] n-(1,3-benzothiazol-2-yl)carbamate Chemical compound CN([C@@H](CCCN)COC(=O)NC=1SC2=CC=CC=C2N=1)C(=O)NCC1=CC=CC(F)=C1F QXUSEWRHWGONFZ-HNNXBMFYSA-N 0.000 claims 1
- YOJFJYMLKGMUCP-SFHVURJKSA-N [(2s)-5-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,4-difluoropentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC(F)(F)CN)C(=O)NCC1=CC=CC(F)=C1Cl YOJFJYMLKGMUCP-SFHVURJKSA-N 0.000 claims 1
- BWPKIDZZVLYIEP-GGYWPGCISA-N [(2s)-5-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4-fluoropentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(F)CN)C(=O)NCC1=CC=CC(F)=C1Cl BWPKIDZZVLYIEP-GGYWPGCISA-N 0.000 claims 1
- FFKXPHJZMDMEHH-FQEVSTJZSA-N [(2s)-5-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-ethyliminopentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CCC(=N)NCC)C(=O)NCC1=CC=CC(F)=C1Cl FFKXPHJZMDMEHH-FQEVSTJZSA-N 0.000 claims 1
- QITMFPIVFHCACM-SFHVURJKSA-N [(2s)-5-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-iminopentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCC(N)=N)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl QITMFPIVFHCACM-SFHVURJKSA-N 0.000 claims 1
- VJQHEOCTJPCKQV-MBABXSBOSA-N [(2s)-5-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]hexyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CCC(N)C)C(=O)NCC1=CC=CC(F)=C1Cl VJQHEOCTJPCKQV-MBABXSBOSA-N 0.000 claims 1
- SMSIGAYLMVFWOQ-KRWDZBQOSA-N [(2s)-5-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pentyl] n-(1,7-naphthyridin-6-yl)carbamate Chemical compound CN([C@@H](CCCN)COC(=O)NC=1N=CC2=NC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl SMSIGAYLMVFWOQ-KRWDZBQOSA-N 0.000 claims 1
- ISNRZHTUBGCMOV-SFHVURJKSA-N [(2s)-5-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pentyl] n-(2,7-naphthyridin-3-yl)carbamate Chemical compound CN([C@@H](CCCN)COC(=O)NC=1N=CC2=CN=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl ISNRZHTUBGCMOV-SFHVURJKSA-N 0.000 claims 1
- BZNRBOWDZOHITP-SFHVURJKSA-N [(2s)-5-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pentyl] n-(3-phenyl-1,2-oxazol-5-yl)carbamate Chemical compound C([C@H](CCCN)N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)OC(=O)NC(ON=1)=CC=1C1=CC=CC=C1 BZNRBOWDZOHITP-SFHVURJKSA-N 0.000 claims 1
- LCDVQGLSSYFJLA-IBGZPJMESA-N [(2s)-5-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCN)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl LCDVQGLSSYFJLA-IBGZPJMESA-N 0.000 claims 1
- DIXQEOLUWPSKGH-FQEVSTJZSA-N [(2s)-5-amino-2-[(2-chloro-4-fluorophenyl)methylcarbamoyl-methylamino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCN)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=C(F)C=C1Cl DIXQEOLUWPSKGH-FQEVSTJZSA-N 0.000 claims 1
- GXZFEIMCPGUGSK-FQEVSTJZSA-N [(2s)-5-amino-2-[(2-chloro-4-fluorophenyl)methylcarbamoyl-methylamino]pentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCN)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=C(F)C=C1Cl GXZFEIMCPGUGSK-FQEVSTJZSA-N 0.000 claims 1
- XIAVUGALURLVBR-ZQRQZVKFSA-N [(2s)-5-amino-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-6,6-difluorohexyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCC(N)C(F)F)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC=C1Cl XIAVUGALURLVBR-ZQRQZVKFSA-N 0.000 claims 1
- IUWYEJQOQBFIFU-FQEVSTJZSA-N [(2s)-5-amino-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCN)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC=C1Cl IUWYEJQOQBFIFU-FQEVSTJZSA-N 0.000 claims 1
- CWITUDSXBRSWMJ-DEOSSOPVSA-N [(2s)-6-acetamido-2-[acetyl-[(2-chlorophenyl)methylamino]amino]hexyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCCCNC(=O)C)NCC1=CC=CC=C1Cl CWITUDSXBRSWMJ-DEOSSOPVSA-N 0.000 claims 1
- MDBBNPUCOSAGHZ-ZWKOTPCHSA-N [(2s,4r)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-(5-phenyl-1,2-oxazol-3-yl)carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)F)C[C@@H](O)CO)OC(=O)NC(=NO1)C=C1C1=CC=CC=C1 MDBBNPUCOSAGHZ-ZWKOTPCHSA-N 0.000 claims 1
- WHIVJEXKFOXDPN-ZWKOTPCHSA-N [(2s,4r)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-(5-phenyl-1,2-oxazol-3-yl)carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)C[C@@H](O)CO)OC(=O)NC(=NO1)C=C1C1=CC=CC=C1 WHIVJEXKFOXDPN-ZWKOTPCHSA-N 0.000 claims 1
- PHIFDXQWSHKXLO-RBUKOAKNSA-N [(2s,4r)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-(6-fluoro-2-hydroxy-1h-isoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N(CC2=CC=C(F)C=C2C=1)O)C[C@@H](O)CO)C(=O)NCC1=CC=CC(F)=C1Cl PHIFDXQWSHKXLO-RBUKOAKNSA-N 0.000 claims 1
- IQXCHFJQHHQRPI-ZWKOTPCHSA-N [(2s,4r)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-[5-(3-fluorophenyl)-1,2-oxazol-3-yl]carbamate Chemical compound C([C@@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)C[C@@H](O)CO)OC(=O)NC(=NO1)C=C1C1=CC=CC(F)=C1 IQXCHFJQHHQRPI-ZWKOTPCHSA-N 0.000 claims 1
- BICGFHYCRGUTIN-UZLBHIALSA-N [(2s,4r)-2-[(2-chlorophenyl)methylcarbamoyl-methylamino]-4-hydroxypentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)C[C@H](O)C)C(=O)NCC1=CC=CC=C1Cl BICGFHYCRGUTIN-UZLBHIALSA-N 0.000 claims 1
- HXQNENQXFZDDJK-RBUKOAKNSA-N [(2s,4r)-2-[acetyl-[(2,3-difluorophenyl)methylamino]amino]-4-hydroxy-5-phosphonooxypentyl] n-(5-phenyl-1,2-oxazol-3-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC1=NOC(=C1)C=1C=CC=CC=1)C[C@@H](O)COP(O)(O)=O)NCC1=CC=CC(F)=C1F HXQNENQXFZDDJK-RBUKOAKNSA-N 0.000 claims 1
- SXKBFVQUEZUZKK-JKSUJKDBSA-N [(2s,4r)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-hydroxy-5-phosphonooxypentyl] n-(1,3-benzothiazol-2-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1SC2=CC=CC=C2N=1)C[C@@H](O)COP(O)(O)=O)NCC1=CC=CC(F)=C1Cl SXKBFVQUEZUZKK-JKSUJKDBSA-N 0.000 claims 1
- WCKBDBAAIBWDGK-JKSUJKDBSA-N [(2s,4r)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-hydroxy-5-phosphonooxypentyl] n-(6-chloro-1,3-benzothiazol-2-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1SC2=CC(Cl)=CC=C2N=1)C[C@@H](O)COP(O)(O)=O)NCC1=CC=CC(F)=C1Cl WCKBDBAAIBWDGK-JKSUJKDBSA-N 0.000 claims 1
- INTOAFVFTVGIJQ-JKSUJKDBSA-N [(2s,4r)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-hydroxy-5-phosphonooxypentyl] n-(6-fluoro-1,3-benzothiazol-2-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1SC2=CC(F)=CC=C2N=1)C[C@@H](O)COP(O)(O)=O)NCC1=CC=CC(F)=C1Cl INTOAFVFTVGIJQ-JKSUJKDBSA-N 0.000 claims 1
- VQGVPNKQIIOIOO-VQTJNVASSA-N [(2s,4r)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-hydroxy-5-phosphonooxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C[C@@H](O)COP(O)(O)=O)NCC1=CC=CC(F)=C1Cl VQGVPNKQIIOIOO-VQTJNVASSA-N 0.000 claims 1
- ZPFWKXFDWAWVQS-RBUKOAKNSA-N [(2s,4r)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-hydroxy-5-phosphonooxypentyl] n-[5-(3-chlorophenyl)-1,2-oxazol-3-yl]carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC1=NOC(=C1)C=1C=C(Cl)C=CC=1)C[C@@H](O)COP(O)(O)=O)NCC1=CC=CC(F)=C1Cl ZPFWKXFDWAWVQS-RBUKOAKNSA-N 0.000 claims 1
- ZDMDGGILTLWAAP-RBUKOAKNSA-N [(2s,4r)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-hydroxy-5-phosphonooxypentyl] n-[5-(3-fluorophenyl)-1,2-oxazol-3-yl]carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC1=NOC(=C1)C=1C=C(F)C=CC=1)C[C@@H](O)COP(O)(O)=O)NCC1=CC=CC(F)=C1Cl ZDMDGGILTLWAAP-RBUKOAKNSA-N 0.000 claims 1
- VQGVPNKQIIOIOO-PMACEKPBSA-N [(2s,4s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4-hydroxy-5-phosphonooxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C[C@H](O)COP(O)(O)=O)NCC1=CC=CC(F)=C1Cl VQGVPNKQIIOIOO-PMACEKPBSA-N 0.000 claims 1
- ZAGNPSXGEFYFHJ-OALUTQOASA-N [(2s,4s)-5-amino-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4-hydroxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C[C@H](O)CN)C(=O)NCC1=CC=CC(F)=C1Cl ZAGNPSXGEFYFHJ-OALUTQOASA-N 0.000 claims 1
- LKQOGHQKUGXELT-AXUWQRLWSA-N [(4s)-4-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]-2-hydroxypentyl] (2r)-2-amino-3-hydroxypropanoate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(O)COC(=O)[C@H](N)CO)NCC1=CC=CC(F)=C1Cl LKQOGHQKUGXELT-AXUWQRLWSA-N 0.000 claims 1
- LKQOGHQKUGXELT-PDATXNNJSA-N [(4s)-4-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]-2-hydroxypentyl] (2s)-2-amino-3-hydroxypropanoate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(O)COC(=O)[C@@H](N)CO)NCC1=CC=CC(F)=C1Cl LKQOGHQKUGXELT-PDATXNNJSA-N 0.000 claims 1
- OPBMAWLZRHHXSK-IQAFUUOHSA-N [(4s)-4-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]-2-hydroxypentyl] (2s)-2-amino-3-methylbutanoate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(O)COC(=O)[C@@H](N)C(C)C)NCC1=CC=CC(F)=C1Cl OPBMAWLZRHHXSK-IQAFUUOHSA-N 0.000 claims 1
- CDEGHZGCJNBPCC-UHFFFAOYSA-N [1-(2-aminoacetyl)-4-[(2,3-dichlorophenyl)methylcarbamoyl]piperidin-4-yl]methyl n-(5-bromopyridin-2-yl)carbamate Chemical compound C1CN(C(=O)CN)CCC1(C(=O)NCC=1C(=C(Cl)C=CC=1)Cl)COC(=O)NC1=CC=C(Br)C=N1 CDEGHZGCJNBPCC-UHFFFAOYSA-N 0.000 claims 1
- VARQFRMJFDUYRW-UHFFFAOYSA-N [1-(2-aminoacetyl)-4-[(2-chlorophenyl)methylcarbamoyl]piperidin-4-yl]methyl n-(4-methyl-1,3-benzothiazol-2-yl)carbamate Chemical compound N=1C=2C(C)=CC=CC=2SC=1NC(=O)OCC1(C(=O)NCC=2C(=CC=CC=2)Cl)CCN(C(=O)CN)CC1 VARQFRMJFDUYRW-UHFFFAOYSA-N 0.000 claims 1
- LHCJQUQZQOBKDN-UHFFFAOYSA-N [1-(2-aminoacetyl)-4-[(2-chlorophenyl)methylcarbamoyl]piperidin-4-yl]methyl n-(5-methylpyridin-2-yl)carbamate Chemical compound N1=CC(C)=CC=C1NC(=O)OCC1(C(=O)NCC=2C(=CC=CC=2)Cl)CCN(C(=O)CN)CC1 LHCJQUQZQOBKDN-UHFFFAOYSA-N 0.000 claims 1
- LXKFTDIOKXHRDX-UHFFFAOYSA-N [1-(2-aminoacetyl)-4-[(2-chlorophenyl)methylcarbamoyl]piperidin-4-yl]methyl n-(5-phenyl-1,3,4-thiadiazol-2-yl)carbamate Chemical compound C1CN(C(=O)CN)CCC1(C(=O)NCC=1C(=CC=CC=1)Cl)COC(=O)NC1=NN=C(C=2C=CC=CC=2)S1 LXKFTDIOKXHRDX-UHFFFAOYSA-N 0.000 claims 1
- AGPSPKAEBKPPQL-UHFFFAOYSA-N [1-(2-aminoacetyl)-4-[(2-chlorophenyl)methylcarbamoyl]piperidin-4-yl]methyl n-(6-methyl-1,3-benzothiazol-2-yl)carbamate Chemical compound S1C2=CC(C)=CC=C2N=C1NC(=O)OCC1(C(=O)NCC=2C(=CC=CC=2)Cl)CCN(C(=O)CN)CC1 AGPSPKAEBKPPQL-UHFFFAOYSA-N 0.000 claims 1
- DSPBNHZJYYXVCV-UHFFFAOYSA-N [1-(2-aminoacetyl)-4-[(2-chlorophenyl)methylcarbamoyl]piperidin-4-yl]methyl n-[6-(trifluoromethyl)-1,3-benzothiazol-2-yl]carbamate Chemical compound C1CN(C(=O)CN)CCC1(C(=O)NCC=1C(=CC=CC=1)Cl)COC(=O)NC1=NC2=CC=C(C(F)(F)F)C=C2S1 DSPBNHZJYYXVCV-UHFFFAOYSA-N 0.000 claims 1
- ITIMLIOIYCMBMX-UHFFFAOYSA-N [1-(2-aminoacetyl)-4-[(2-chlorophenyl)methylcarbamoyl]piperidin-4-yl]methyl n-isoquinolin-3-ylcarbamate Chemical compound C1CN(C(=O)CN)CCC1(C(=O)NCC=1C(=CC=CC=1)Cl)COC(=O)NC1=CC2=CC=CC=C2C=N1 ITIMLIOIYCMBMX-UHFFFAOYSA-N 0.000 claims 1
- QTSYZQUODMYDOL-UHFFFAOYSA-N [1-(2-aminoacetyl)-4-[(2-chlorophenyl)methylcarbamoyl]piperidin-4-yl]methyl n-thiophen-2-ylcarbamate Chemical compound C1CN(C(=O)CN)CCC1(C(=O)NCC=1C(=CC=CC=1)Cl)COC(=O)NC1=CC=CS1 QTSYZQUODMYDOL-UHFFFAOYSA-N 0.000 claims 1
- RNXZAWNMNBZJCA-UHFFFAOYSA-N [3-(1-benzylimidazol-2-yl)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]propyl] n-isoquinolin-3-ylcarbamate Chemical compound C=1C=CC(F)=C(Cl)C=1CNC(=O)N(C)C(COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC1=NC=CN1CC1=CC=CC=C1 RNXZAWNMNBZJCA-UHFFFAOYSA-N 0.000 claims 1
- ZIMGSJCTWAYYTR-UHFFFAOYSA-N [3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-3-methylhex-5-enyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(C)(CC=C)C(=O)NCC1=CC=CC(F)=C1Cl ZIMGSJCTWAYYTR-UHFFFAOYSA-N 0.000 claims 1
- NOYDWDYVPDDGLF-UHFFFAOYSA-N [3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-3-methylhexyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(C)(CCC)C(=O)NCC1=CC=CC(F)=C1Cl NOYDWDYVPDDGLF-UHFFFAOYSA-N 0.000 claims 1
- DAVDXSDADTWEIP-UHFFFAOYSA-N [3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-5-(2,3-dihydroxypropanoylamino)-3-methylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(CCNC(=O)C(O)CO)(C)C(=O)NCC1=CC=CC(F)=C1Cl DAVDXSDADTWEIP-UHFFFAOYSA-N 0.000 claims 1
- BILRWSPWSFWIMH-UHFFFAOYSA-N [3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-5-hydroxy-3-methylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(CCO)(C)C(=O)NCC1=CC=CC(F)=C1Cl BILRWSPWSFWIMH-UHFFFAOYSA-N 0.000 claims 1
- ZBRJCZMILXMOKH-UHFFFAOYSA-N [3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-6,7-dihydroxy-3-methylheptyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(C)(CCC(O)CO)C(=O)NCC1=CC=CC(F)=C1Cl ZBRJCZMILXMOKH-UHFFFAOYSA-N 0.000 claims 1
- RABCQFVRVRZQMG-UHFFFAOYSA-N [3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-6-hydroxy-3-methylhexyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(CCCO)(C)C(=O)NCC1=CC=CC(F)=C1Cl RABCQFVRVRZQMG-UHFFFAOYSA-N 0.000 claims 1
- IWIAAIWVHFUZDY-UHFFFAOYSA-N [4-[(2-chloro-3-fluorophenyl)methylamino]-3,3-dimethyl-4-oxobutyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(C)(C)C(=O)NCC1=CC=CC(F)=C1Cl IWIAAIWVHFUZDY-UHFFFAOYSA-N 0.000 claims 1
- MODJKUSLHRLDJP-UHFFFAOYSA-N [4-[(2-chloro-3-fluorophenyl)methylamino]-3-methyl-4-oxobutyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(C)C(=O)NCC1=CC=CC(F)=C1Cl MODJKUSLHRLDJP-UHFFFAOYSA-N 0.000 claims 1
- QCNJDEHZHGAQSH-UHFFFAOYSA-N [5-[(2-aminoacetyl)amino]-3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-3-methylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(CCNC(=O)CN)(C)C(=O)NCC1=CC=CC(F)=C1Cl QCNJDEHZHGAQSH-UHFFFAOYSA-N 0.000 claims 1
- FRJUFFIXWJGUOP-LWAJAQLZSA-N [5-[[(2s)-2-amino-3-hydroxypropanoyl]amino]-3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-3-methylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(CCNC(=O)[C@@H](N)CO)(C)C(=O)NCC1=CC=CC(F)=C1Cl FRJUFFIXWJGUOP-LWAJAQLZSA-N 0.000 claims 1
- JZHJKLBRUSATPN-UHFFFAOYSA-N [5-amino-3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-3-methylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(CCN)(C)C(=O)NCC1=CC=CC(F)=C1Cl JZHJKLBRUSATPN-UHFFFAOYSA-N 0.000 claims 1
- YJMVWSKZHVEXIZ-UHFFFAOYSA-N [5-amino-3-[(2-chloro-4-fluorophenyl)methylcarbamoyl]-3-methylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(CCN)(C)C(=O)NCC1=CC=C(F)C=C1Cl YJMVWSKZHVEXIZ-UHFFFAOYSA-N 0.000 claims 1
- QSDKHCBMAZULFU-UHFFFAOYSA-N [6-[(2-aminoacetyl)amino]-3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-3-methylhexyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(CCCNC(=O)CN)(C)C(=O)NCC1=CC=CC(F)=C1Cl QSDKHCBMAZULFU-UHFFFAOYSA-N 0.000 claims 1
- OUTXNGWCUMLRNK-UHFFFAOYSA-N [6-amino-3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-3-methylhexyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(CCCN)(C)C(=O)NCC1=CC=CC(F)=C1Cl OUTXNGWCUMLRNK-UHFFFAOYSA-N 0.000 claims 1
- VONYQZAORIPTTB-UHFFFAOYSA-N [7-[(2-aminoacetyl)amino]-3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-3-methylheptyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(CCCCNC(=O)CN)(C)C(=O)NCC1=CC=CC(F)=C1Cl VONYQZAORIPTTB-UHFFFAOYSA-N 0.000 claims 1
- AHMFUGVRUYGQPX-UHFFFAOYSA-N [7-amino-3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-3-methylheptyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(CCCCN)(C)C(=O)NCC1=CC=CC(F)=C1Cl AHMFUGVRUYGQPX-UHFFFAOYSA-N 0.000 claims 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 claims 1
- UGUUDTWORXNLAK-UHFFFAOYSA-N azidoalcohol Chemical compound ON=[N+]=[N-] UGUUDTWORXNLAK-UHFFFAOYSA-N 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- CMBUTBAXZXBQGV-VWLOTQADSA-N benzyl N-[(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]propyl]carbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=C(C=C2C1)F)CNC(=O)OCC1=CC=CC=C1 CMBUTBAXZXBQGV-VWLOTQADSA-N 0.000 claims 1
- UMWZZAJHUNJVEI-PVCWFJFTSA-N benzyl n-[(5s)-5-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-1,1-difluoro-6-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]hexan-2-yl]carbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(C(F)F)NC(=O)OCC1=CC=CC=C1 UMWZZAJHUNJVEI-PVCWFJFTSA-N 0.000 claims 1
- DWSYMNWJOYKKCK-UHFFFAOYSA-N butyl diethyl phosphate Chemical compound CCCCOP(=O)(OCC)OCC DWSYMNWJOYKKCK-UHFFFAOYSA-N 0.000 claims 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- ITJPTURSPJESQC-UHFFFAOYSA-N diethyl pentyl phosphate Chemical compound CCCCCOP(=O)(OCC)OCC ITJPTURSPJESQC-UHFFFAOYSA-N 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- URWFYKDUIANHIR-UHFFFAOYSA-N ditert-butyl ethyl phosphate Chemical compound CCOP(=O)(OC(C)(C)C)OC(C)(C)C URWFYKDUIANHIR-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 201000011191 dyskinesia of esophagus Diseases 0.000 claims 1
- LNOQURRKNJKKBU-UHFFFAOYSA-N ethyl piperazine-1-carboxylate Chemical compound CCOC(=O)N1CCNCC1 LNOQURRKNJKKBU-UHFFFAOYSA-N 0.000 claims 1
- VDRBDINALVEVEB-UHFFFAOYSA-N hexyl dimethyl phosphate Chemical compound CCCCCCOP(=O)(OC)OC VDRBDINALVEVEB-UHFFFAOYSA-N 0.000 claims 1
- UTCSSFWDNNEEBH-UHFFFAOYSA-N imidazo[1,2-a]pyridine Chemical compound C1=CC=CC2=NC=CN21 UTCSSFWDNNEEBH-UHFFFAOYSA-N 0.000 claims 1
- HVLHXIVRXGSVJC-UHFFFAOYSA-N isocyanato propanoate Chemical compound CCC(=O)ON=C=O HVLHXIVRXGSVJC-UHFFFAOYSA-N 0.000 claims 1
- KKSZSACCVDIWIE-UHFFFAOYSA-N isoquinoline-3-carboxamide Chemical compound C1=CC=C2C=NC(C(=O)N)=CC2=C1 KKSZSACCVDIWIE-UHFFFAOYSA-N 0.000 claims 1
- UVMPXVLAGSCZHW-NRFANRHFSA-N methyl (5s)-5-[acetyl-[(2,3-dichlorophenyl)methylamino]amino]-6-(isoquinolin-3-ylcarbamoyloxy)hexanoate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCCC(=O)OC)NCC1=CC=CC(Cl)=C1Cl UVMPXVLAGSCZHW-NRFANRHFSA-N 0.000 claims 1
- BWIZGEWTDGFJHI-FQEVSTJZSA-N methyl (5s)-5-[acetyl-[(2,3-difluorophenyl)methylamino]amino]-6-[[5-(4-fluorophenyl)-1,2-oxazol-3-yl]carbamoyloxy]hexanoate Chemical compound C([C@H](CCCC(=O)OC)N(NCC=1C(=C(F)C=CC=1)F)C(C)=O)OC(=O)NC(=NO1)C=C1C1=CC=C(F)C=C1 BWIZGEWTDGFJHI-FQEVSTJZSA-N 0.000 claims 1
- XDYQVQMAYZKKHN-IBGZPJMESA-N methyl (5s)-5-[acetyl-[(2,3-difluorophenyl)methylamino]amino]-6-[[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-yl]carbamoyloxy]hexanoate Chemical compound C([C@H](CCCC(=O)OC)N(NCC=1C(=C(F)C=CC=1)F)C(C)=O)OC(=O)NC(S1)=NN=C1C1=CC=C(F)C=C1 XDYQVQMAYZKKHN-IBGZPJMESA-N 0.000 claims 1
- MOIUGWXMLJKUIK-IBGZPJMESA-N methyl (5s)-5-[acetyl-[(2,3-difluorophenyl)methylamino]amino]-6-[[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]carbamoyloxy]hexanoate Chemical compound C([C@H](CCCC(=O)OC)N(NCC=1C(=C(F)C=CC=1)F)C(C)=O)OC(=O)NC(S1)=NN=C1C1=CC=C(OC)C=C1 MOIUGWXMLJKUIK-IBGZPJMESA-N 0.000 claims 1
- AYVYZLWZRDHVGD-AWEZNQCLSA-N methyl (5s)-5-[acetyl-[(2,3-difluorophenyl)methylamino]amino]-6-[[5-(trifluoromethyl)-1,2-oxazol-3-yl]carbamoyloxy]hexanoate Chemical compound C([C@H](CCCC(=O)OC)N(NCC=1C(=C(F)C=CC=1)F)C(C)=O)OC(=O)NC=1C=C(C(F)(F)F)ON=1 AYVYZLWZRDHVGD-AWEZNQCLSA-N 0.000 claims 1
- KBSRSTQRXORICM-FQEVSTJZSA-N methyl (5s)-5-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-6-(2,6-naphthyridin-3-ylcarbamoyloxy)hexanoate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=NC=C2C=1)CCCC(=O)OC)NCC1=CC=CC(F)=C1Cl KBSRSTQRXORICM-FQEVSTJZSA-N 0.000 claims 1
- WICWVCCLEIXRQP-FQEVSTJZSA-N methyl (5s)-5-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-6-(2,7-naphthyridin-3-ylcarbamoyloxy)hexanoate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CN=CC=C2C=1)CCCC(=O)OC)NCC1=CC=CC(F)=C1Cl WICWVCCLEIXRQP-FQEVSTJZSA-N 0.000 claims 1
- KUENXMOJKRSHHG-QFIPXVFZSA-N methyl (5s)-5-[acetyl-[(2-chloro-4-fluorophenyl)methylamino]amino]-6-(isoquinolin-3-ylcarbamoyloxy)hexanoate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCCC(=O)OC)NCC1=CC=C(F)C=C1Cl KUENXMOJKRSHHG-QFIPXVFZSA-N 0.000 claims 1
- CSSIICKTWVZLQW-QFIPXVFZSA-N methyl (5s)-5-[acetyl-[(2-chlorophenyl)methylamino]amino]-6-(isoquinolin-3-ylcarbamoyloxy)hexanoate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCCC(=O)OC)NCC1=CC=CC=C1Cl CSSIICKTWVZLQW-QFIPXVFZSA-N 0.000 claims 1
- XPXSUVOWUXDJEB-NRFANRHFSA-N methyl (5s)-5-[acetyl-[(3-chloro-2-fluorophenyl)methylamino]amino]-6-(isoquinolin-3-ylcarbamoyloxy)hexanoate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCCC(=O)OC)NCC1=CC=CC(Cl)=C1F XPXSUVOWUXDJEB-NRFANRHFSA-N 0.000 claims 1
- UUIQMZJEGPQKFD-UHFFFAOYSA-N n-butyric acid methyl ester Natural products CCCC(=O)OC UUIQMZJEGPQKFD-UHFFFAOYSA-N 0.000 claims 1
- 235000005152 nicotinamide Nutrition 0.000 claims 1
- 239000011570 nicotinamide Substances 0.000 claims 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 1
- LZMATGARSSLFMQ-UHFFFAOYSA-N propan-2-ylurea Chemical compound CC(C)NC(N)=O LZMATGARSSLFMQ-UHFFFAOYSA-N 0.000 claims 1
- NYCVCXMSZNOGDH-UHFFFAOYSA-N pyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCCC1 NYCVCXMSZNOGDH-UHFFFAOYSA-N 0.000 claims 1
- 125000005493 quinolyl group Chemical group 0.000 claims 1
- DCIAHNZYMKFMKZ-QHCPKHFHSA-N tert-butyl N-[[(4S)-4-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]pentyl]sulfamoyl]carbamate Chemical compound CC(=O)N([C@@H](CCCNS(=O)(=O)NC(=O)OC(C)(C)C)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl DCIAHNZYMKFMKZ-QHCPKHFHSA-N 0.000 claims 1
- WXGIKZYRVVBFOQ-RUBXLXHKSA-N tert-butyl n-[(2s)-1-[[3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-5-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]-3-methylpentyl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(C)(CCNC(=O)[C@H](CO)NC(=O)OC(C)(C)C)C(=O)NCC1=CC=CC(F)=C1Cl WXGIKZYRVVBFOQ-RUBXLXHKSA-N 0.000 claims 1
- JLTZMJZRXZAKIL-NRFANRHFSA-N tert-butyl n-[(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]propyl]carbamate Chemical compound CC(=O)N([C@@H](CNC(=O)OC(C)(C)C)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NCC1=CC=CC(F)=C1Cl JLTZMJZRXZAKIL-NRFANRHFSA-N 0.000 claims 1
- GNDMUDSNIZKJTA-QFIPXVFZSA-N tert-butyl n-[(4s)-4-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]pentyl]carbamate Chemical compound CN([C@@H](CCCNC(=O)OC(C)(C)C)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl GNDMUDSNIZKJTA-QFIPXVFZSA-N 0.000 claims 1
- GLLYZBNBSSUSAD-UHFFFAOYSA-N tert-butyl n-[2-[[2-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-4-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]-2-methylbutyl]amino]-2-oxoethyl]carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(C)(CNC(=O)CNC(=O)OC(C)(C)C)C(=O)NCC1=CC=CC(F)=C1Cl GLLYZBNBSSUSAD-UHFFFAOYSA-N 0.000 claims 1
- OTMSETWSXLUIMK-UHFFFAOYSA-N tert-butyl n-[2-[[3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-5-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]-3-methylpentyl]amino]-2-oxoethyl]carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(C)(CCNC(=O)CNC(=O)OC(C)(C)C)C(=O)NCC1=CC=CC(F)=C1Cl OTMSETWSXLUIMK-UHFFFAOYSA-N 0.000 claims 1
- UYWASBMTPHWEGY-UHFFFAOYSA-N tert-butyl n-[3-[(2-chloro-3-fluorophenyl)methylcarbamoyl]-5-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]-3-methylpentyl]carbamate Chemical compound C=1C2=CC(F)=CC=C2C=NC=1NC(=O)OCCC(C)(CCNC(=O)OC(C)(C)C)C(=O)NCC1=CC=CC(F)=C1Cl UYWASBMTPHWEGY-UHFFFAOYSA-N 0.000 claims 1
- 239000012991 xanthate Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 273
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 200
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 183
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 150
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 130
- 235000019439 ethyl acetate Nutrition 0.000 description 129
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 127
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 100
- 238000006243 chemical reaction Methods 0.000 description 95
- 239000011541 reaction mixture Substances 0.000 description 95
- 239000011734 sodium Substances 0.000 description 83
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 80
- 239000012267 brine Substances 0.000 description 77
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 77
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 75
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 72
- 229920006395 saturated elastomer Polymers 0.000 description 61
- 239000007787 solid Substances 0.000 description 59
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 55
- 238000004007 reversed phase HPLC Methods 0.000 description 53
- 239000000741 silica gel Substances 0.000 description 52
- 229910002027 silica gel Inorganic materials 0.000 description 52
- 239000012044 organic layer Substances 0.000 description 51
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 46
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 43
- 238000002360 preparation method Methods 0.000 description 43
- 239000002904 solvent Substances 0.000 description 41
- 238000000746 purification Methods 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 37
- 239000000706 filtrate Substances 0.000 description 35
- 238000003756 stirring Methods 0.000 description 35
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 31
- 125000000753 cycloalkyl group Chemical group 0.000 description 31
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 description 28
- 239000000460 chlorine Substances 0.000 description 26
- 125000001424 substituent group Chemical group 0.000 description 25
- 125000004432 carbon atom Chemical group C* 0.000 description 24
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 23
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 21
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 20
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 18
- 229910052757 nitrogen Inorganic materials 0.000 description 18
- 235000021317 phosphate Nutrition 0.000 description 17
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 125000005842 heteroatom Chemical group 0.000 description 16
- 229910052760 oxygen Inorganic materials 0.000 description 16
- 239000002244 precipitate Substances 0.000 description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 14
- 239000000872 buffer Substances 0.000 description 14
- ITWNHVUNXRNKFN-UHFFFAOYSA-N isoquinolin-3-ylcarbamic acid Chemical compound C1=CC=C2C=NC(NC(=O)O)=CC2=C1 ITWNHVUNXRNKFN-UHFFFAOYSA-N 0.000 description 14
- 125000004043 oxo group Chemical group O=* 0.000 description 14
- 230000002829 reductive effect Effects 0.000 description 14
- 229910052717 sulfur Inorganic materials 0.000 description 14
- 125000003396 thiol group Chemical group [H]S* 0.000 description 13
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 12
- NXLNNXIXOYSCMB-UHFFFAOYSA-N (4-nitrophenyl) carbonochloridate Chemical compound [O-][N+](=O)C1=CC=C(OC(Cl)=O)C=C1 NXLNNXIXOYSCMB-UHFFFAOYSA-N 0.000 description 11
- 239000012230 colorless oil Substances 0.000 description 11
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 11
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 11
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 10
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 10
- 239000011575 calcium Substances 0.000 description 10
- 229910052791 calcium Inorganic materials 0.000 description 10
- BKHDVLNPBLSCKA-UHFFFAOYSA-N isoquinoline-3-carbonyl azide Chemical compound C1=CC=C2C=NC(C(=O)N=[N+]=[N-])=CC2=C1 BKHDVLNPBLSCKA-UHFFFAOYSA-N 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- UGAKDDOYQSBOJJ-UHFFFAOYSA-N 6-fluoroisoquinoline-3-carbonyl azide Chemical compound C1=NC(C(=O)N=[N+]=[N-])=CC2=CC(F)=CC=C21 UGAKDDOYQSBOJJ-UHFFFAOYSA-N 0.000 description 9
- 150000005829 chemical entities Chemical class 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 229910000104 sodium hydride Inorganic materials 0.000 description 9
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Substances C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 description 9
- 125000003545 alkoxy group Chemical group 0.000 description 8
- 238000003556 assay Methods 0.000 description 8
- 230000007062 hydrolysis Effects 0.000 description 8
- 238000006460 hydrolysis reaction Methods 0.000 description 8
- RUZLIIJDZBWWSA-INIZCTEOSA-N methyl 2-[[(1s)-1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoate Chemical group COC(=O)C1=CC=CC=C1N[C@@H](C)C1=CC(C)=CN2C(=O)C=C(N3CCOCC3)N=C12 RUZLIIJDZBWWSA-INIZCTEOSA-N 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 8
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 238000001914 filtration Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000003960 organic solvent Substances 0.000 description 7
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 7
- IONJNTZSNXRLAZ-UHFFFAOYSA-N (2-chloro-3-fluorophenyl)methanamine;hydrochloride Chemical compound Cl.NCC1=CC=CC(F)=C1Cl IONJNTZSNXRLAZ-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 6
- 208000005392 Spasm Diseases 0.000 description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 6
- 210000003128 head Anatomy 0.000 description 6
- 230000003993 interaction Effects 0.000 description 6
- 239000000651 prodrug Substances 0.000 description 6
- 229940002612 prodrug Drugs 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- 125000006413 ring segment Chemical group 0.000 description 6
- 239000012312 sodium hydride Substances 0.000 description 6
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 6
- DTNYGEBHHWVMBK-UHFFFAOYSA-N (2-chloro-3-fluorophenyl)methanamine Chemical compound NCC1=CC=CC(F)=C1Cl DTNYGEBHHWVMBK-UHFFFAOYSA-N 0.000 description 5
- TXCHRJONRPTCKU-UHFFFAOYSA-N (4-nitrophenyl) n-[(2-chloro-3-fluorophenyl)methyl]carbamate Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC(=O)NCC1=CC=CC(F)=C1Cl TXCHRJONRPTCKU-UHFFFAOYSA-N 0.000 description 5
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 5
- 208000007101 Muscle Cramp Diseases 0.000 description 5
- 102100038303 Myosin-2 Human genes 0.000 description 5
- 101710204037 Myosin-2 Proteins 0.000 description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 125000002837 carbocyclic group Chemical group 0.000 description 5
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 238000003818 flash chromatography Methods 0.000 description 5
- 235000019253 formic acid Nutrition 0.000 description 5
- 208000037805 labour Diseases 0.000 description 5
- 239000012299 nitrogen atmosphere Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000012453 solvate Substances 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 239000011593 sulfur Chemical group 0.000 description 5
- AWQAQKBHUUHQHD-UHFFFAOYSA-N (6-fluoroisoquinolin-3-yl)carbamic acid Chemical compound FC1=CC=C2C=NC(NC(=O)O)=CC2=C1 AWQAQKBHUUHQHD-UHFFFAOYSA-N 0.000 description 4
- UWTNPUDTAFOVFX-QWHCGFSZSA-N 3-[(2-chloro-3-fluorophenyl)methyl]-1-[(2s)-1-[(4r)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-hydroxypropan-2-yl]-1-methylurea Chemical compound C([C@@H](CO)N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)[C@@H]1COC(C)(C)O1 UWTNPUDTAFOVFX-QWHCGFSZSA-N 0.000 description 4
- VHAZGGYASQLEDD-NSHDSACASA-N 3-[(2-chloro-3-fluorophenyl)methyl]-1-[(2s)-1-hydroxypent-4-en-2-yl]-1-methylurea Chemical compound C=CC[C@@H](CO)N(C)C(=O)NCC1=CC=CC(F)=C1Cl VHAZGGYASQLEDD-NSHDSACASA-N 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 125000002947 alkylene group Chemical group 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000012458 free base Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- QWNDSIJBHSRUDW-IBGZPJMESA-N methyl (4s)-4-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-5-(isoquinolin-3-ylcarbamoyloxy)pentanoate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCC(=O)OC)C(=O)NCC1=CC=CC(F)=C1F QWNDSIJBHSRUDW-IBGZPJMESA-N 0.000 description 4
- 210000003632 microfilament Anatomy 0.000 description 4
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- JSYAOJSUOPLEPB-UHFFFAOYSA-N propyl n-isoquinolin-3-ylcarbamate Chemical compound C1=CC=C2C=NC(NC(=O)OCCC)=CC2=C1 JSYAOJSUOPLEPB-UHFFFAOYSA-N 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- SOSDTMHWSKNYMZ-AWEZNQCLSA-N tert-butyl n-[(2s)-1-[tert-butyl(dimethyl)silyl]oxypent-4-en-2-yl]-n-methylcarbamate Chemical compound CC(C)(C)OC(=O)N(C)[C@@H](CC=C)CO[Si](C)(C)C(C)(C)C SOSDTMHWSKNYMZ-AWEZNQCLSA-N 0.000 description 4
- GXQUCLYSDCZTHK-ZDUSSCGKSA-N tert-butyl n-[(2s)-1-[tert-butyl(dimethyl)silyl]oxypent-4-en-2-yl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@@H](CC=C)CO[Si](C)(C)C(C)(C)C GXQUCLYSDCZTHK-ZDUSSCGKSA-N 0.000 description 4
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 4
- OHZUCDHZOHSBPZ-UHFFFAOYSA-N (2,3-difluorophenyl)methanamine Chemical compound NCC1=CC=CC(F)=C1F OHZUCDHZOHSBPZ-UHFFFAOYSA-N 0.000 description 3
- OMIBPPOIBLWLFN-LURJTMIESA-N (2s)-2-(methylamino)pent-4-en-1-ol Chemical compound CN[C@H](CO)CC=C OMIBPPOIBLWLFN-LURJTMIESA-N 0.000 description 3
- BUPDPLXLAKNJMI-ZETCQYMHSA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]pent-4-enoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC=C BUPDPLXLAKNJMI-ZETCQYMHSA-N 0.000 description 3
- XVBNZCHHXPZHDQ-UHFFFAOYSA-N 1,3-benzothiazole-2-carbonyl azide Chemical compound C1=CC=C2SC(C(=O)N=[N+]=[N-])=NC2=C1 XVBNZCHHXPZHDQ-UHFFFAOYSA-N 0.000 description 3
- 108091006112 ATPases Proteins 0.000 description 3
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 3
- 208000007914 Labor Pain Diseases 0.000 description 3
- 208000035945 Labour pain Diseases 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 102000002151 Microfilament Proteins Human genes 0.000 description 3
- 108010040897 Microfilament Proteins Proteins 0.000 description 3
- LFTLOKWAGJYHHR-UHFFFAOYSA-N N-methylmorpholine N-oxide Chemical compound CN1(=O)CCOCC1 LFTLOKWAGJYHHR-UHFFFAOYSA-N 0.000 description 3
- XGEGHDBEHXKFPX-UHFFFAOYSA-N N-methylthiourea Natural products CNC(N)=O XGEGHDBEHXKFPX-UHFFFAOYSA-N 0.000 description 3
- PCNAQCUHYBRJED-IBGZPJMESA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-5-phosphonooxypentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCOP(O)(O)=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1F PCNAQCUHYBRJED-IBGZPJMESA-N 0.000 description 3
- POQOKRRETJRPHT-RBUKOAKNSA-N [(2s,4r)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)C[C@@H](O)CO)C(=O)NCC1=CC=CC(F)=C1F POQOKRRETJRPHT-RBUKOAKNSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- UZIDMGDVUHUGOO-SFHVURJKSA-N benzyl (4s)-4-[3-(1,3-dioxoisoindol-2-yl)propyl]-5-oxo-1,3-oxazolidine-3-carboxylate Chemical compound N1([C@H](C(=O)OC1)CCCN1C(C2=CC=CC=C2C1=O)=O)C(=O)OCC1=CC=CC=C1 UZIDMGDVUHUGOO-SFHVURJKSA-N 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000006196 drop Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000012285 osmium tetroxide Substances 0.000 description 3
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 230000010412 perfusion Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 125000004159 quinolin-2-yl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C([H])C(*)=NC2=C1[H] 0.000 description 3
- 125000004548 quinolin-3-yl group Chemical group N1=CC(=CC2=CC=CC=C12)* 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 3
- 235000010265 sodium sulphite Nutrition 0.000 description 3
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 125000004434 sulfur atom Chemical group 0.000 description 3
- SHZQFTGRSXLBBA-AWEZNQCLSA-N tert-butyl n-[(2s)-1-azido-3-phenylmethoxypropan-2-yl]-n-methylcarbamate Chemical compound CC(C)(C)OC(=O)N(C)[C@@H](CN=[N+]=[N-])COCC1=CC=CC=C1 SHZQFTGRSXLBBA-AWEZNQCLSA-N 0.000 description 3
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 3
- GIIYCENPYHKOTP-UHFFFAOYSA-N (2,2-dimethyl-1,3-dioxolan-4-yl)methyl trifluoromethanesulfonate Chemical compound CC1(C)OCC(COS(=O)(=O)C(F)(F)F)O1 GIIYCENPYHKOTP-UHFFFAOYSA-N 0.000 description 2
- ZHBPUAVUQAELPB-NSHDSACASA-N (2s)-1-[tert-butyl(dimethyl)silyl]oxy-n-methylpent-4-en-2-amine Chemical compound C=CC[C@H](NC)CO[Si](C)(C)C(C)(C)C ZHBPUAVUQAELPB-NSHDSACASA-N 0.000 description 2
- UNVDWLOVAOOSQC-VIFPVBQESA-N (2s)-2-(methylamino)-3-pyridin-2-ylpropan-1-ol Chemical compound CN[C@H](CO)CC1=CC=CC=N1 UNVDWLOVAOOSQC-VIFPVBQESA-N 0.000 description 2
- MQPNGCUDSUWPCW-ZETCQYMHSA-N (2s)-3-(1h-imidazol-5-yl)-2-(methylamino)propan-1-ol Chemical compound CN[C@H](CO)CC1=CNC=N1 MQPNGCUDSUWPCW-ZETCQYMHSA-N 0.000 description 2
- WEEQAYUCVHBXJK-QMMMGPOBSA-N (2s)-6-methoxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]-6-oxohexanoic acid Chemical compound COC(=O)CCC[C@@H](C(O)=O)NC(=O)OC(C)(C)C WEEQAYUCVHBXJK-QMMMGPOBSA-N 0.000 description 2
- ZIRUOLQVELBPBE-SFHVURJKSA-N (4s)-4-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]pentanoic acid Chemical compound CN([C@@H](CCC(O)=O)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl ZIRUOLQVELBPBE-SFHVURJKSA-N 0.000 description 2
- UUYQXUARAQGDNR-ZDUSSCGKSA-N (4s)-5-[tert-butyl(dimethyl)silyl]oxy-2,2-dimethyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid Chemical compound CC(C)(C)OC(=O)N[C@@H](CC(C)(C)C(O)=O)CO[Si](C)(C)C(C)(C)C UUYQXUARAQGDNR-ZDUSSCGKSA-N 0.000 description 2
- DQHNOUXNRYHTJW-JTQLQIEISA-N (5s)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-3,3-dimethylpyrrolidin-2-one Chemical compound CC(C)(C)[Si](C)(C)OC[C@@H]1CC(C)(C)C(=O)N1 DQHNOUXNRYHTJW-JTQLQIEISA-N 0.000 description 2
- NUPOYZPOLQAMAK-VIFPVBQESA-N (5s)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]pyrrolidin-2-one Chemical compound CC(C)(C)[Si](C)(C)OC[C@@H]1CCC(=O)N1 NUPOYZPOLQAMAK-VIFPVBQESA-N 0.000 description 2
- 125000004505 1,2,4-oxadiazol-5-yl group Chemical group O1N=CN=C1* 0.000 description 2
- GYADLBSESMQVEF-UHFFFAOYSA-N 1,3-benzothiazole-2-carbohydrazide Chemical compound C1=CC=C2SC(C(=O)NN)=NC2=C1 GYADLBSESMQVEF-UHFFFAOYSA-N 0.000 description 2
- RKKYQDXCECRDKI-INIZCTEOSA-N 1-[(2s)-1-[tert-butyl(dimethyl)silyl]oxy-5-hydroxypentan-2-yl]-3-[(2,3-difluorophenyl)methyl]-1-methylurea Chemical compound CC(C)(C)[Si](C)(C)OC[C@H](CCCO)N(C)C(=O)NCC1=CC=CC(F)=C1F RKKYQDXCECRDKI-INIZCTEOSA-N 0.000 description 2
- IIEJOBYJBBGPSV-INIZCTEOSA-N 1-[(2s)-1-[tert-butyl(dimethyl)silyl]oxypent-4-en-2-yl]-3-[(2,3-difluorophenyl)methyl]-1-methylurea Chemical compound CC(C)(C)[Si](C)(C)OC[C@H](CC=C)N(C)C(=O)NCC1=CC=CC(F)=C1F IIEJOBYJBBGPSV-INIZCTEOSA-N 0.000 description 2
- QKKHFONDGYRAIU-UHFFFAOYSA-N 2,7-naphthyridine-3-carbonyl azide Chemical compound C1=NC=C2C=NC(C(=O)N=[N+]=[N-])=CC2=C1 QKKHFONDGYRAIU-UHFFFAOYSA-N 0.000 description 2
- REGNBBZZTQVCJU-UHFFFAOYSA-N 2,7-naphthyridine-3-carboxylic acid Chemical compound C1=NC=C2C=NC(C(=O)O)=CC2=C1 REGNBBZZTQVCJU-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- VRPJIFMKZZEXLR-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid Chemical compound CC(C)(C)OC(=O)NCC(O)=O VRPJIFMKZZEXLR-UHFFFAOYSA-N 0.000 description 2
- OSALQEAYMNEZKK-JTQLQIEISA-N 2-[(4s)-5-hydroxy-4-(methylamino)pentyl]isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCC[C@@H](CO)NC)C(=O)C2=C1 OSALQEAYMNEZKK-JTQLQIEISA-N 0.000 description 2
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 2
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- SEQWVIMFMBLAPM-UHFFFAOYSA-N 3-(3-fluorophenyl)-1,2-oxazole-5-carbonyl azide Chemical compound FC1=CC=CC(C2=NOC(=C2)C(=O)N=[N+]=[N-])=C1 SEQWVIMFMBLAPM-UHFFFAOYSA-N 0.000 description 2
- FRBLJZQLWAJMTD-HNNXBMFYSA-N 3-[(2-chloro-3-fluorophenyl)methyl]-1-[(2s)-5-(1,3-dioxoisoindol-2-yl)-1-hydroxypentan-2-yl]-1-methylurea Chemical compound CN([C@H](CO)CCCN1C(C2=CC=CC=C2C1=O)=O)C(=O)NCC1=CC=CC(F)=C1Cl FRBLJZQLWAJMTD-HNNXBMFYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- 125000006284 3-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(F)=C1[H])C([H])([H])* 0.000 description 2
- JGZOFDUEAFKXBF-UHFFFAOYSA-N 3-phenyl-1,2-oxazole-5-carbonyl azide Chemical compound O1C(C(=O)N=[N+]=[N-])=CC(C=2C=CC=CC=2)=N1 JGZOFDUEAFKXBF-UHFFFAOYSA-N 0.000 description 2
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 2
- JBQURZYHKJWTJI-UHFFFAOYSA-N 5-(2-tert-butylsilyloxypropan-2-yl)pyrrolidin-2-one Chemical compound C(C)(C)(C)[SiH2]OC(C1CCC(N1)=O)(C)C JBQURZYHKJWTJI-UHFFFAOYSA-N 0.000 description 2
- UBUCYRGLGZNLGB-UHFFFAOYSA-N 5-(3-fluorophenyl)-1,2-oxazole-3-carbohydrazide Chemical compound O1N=C(C(=O)NN)C=C1C1=CC=CC(F)=C1 UBUCYRGLGZNLGB-UHFFFAOYSA-N 0.000 description 2
- TYQYGUYTBMUNNL-UHFFFAOYSA-N 5-(3-fluorophenyl)-1,2-oxazole-3-carbonyl azide Chemical compound FC1=CC=CC(C=2ON=C(C=2)C(=O)N=[N+]=[N-])=C1 TYQYGUYTBMUNNL-UHFFFAOYSA-N 0.000 description 2
- 125000004008 6 membered carbocyclic group Chemical group 0.000 description 2
- BBVCMUHTDCDNGC-UHFFFAOYSA-N 6-fluoroisoquinoline-3-carbohydrazide Chemical compound FC1=CC=C2C=NC(C(=O)NN)=CC2=C1 BBVCMUHTDCDNGC-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010069632 Bladder dysfunction Diseases 0.000 description 2
- DKZXWPLUNMIMLK-UHFFFAOYSA-N C1=CC=C(C(=C1)C(C=O)C(=O)C(=O)O)F Chemical compound C1=CC=C(C(=C1)C(C=O)C(=O)C(=O)O)F DKZXWPLUNMIMLK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- HZXJUQGAKQQPAL-UHFFFAOYSA-N FC=1C=C2C=C(N=CC2=CC1)NC(OCCC)=O Chemical compound FC=1C=C2C=C(N=CC2=CC1)NC(OCCC)=O HZXJUQGAKQQPAL-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- 244000118681 Iresine herbstii Species 0.000 description 2
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 2
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- 150000001204 N-oxides Chemical class 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 2
- 102000001708 Protein Isoforms Human genes 0.000 description 2
- 108010029485 Protein Isoforms Proteins 0.000 description 2
- 102000013009 Pyruvate Kinase Human genes 0.000 description 2
- 108020005115 Pyruvate Kinase Proteins 0.000 description 2
- 101000924984 Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) 3-dehydroquinate dehydratase Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
- 206010047163 Vasospasm Diseases 0.000 description 2
- VCQIKVNHNKFOGM-NRFANRHFSA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-5-dimethoxyphosphoryloxypentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCCOP(=O)(OC)OC)C(=O)NCC1=CC=CC(F)=C1F VCQIKVNHNKFOGM-NRFANRHFSA-N 0.000 description 2
- MABJFYSSXKZYFB-FQEVSTJZSA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-6-phosphonooxyhexyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](CCCCOP(O)(O)=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1F MABJFYSSXKZYFB-FQEVSTJZSA-N 0.000 description 2
- FFBRPVVSFFNVRN-ZDUSSCGKSA-N [(2s)-6-methoxy-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]-6-oxohexyl] imidazole-1-carboxylate Chemical compound COC(=O)CCC[C@H](N(C)C(=O)OC(C)(C)C)COC(=O)N1C=CN=C1 FFBRPVVSFFNVRN-ZDUSSCGKSA-N 0.000 description 2
- JVGKBPKNXKOQOH-KRWDZBQOSA-N [(4s)-5-[tert-butyl(dimethyl)silyl]oxy-2,2-dimethyl-4-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]pentyl] acetate Chemical compound CC(C)(C)OC(=O)N(C)[C@H](CO[Si](C)(C)C(C)(C)C)CC(C)(C)COC(C)=O JVGKBPKNXKOQOH-KRWDZBQOSA-N 0.000 description 2
- LSEOOOSAGCNNAX-HNNXBMFYSA-N [(4s)-5-[tert-butyl(dimethyl)silyl]oxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]pentyl] acetate Chemical compound CC(=O)OCCC[C@@H](CO[Si](C)(C)C(C)(C)C)NC(=O)OC(C)(C)C LSEOOOSAGCNNAX-HNNXBMFYSA-N 0.000 description 2
- NEIUPWXFHYRAJV-INIZCTEOSA-N [(4s)-5-[tert-butyl(dimethyl)silyl]oxy-4-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]pentyl] acetate Chemical compound CC(C)(C)OC(=O)N(C)[C@H](CO[Si](C)(C)C(C)(C)C)CCCOC(C)=O NEIUPWXFHYRAJV-INIZCTEOSA-N 0.000 description 2
- HNYXHRONVORMHS-UHFFFAOYSA-N [2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(6,8-dihydro-5h-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)pentyl] n-isoquinolin-3-ylcarbamate Chemical compound C1CN2C=NN=C2CN1CCCC(COC(=O)NC=1N=CC2=CC=CC=C2C=1)N(C)C(=O)NCC1=CC=CC(F)=C1Cl HNYXHRONVORMHS-UHFFFAOYSA-N 0.000 description 2
- LQUMCSAFYMZKCB-UHFFFAOYSA-N [2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-oxopentyl] n-isoquinolin-3-ylcarbamate Chemical compound C=1C2=CC=CC=C2C=NC=1NC(=O)OCC(CCC=O)N(C)C(=O)NCC1=CC=CC(F)=C1Cl LQUMCSAFYMZKCB-UHFFFAOYSA-N 0.000 description 2
- SORGEQQSQGNZFI-UHFFFAOYSA-N [azido(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(N=[N+]=[N-])OC1=CC=CC=C1 SORGEQQSQGNZFI-UHFFFAOYSA-N 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000004103 aminoalkyl group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- AHCGAYIGYXTOHD-INIZCTEOSA-N benzyl (2s)-2-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-oxopyrrolidine-1-carboxylate Chemical compound CC(C)(C)[Si](C)(C)OC[C@@H]1CCC(=O)N1C(=O)OCC1=CC=CC=C1 AHCGAYIGYXTOHD-INIZCTEOSA-N 0.000 description 2
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 125000006580 bicyclic heterocycloalkyl group Chemical group 0.000 description 2
- 210000000013 bile duct Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 239000010779 crude oil Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical compound C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- LJOQGZACKSYWCH-UHFFFAOYSA-N dihydro quinine Natural products C1=C(OC)C=C2C(C(O)C3CC4CCN3CC4CC)=CC=NC2=C1 LJOQGZACKSYWCH-UHFFFAOYSA-N 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- GPSJGANDCOWRQD-QFIPXVFZSA-N ditert-butyl [(4s)-5-[tert-butyl(dimethyl)silyl]oxy-4-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]pentyl] phosphate Chemical compound CC(C)(C)OP(=O)(OC(C)(C)C)OCCC[C@@H](CO[Si](C)(C)C(C)(C)C)N(C)C(=O)NCC1=CC=CC(F)=C1F GPSJGANDCOWRQD-QFIPXVFZSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- VRHAQNTWKSVEEC-UHFFFAOYSA-N ethyl 1,3-dioxoisoindole-2-carboxylate Chemical compound C1=CC=C2C(=O)N(C(=O)OCC)C(=O)C2=C1 VRHAQNTWKSVEEC-UHFFFAOYSA-N 0.000 description 2
- STKHVSUVJQOXSL-UHFFFAOYSA-N ethyl 5-(3-fluorophenyl)-1,2-oxazole-3-carboxylate Chemical compound O1N=C(C(=O)OCC)C=C1C1=CC=CC(F)=C1 STKHVSUVJQOXSL-UHFFFAOYSA-N 0.000 description 2
- 239000003889 eye drop Substances 0.000 description 2
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 2
- 238000001030 gas--liquid chromatography Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 125000001188 haloalkyl group Chemical group 0.000 description 2
- 125000005059 halophenyl group Chemical group 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- IDYZQKSKOOQSDM-UHFFFAOYSA-N hexyl n-isoquinolin-3-ylcarbamate Chemical compound C1=CC=C2C=NC(NC(=O)OCCCCCC)=CC2=C1 IDYZQKSKOOQSDM-UHFFFAOYSA-N 0.000 description 2
- 108700038605 human Smooth muscle Proteins 0.000 description 2
- 102000043827 human Smooth muscle Human genes 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 description 2
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 2
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical compound C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 description 2
- HNDWQGCPRVVPSZ-UHFFFAOYSA-N isoquinoline-3-carbohydrazide Chemical compound C1=CC=C2C=NC(C(=O)NN)=CC2=C1 HNDWQGCPRVVPSZ-UHFFFAOYSA-N 0.000 description 2
- 239000012035 limiting reagent Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- VWZYHOFPRJIFTM-NSHDSACASA-N methyl (4s)-4-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-hydroxypentanoate Chemical compound COC(=O)CC[C@@H](CO)N(C)C(=O)NCC1=CC=CC(F)=C1Cl VWZYHOFPRJIFTM-NSHDSACASA-N 0.000 description 2
- FRADJPGIXSNYQM-AWEZNQCLSA-N methyl (4s)-5-[tert-butyl(dimethyl)silyl]oxy-4-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]pentanoate Chemical compound COC(=O)CC[C@@H](CO[Si](C)(C)C(C)(C)C)N(C)C(=O)OC(C)(C)C FRADJPGIXSNYQM-AWEZNQCLSA-N 0.000 description 2
- NRPJTSTURIPNKO-HNNXBMFYSA-N methyl (5s)-6-(isoquinolin-3-ylcarbamoyloxy)-5-(methylamino)hexanoate Chemical compound C1=CC=C2C=NC(NC(=O)OC[C@H](CCCC(=O)OC)NC)=CC2=C1 NRPJTSTURIPNKO-HNNXBMFYSA-N 0.000 description 2
- HGIOUDLSNGQKLI-AWEZNQCLSA-N methyl (5s)-6-[tert-butyl(dimethyl)silyl]oxy-5-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoate Chemical compound COC(=O)CCC[C@@H](CO[Si](C)(C)C(C)(C)C)NC(=O)OC(C)(C)C HGIOUDLSNGQKLI-AWEZNQCLSA-N 0.000 description 2
- ZZCXQYQXTMPBTR-HNNXBMFYSA-N methyl (5s)-6-[tert-butyl(dimethyl)silyl]oxy-5-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]hexanoate Chemical compound COC(=O)CCC[C@@H](CO[Si](C)(C)C(C)(C)C)N(C)C(=O)OC(C)(C)C ZZCXQYQXTMPBTR-HNNXBMFYSA-N 0.000 description 2
- NWMMYQIASSPMQS-VIFPVBQESA-N methyl (5s)-6-hydroxy-5-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoate Chemical compound COC(=O)CCC[C@@H](CO)NC(=O)OC(C)(C)C NWMMYQIASSPMQS-VIFPVBQESA-N 0.000 description 2
- ZVTIGMDXMOQUEL-JTQLQIEISA-N methyl (5s)-6-hydroxy-5-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]hexanoate Chemical compound COC(=O)CCC[C@@H](CO)N(C)C(=O)OC(C)(C)C ZVTIGMDXMOQUEL-JTQLQIEISA-N 0.000 description 2
- UXDXURSGQKKSJW-UHFFFAOYSA-N methyl 6-fluoro-1,2,3,4-tetrahydroisoquinoline-3-carboxylate Chemical compound FC1=CC=C2CNC(C(=O)OC)CC2=C1 UXDXURSGQKKSJW-UHFFFAOYSA-N 0.000 description 2
- XXUMEOYMUHEQKZ-UHFFFAOYSA-N methyl 6-fluoroisoquinoline-3-carboxylate Chemical compound FC1=CC=C2C=NC(C(=O)OC)=CC2=C1 XXUMEOYMUHEQKZ-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 210000000663 muscle cell Anatomy 0.000 description 2
- 230000004118 muscle contraction Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 210000001087 myotubule Anatomy 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 125000006501 nitrophenyl group Chemical group 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 210000000277 pancreatic duct Anatomy 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- CPOZZFASGDRUOU-UHFFFAOYSA-N pentyl N-(5-chloropyridin-2-yl)carbamate Chemical compound ClC=1C=CC(=NC=1)NC(OCCCCC)=O CPOZZFASGDRUOU-UHFFFAOYSA-N 0.000 description 2
- YXRQDLWVKJZFOU-UHFFFAOYSA-N pentyl N-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C(CCCC)OC(NC=1N=CC2=CC=C(C=C2C=1)F)=O YXRQDLWVKJZFOU-UHFFFAOYSA-N 0.000 description 2
- PSDDFVMTNJSQEC-UHFFFAOYSA-N pentyl N-isoquinolin-3-ylcarbamate Chemical compound C1=NC(=CC2=CC=CC=C12)NC(OCCCCC)=O PSDDFVMTNJSQEC-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 208000002815 pulmonary hypertension Diseases 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 208000037905 systemic hypertension Diseases 0.000 description 2
- IEIJJCDOVWGDCH-ZDUSSCGKSA-N tert-butyl 4-[(2s)-3-hydroxy-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propyl]imidazole-1-carboxylate Chemical compound CC(C)(C)OC(=O)N(C)[C@H](CO)CC1=CN(C(=O)OC(C)(C)C)C=N1 IEIJJCDOVWGDCH-ZDUSSCGKSA-N 0.000 description 2
- KDFXZMOAPQYTTE-KRWDZBQOSA-N tert-butyl 4-[(4s)-4-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-hydroxypentanoyl]piperazine-1-carboxylate Chemical compound C([C@@H](CO)N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)CC(=O)N1CCN(C(=O)OC(C)(C)C)CC1 KDFXZMOAPQYTTE-KRWDZBQOSA-N 0.000 description 2
- ZINOXVGNWMIHBU-KRWDZBQOSA-N tert-butyl 4-[(4s)-5-[tert-butyl(dimethyl)silyl]oxy-4-(methylamino)pentanoyl]piperazine-1-carboxylate Chemical compound CC(C)(C)[Si](C)(C)OC[C@@H](NC)CCC(=O)N1CCN(C(=O)OC(C)(C)C)CC1 ZINOXVGNWMIHBU-KRWDZBQOSA-N 0.000 description 2
- MNBWQQCYBRMLGQ-QHCPKHFHSA-N tert-butyl 4-[(4s)-5-[tert-butyl(dimethyl)silyl]oxy-4-(phenylmethoxycarbonylamino)pentanoyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C(=O)CC[C@@H](CO[Si](C)(C)C(C)(C)C)NC(=O)OCC1=CC=CC=C1 MNBWQQCYBRMLGQ-QHCPKHFHSA-N 0.000 description 2
- IEFDLLSILXFLDO-DEOSSOPVSA-N tert-butyl 4-[(4s)-5-[tert-butyl(dimethyl)silyl]oxy-4-[methyl(phenylmethoxycarbonyl)amino]pentanoyl]piperazine-1-carboxylate Chemical compound C([C@H](N(C)C(=O)OCC=1C=CC=CC=1)CO[Si](C)(C)C(C)(C)C)CC(=O)N1CCN(C(=O)OC(C)(C)C)CC1 IEFDLLSILXFLDO-DEOSSOPVSA-N 0.000 description 2
- UJJDEOLXODWCGK-UHFFFAOYSA-N tert-butyl carbonochloridate Chemical compound CC(C)(C)OC(Cl)=O UJJDEOLXODWCGK-UHFFFAOYSA-N 0.000 description 2
- OEPXMQSOEHQAJI-AWEZNQCLSA-N tert-butyl n-[(2s)-1-[tert-butyl(dimethyl)silyl]oxy-5-hydroxy-4,4-dimethylpentan-2-yl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@@H](CC(C)(C)CO)CO[Si](C)(C)C(C)(C)C OEPXMQSOEHQAJI-AWEZNQCLSA-N 0.000 description 2
- GUNIDPYOECZUPN-ZDUSSCGKSA-N tert-butyl n-[(2s)-1-azido-3-phenylmethoxypropan-2-yl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@@H](CN=[N+]=[N-])COCC1=CC=CC=C1 GUNIDPYOECZUPN-ZDUSSCGKSA-N 0.000 description 2
- ABDSMVSRKFOYMR-QMMMGPOBSA-N tert-butyl n-[(2s)-1-hydroxypent-4-en-2-yl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@H](CO)CC=C ABDSMVSRKFOYMR-QMMMGPOBSA-N 0.000 description 2
- MEXIZFFDEHHMJH-UHFFFAOYSA-N tert-butyl n-[1-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]-3-(isoquinolin-3-ylcarbamoyloxy)propan-2-yl]-n-methylcarbamate Chemical compound C=1C2=CC=CC=C2C=NC=1NC(=O)OCC(N(C)C(=O)OC(C)(C)C)COCC1COC(C)(C)O1 MEXIZFFDEHHMJH-UHFFFAOYSA-N 0.000 description 2
- ZKYSXDYWNSBRDR-UHFFFAOYSA-N tert-butyl n-[1-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]-3-phenylmethoxypropan-2-yl]-n-methylcarbamate Chemical compound C=1C=CC=CC=1COCC(N(C)C(=O)OC(C)(C)C)COCC1COC(C)(C)O1 ZKYSXDYWNSBRDR-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- CBKWAXKMZUULLO-UHFFFAOYSA-N (2-chloro-4-fluorophenyl)methanamine Chemical compound NCC1=CC=C(F)C=C1Cl CBKWAXKMZUULLO-UHFFFAOYSA-N 0.000 description 1
- FRQWVAWXEBTURS-UHFFFAOYSA-N (2-nitrophenyl) carbamate Chemical compound NC(=O)OC1=CC=CC=C1[N+]([O-])=O FRQWVAWXEBTURS-UHFFFAOYSA-N 0.000 description 1
- BCBCCYKIPPMWKV-RGMNGODLSA-N (2s)-2-(methylamino)pent-4-en-1-ol;hydrochloride Chemical compound Cl.CN[C@H](CO)CC=C BCBCCYKIPPMWKV-RGMNGODLSA-N 0.000 description 1
- WNNNWFKQCKFSDK-BYPYZUCNSA-N (2s)-2-aminopent-4-enoic acid Chemical compound OC(=O)[C@@H](N)CC=C WNNNWFKQCKFSDK-BYPYZUCNSA-N 0.000 description 1
- PNVFTLDMLLRZOB-YFKPBYRVSA-N (2s)-2-azaniumyl-6-methoxy-6-oxohexanoate Chemical compound COC(=O)CCC[C@H](N)C(O)=O PNVFTLDMLLRZOB-YFKPBYRVSA-N 0.000 description 1
- AYMLQYFMYHISQO-QMMMGPOBSA-N (2s)-3-(1h-imidazol-3-ium-5-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CN=CN1 AYMLQYFMYHISQO-QMMMGPOBSA-N 0.000 description 1
- ZYGRWJVRLNJIMR-NSHDSACASA-N (2s)-5-azaniumyl-2-(phenylmethoxycarbonylamino)pentanoate Chemical compound NCCC[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 ZYGRWJVRLNJIMR-NSHDSACASA-N 0.000 description 1
- PHZFDRHVQXOJCN-JTQLQIEISA-N (3S)-2-tert-butylsilyloxy-N,2-dimethylhex-5-en-3-amine Chemical compound C(C)(C)(C)[SiH2]OC([C@H](CC=C)NC)(C)C PHZFDRHVQXOJCN-JTQLQIEISA-N 0.000 description 1
- MULKBDGJPDNJAL-NSHDSACASA-N (4s)-5-[tert-butyl(dimethyl)silyl]oxy-4-(methylamino)pentan-1-ol Chemical compound OCCC[C@H](NC)CO[Si](C)(C)C(C)(C)C MULKBDGJPDNJAL-NSHDSACASA-N 0.000 description 1
- HOBJEFOCIRXQKH-BYPYZUCNSA-N (5s)-5-(hydroxymethyl)pyrrolidin-2-one Chemical compound OC[C@@H]1CCC(=O)N1 HOBJEFOCIRXQKH-BYPYZUCNSA-N 0.000 description 1
- MJWSKPJDWLGKGH-IBGZPJMESA-N (5s)-5-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-6-(isoquinolin-3-ylcarbamoyloxy)hexanoic acid Chemical compound CN([C@@H](CCCC(O)=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1F MJWSKPJDWLGKGH-IBGZPJMESA-N 0.000 description 1
- VYBJLGCAWGAKAA-ZETCQYMHSA-N (7as)-3,3,6,6-tetramethyl-7,7a-dihydro-1h-pyrrolo[1,2-c][1,3]oxazol-5-one Chemical compound C1OC(C)(C)N2C(=O)C(C)(C)C[C@H]21 VYBJLGCAWGAKAA-ZETCQYMHSA-N 0.000 description 1
- YTXXRLXVAZGQAL-LURJTMIESA-N (7as)-3,3-dimethyl-1,6,7,7a-tetrahydropyrrolo[1,2-c][1,3]oxazol-5-one Chemical compound C1CC(=O)N2C(C)(C)OC[C@@H]21 YTXXRLXVAZGQAL-LURJTMIESA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 description 1
- ICLYJLBTOGPLMC-KVVVOXFISA-N (z)-octadec-9-enoate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCC\C=C/CCCCCCCC(O)=O ICLYJLBTOGPLMC-KVVVOXFISA-N 0.000 description 1
- KZKRRZFCAYOXQE-UHFFFAOYSA-N 1$l^{2}-azinane Chemical group C1CC[N]CC1 KZKRRZFCAYOXQE-UHFFFAOYSA-N 0.000 description 1
- BWKMGYQJPOAASG-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid Chemical compound C1=CC=C2CNC(C(=O)O)CC2=C1 BWKMGYQJPOAASG-UHFFFAOYSA-N 0.000 description 1
- HCEKGPAHZCYRBZ-UHFFFAOYSA-N 1-(3-fluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1 HCEKGPAHZCYRBZ-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- IJASCCMTTVOUDW-INIZCTEOSA-N 1-[(2s)-1-[tert-butyl(dimethyl)silyl]oxypent-4-en-2-yl]-3-[(2-chloro-3-fluorophenyl)methyl]-1-methylurea Chemical compound CC(C)(C)[Si](C)(C)OC[C@H](CC=C)N(C)C(=O)NCC1=CC=CC(F)=C1Cl IJASCCMTTVOUDW-INIZCTEOSA-N 0.000 description 1
- JQBMPZQQDJQYIL-JKSUJKDBSA-N 1-[(2s,4r)-1-[tert-butyl(dimethyl)silyl]oxy-4,5-dihydroxypentan-2-yl]-3-[(2-chloro-3-fluorophenyl)methyl]-1-methylurea Chemical compound CC(C)(C)[Si](C)(C)OC[C@H](C[C@@H](O)CO)N(C)C(=O)NCC1=CC=CC(F)=C1Cl JQBMPZQQDJQYIL-JKSUJKDBSA-N 0.000 description 1
- 125000004973 1-butenyl group Chemical group C(=CCC)* 0.000 description 1
- OUZNWVUVTWQCIG-UHFFFAOYSA-N 1-chloro-2,7-naphthyridine-3-carboxylic acid Chemical compound C1=NC=C2C(Cl)=NC(C(=O)O)=CC2=C1 OUZNWVUVTWQCIG-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- HEWZVZIVELJPQZ-UHFFFAOYSA-N 2,2-dimethoxypropane Chemical compound COC(C)(C)OC HEWZVZIVELJPQZ-UHFFFAOYSA-N 0.000 description 1
- XSGMGAINOILNJR-UHFFFAOYSA-N 2-(9h-fluoren-9-ylmethoxycarbonylamino)-3-methyl-3-tritylsulfanylbutanoic acid Chemical compound C12=CC=CC=C2C2=CC=CC=C2C1COC(=O)NC(C(O)=O)C(C)(C)SC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 XSGMGAINOILNJR-UHFFFAOYSA-N 0.000 description 1
- UDWNKZLRXYGLFN-UHFFFAOYSA-N 2-[bromo(tert-butyl)phosphoryl]-2-methylpropane Chemical compound CC(C)(C)P(Br)(=O)C(C)(C)C UDWNKZLRXYGLFN-UHFFFAOYSA-N 0.000 description 1
- ZXFPNENMLCAHOI-UHFFFAOYSA-N 2-[bromo-[(2-methylpropan-2-yl)oxy]phosphoryl]oxy-2-methylpropane Chemical compound CC(C)(C)OP(Br)(=O)OC(C)(C)C ZXFPNENMLCAHOI-UHFFFAOYSA-N 0.000 description 1
- VWHRYODZTDMVSS-UHFFFAOYSA-N 2-azaniumyl-3-(3-fluorophenyl)propanoate Chemical compound OC(=O)C(N)CC1=CC=CC(F)=C1 VWHRYODZTDMVSS-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- ROXFZJBRIXTCPI-UHFFFAOYSA-N 2-chloro-3-fluorobenzonitrile Chemical compound FC1=CC=CC(C#N)=C1Cl ROXFZJBRIXTCPI-UHFFFAOYSA-N 0.000 description 1
- IVHKZCSZELZKSJ-UHFFFAOYSA-N 2-hydroxyethyl sulfonate Chemical compound OCCOS(=O)=O IVHKZCSZELZKSJ-UHFFFAOYSA-N 0.000 description 1
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 description 1
- CVVXSAIVVCFTPG-UHFFFAOYSA-N 3-(3-fluorophenyl)-1,2-oxazole-5-carbohydrazide Chemical compound O1C(C(=O)NN)=CC(C=2C=C(F)C=CC=2)=N1 CVVXSAIVVCFTPG-UHFFFAOYSA-N 0.000 description 1
- UFBUQALMQUCGQA-UHFFFAOYSA-N 3-(3-fluorophenyl)-1,2-oxazole-5-carboxylic acid Chemical compound O1C(C(=O)O)=CC(C=2C=C(F)C=CC=2)=N1 UFBUQALMQUCGQA-UHFFFAOYSA-N 0.000 description 1
- DRVCODLBSRVFDS-NSHDSACASA-N 3-[(2,3-difluorophenyl)methyl]-1-[(2s)-1-hydroxypent-4-en-2-yl]-1-methylurea Chemical compound C=CC[C@@H](CO)N(C)C(=O)NCC1=CC=CC(F)=C1F DRVCODLBSRVFDS-NSHDSACASA-N 0.000 description 1
- NTQCALCSNAKPIB-AWEZNQCLSA-N 3-[(2-chloro-3-fluorophenyl)methyl]-1-[(2s)-1-hydroxy-3-pyridin-2-ylpropan-2-yl]-1-methylurea Chemical compound C([C@@H](CO)N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)C1=CC=CC=N1 NTQCALCSNAKPIB-AWEZNQCLSA-N 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- 125000005917 3-methylpentyl group Chemical group 0.000 description 1
- YGTFDJRCCBKLDM-UHFFFAOYSA-N 3-phenyl-1,2-oxazole-5-carboxylic acid Chemical compound O1C(C(=O)O)=CC(C=2C=CC=CC=2)=N1 YGTFDJRCCBKLDM-UHFFFAOYSA-N 0.000 description 1
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
- XLAPHZHNODDMDD-UHFFFAOYSA-N 4-methylpyridine-3-carbonitrile Chemical compound CC1=CC=NC=C1C#N XLAPHZHNODDMDD-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000004606 5,6,7,8-tetrahydroisoquinolinyl group Chemical group C1(=NC=CC=2CCCCC12)* 0.000 description 1
- HOBJEFOCIRXQKH-UHFFFAOYSA-N 5-(hydroxymethyl)pyrrolidin-2-one Chemical compound OCC1CCC(=O)N1 HOBJEFOCIRXQKH-UHFFFAOYSA-N 0.000 description 1
- NJHGVAYLDHROPT-UHFFFAOYSA-N 5-(trifluoromethyl)pyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(C(F)(F)F)C=N1 NJHGVAYLDHROPT-UHFFFAOYSA-N 0.000 description 1
- GJLOKYIYZIOIPN-UHFFFAOYSA-N 5-chloropyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(Cl)C=N1 GJLOKYIYZIOIPN-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- SRLSCFGRFIBSHD-UHFFFAOYSA-N 6-fluoro-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid Chemical compound FC1=CC=C2CNC(C(=O)O)CC2=C1 SRLSCFGRFIBSHD-UHFFFAOYSA-N 0.000 description 1
- BDDLHHRCDSJVKV-UHFFFAOYSA-N 7028-40-2 Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O BDDLHHRCDSJVKV-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000014825 Abnormal muscle tone Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- IDCVHZXKHRTPCD-UHFFFAOYSA-N C(C1=CC=CC=C1)OCC(COCC1OC(OC1)(C)C)NC(O)=O Chemical compound C(C1=CC=CC=C1)OCC(COCC1OC(OC1)(C)C)NC(O)=O IDCVHZXKHRTPCD-UHFFFAOYSA-N 0.000 description 1
- IZHNLFTUPFGRBC-SJORKVTESA-N C(N)(OC=1N=C(C2=CC=CC=C2C1)C[C@@H](C[C@@H](CO)O)N(C(=O)NCC1=C(C(=CC=C1)F)F)C)=O Chemical compound C(N)(OC=1N=C(C2=CC=CC=C2C1)C[C@@H](C[C@@H](CO)O)N(C(=O)NCC1=C(C(=CC=C1)F)F)C)=O IZHNLFTUPFGRBC-SJORKVTESA-N 0.000 description 1
- YLIDXCXKFYITNV-UHFFFAOYSA-N C1=NC(=CC2=CC=NC=C12)C(=O)OC(C)Cl Chemical compound C1=NC(=CC2=CC=NC=C12)C(=O)OC(C)Cl YLIDXCXKFYITNV-UHFFFAOYSA-N 0.000 description 1
- LORQPUJBBOJIJN-UHFFFAOYSA-N CC1(OCC(O1)COCC(CO)N(C(O)=O)C)C Chemical compound CC1(OCC(O1)COCC(CO)N(C(O)=O)C)C LORQPUJBBOJIJN-UHFFFAOYSA-N 0.000 description 1
- IUMOVYWOVMBDQV-UHFFFAOYSA-N CCCCCOC(=O)Nc1nc2ccccc2s1 Chemical compound CCCCCOC(=O)Nc1nc2ccccc2s1 IUMOVYWOVMBDQV-UHFFFAOYSA-N 0.000 description 1
- OBTHHYSYSDIGDD-FQEVSTJZSA-N CN([C@@H](CCCCO)CN(C1=CC2=CC=CC=C2C=N1)C(=O)O)C(=O)NCC3=C(C(=CC=C3)F)Cl Chemical compound CN([C@@H](CCCCO)CN(C1=CC2=CC=CC=C2C=N1)C(=O)O)C(=O)NCC3=C(C(=CC=C3)F)Cl OBTHHYSYSDIGDD-FQEVSTJZSA-N 0.000 description 1
- LTJKPABLXAWDRJ-SFTDATJTSA-N CN([C@@H](C[C@@H](COP(=O)(OC)OC)O)CN(C1=CC2=CC=CC=C2C=N1)C(=O)O)C(=O)NCC3=C(C(=CC=C3)F)F Chemical compound CN([C@@H](C[C@@H](COP(=O)(OC)OC)O)CN(C1=CC2=CC=CC=C2C=N1)C(=O)O)C(=O)NCC3=C(C(=CC=C3)F)F LTJKPABLXAWDRJ-SFTDATJTSA-N 0.000 description 1
- LTJKPABLXAWDRJ-LEWJYISDSA-N CN([C@@H](C[C@H](COP(=O)(OC)OC)O)CN(C1=CC2=CC=CC=C2C=N1)C(=O)O)C(=O)NCC3=C(C(=CC=C3)F)F Chemical compound CN([C@@H](C[C@H](COP(=O)(OC)OC)O)CN(C1=CC2=CC=CC=C2C=N1)C(=O)O)C(=O)NCC3=C(C(=CC=C3)F)F LTJKPABLXAWDRJ-LEWJYISDSA-N 0.000 description 1
- OMCXDUATVFBLSO-MOPGFXCFSA-N CN([C@H](C[C@@H](CO)O)CN(C1=CC2=CC=CC=C2C=N1)C(=O)O)C(=O)NCC3=C(C(=CC=C3)F)Cl Chemical compound CN([C@H](C[C@@H](CO)O)CN(C1=CC2=CC=CC=C2C=N1)C(=O)O)C(=O)NCC3=C(C(=CC=C3)F)Cl OMCXDUATVFBLSO-MOPGFXCFSA-N 0.000 description 1
- 102000000584 Calmodulin Human genes 0.000 description 1
- 108010041952 Calmodulin Proteins 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- MJIKDGUWHUDCCC-QZTJIDSGSA-N ClC1=C(CN([C@@H](CC2=NC=CC3=CC=CC=C23)C[C@H](CO)O)C)C=CC=C1F Chemical compound ClC1=C(CN([C@@H](CC2=NC=CC3=CC=CC=C23)C[C@H](CO)O)C)C=CC=C1F MJIKDGUWHUDCCC-QZTJIDSGSA-N 0.000 description 1
- SURSJKSUYWWELR-OAQYLSRUSA-N ClC1=C(CNC(N(C)[C@H](CC2=NC=CC3=CC(=CC=C23)F)CC(COP(=O)(OC)OC)(C)C)=O)C=CC=C1F Chemical compound ClC1=C(CNC(N(C)[C@H](CC2=NC=CC3=CC(=CC=C23)F)CC(COP(=O)(OC)OC)(C)C)=O)C=CC=C1F SURSJKSUYWWELR-OAQYLSRUSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 208000034423 Delivery Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 208000017228 Gastrointestinal motility disease Diseases 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000837 Heparan sulfate analogue Polymers 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020853 Hypertonic bladder Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021718 Induced labour Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 108030001204 Myosin ATPases Proteins 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- VXUFCKSNTZQLDF-ZDUSSCGKSA-N N[C@@](C(=O)O)(CCC)NC(=O)OCC1=CC=CC=C1 Chemical compound N[C@@](C(=O)O)(CCC)NC(=O)OCC1=CC=CC=C1 VXUFCKSNTZQLDF-ZDUSSCGKSA-N 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 208000009722 Overactive Urinary Bladder Diseases 0.000 description 1
- DYCOUMPGYZQRSE-UHFFFAOYSA-L P(=O)(OC(CCCC)(C)C)([O-])[O-].[Na+].[Na+] Chemical compound P(=O)(OC(CCCC)(C)C)([O-])[O-].[Na+].[Na+] DYCOUMPGYZQRSE-UHFFFAOYSA-L 0.000 description 1
- 101100272976 Panax ginseng CYP716A53v2 gene Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 101710101148 Probable 6-oxopurine nucleoside phosphorylase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000006193 Pulmonary infarction Diseases 0.000 description 1
- 102000030764 Purine-nucleoside phosphorylase Human genes 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 201000004239 Secondary hypertension Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- BCXRMGAQNNSRPU-QHCPKHFHSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-pyridin-2-ylpropyl] N-isoquinolin-3-ylcarbamate Chemical compound ClC1=C(C=CC=C1F)CNN(C(=O)C)[C@H](COC(=O)NC=1N=CC2=CC=CC=C2C1)CC1=NC=CC=C1 BCXRMGAQNNSRPU-QHCPKHFHSA-N 0.000 description 1
- XNHXOKXMAVSSQG-INIZCTEOSA-N [(2S)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-5-aminopentyl] N-(5-chloropyridin-2-yl)carbamate Chemical compound CC(=O)N([C@@H](CCCN)COC(=O)NC=1N=CC(Cl)=CC=1)NCC1=CC=CC(F)=C1Cl XNHXOKXMAVSSQG-INIZCTEOSA-N 0.000 description 1
- LPUIUEJJTGUGIJ-RBUKOAKNSA-N [(2S,4R)-2-[(2,3-difluorophenyl)methyl-methylamino]-4,5-dihydroxypentyl]-isoquinolin-3-ylcarbamic acid Chemical compound CN([C@@H](C[C@@H](O)CO)CN(C(O)=O)C=1N=CC2=CC=CC=C2C=1)CC1=CC=CC(F)=C1F LPUIUEJJTGUGIJ-RBUKOAKNSA-N 0.000 description 1
- LOMPZEWGCARYIZ-OALUTQOASA-N [(2S,4S)-2-[(2-chloro-3-fluorophenyl)methyl-methylamino]-4,5-dihydroxypentyl]-isoquinolin-3-ylcarbamic acid Chemical compound CN([C@@H](C[C@H](O)CO)CN(C(O)=O)C=1N=CC2=CC=CC=C2C=1)CC1=CC=CC(F)=C1Cl LOMPZEWGCARYIZ-OALUTQOASA-N 0.000 description 1
- AREKIEISDIXWPG-QFIPXVFZSA-N [(2s)-2-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-6-dimethoxyphosphoryloxyhexyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCCCOP(=O)(OC)OC)C(=O)NCC1=CC=CC(F)=C1F AREKIEISDIXWPG-QFIPXVFZSA-N 0.000 description 1
- OKQFMERECHVSGL-NRFANRHFSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-(5,6,7,8-tetrahydroimidazo[1,5-a]pyrazin-3-yl)propyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC=1N2CCNCC2=CN=1)C(=O)NCC1=CC=CC(F)=C1Cl OKQFMERECHVSGL-NRFANRHFSA-N 0.000 description 1
- CGQVJQDUUJPIEZ-PMACEKPBSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-[(2s)-2,3-dihydroxypropoxy]propyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@@H](COC[C@@H](O)CO)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl CGQVJQDUUJPIEZ-PMACEKPBSA-N 0.000 description 1
- ABVBUEHGQRXTRH-IBGZPJMESA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(1,3-dioxoisoindol-2-yl)pentyl] n-(5-chloropyridin-2-yl)carbamate Chemical compound C([C@H](CCCN1C(C2=CC=CC=C2C1=O)=O)N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)OC(=O)NC1=CC=C(Cl)C=N1 ABVBUEHGQRXTRH-IBGZPJMESA-N 0.000 description 1
- YOFFXLNXOKCANY-VWLOTQADSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-[[(cyanoamino)-phenoxymethylidene]amino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CCN\C(=N\C#N)OC1=CC=CC=C1 YOFFXLNXOKCANY-VWLOTQADSA-N 0.000 description 1
- QKXVPEHUCUIQOP-BGERDNNASA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-dimethoxyphosphoryloxy-4-hydroxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(O)COP(=O)(OC)OC)C(=O)NCC1=CC=CC(F)=C1Cl QKXVPEHUCUIQOP-BGERDNNASA-N 0.000 description 1
- MWSJAWGYORAMDX-FQEVSTJZSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-hydroxy-4,4-dimethylpentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(C)(C)CO)C(=O)NCC1=CC=CC(F)=C1Cl MWSJAWGYORAMDX-FQEVSTJZSA-N 0.000 description 1
- XODOEZDCMCMFJW-SFHVURJKSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-oxo-5-piperazin-1-ylpentyl] n-(1,3-benzothiazol-2-yl)carbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1SC2=CC=CC=C2N=1)CC(=O)N1CCNCC1 XODOEZDCMCMFJW-SFHVURJKSA-N 0.000 description 1
- VPTALIRDEYAPHX-QFIPXVFZSA-N [(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-oxo-5-piperazin-1-ylpentyl] n-isoquinolin-3-ylcarbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1N=CC2=CC=CC=C2C=1)CC(=O)N1CCNCC1 VPTALIRDEYAPHX-QFIPXVFZSA-N 0.000 description 1
- MISBRHFXBXUMAU-LEWJYISDSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-3-[(2r)-2-hydroxy-3-phosphonooxypropoxy]propyl] n-isoquinolin-3-ylcarbamate Chemical compound CC(=O)N([C@@H](COC[C@@H](O)COP(O)(O)=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)NCC1=CC=CC(F)=C1Cl MISBRHFXBXUMAU-LEWJYISDSA-N 0.000 description 1
- DLSPEVZOOQLKCA-NRFANRHFSA-N [(2s)-2-[acetyl-[(2-chloro-3-fluorophenyl)methylamino]amino]-4,4-dimethyl-5-phosphonooxypentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CC(=O)N([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CC(C)(C)COP(O)(O)=O)NCC1=CC=CC(F)=C1Cl DLSPEVZOOQLKCA-NRFANRHFSA-N 0.000 description 1
- SKWPUYHAIJWFDK-SFHVURJKSA-N [(2s)-3-[(2-aminoacetyl)amino]-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]propyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CNC(=O)CN)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl SKWPUYHAIJWFDK-SFHVURJKSA-N 0.000 description 1
- WYKWOCMQGCPNTH-FQEVSTJZSA-N [(2s)-5-[(2-aminoacetyl)amino]-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pentyl] n-(6-fluoroisoquinolin-3-yl)carbamate Chemical compound CN([C@@H](CCCNC(=O)CN)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl WYKWOCMQGCPNTH-FQEVSTJZSA-N 0.000 description 1
- HLEXQOJKMXKUKE-RBUKOAKNSA-N [(2s,4r)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)C[C@@H](O)CO)C(=O)NCC1=CC=CC(F)=C1Cl HLEXQOJKMXKUKE-RBUKOAKNSA-N 0.000 description 1
- HLEXQOJKMXKUKE-OALUTQOASA-N [(2s,4s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-4,5-dihydroxypentyl] n-isoquinolin-3-ylcarbamate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)C[C@H](O)CO)C(=O)NCC1=CC=CC(F)=C1Cl HLEXQOJKMXKUKE-OALUTQOASA-N 0.000 description 1
- RNVYQYLELCKWAN-RXMQYKEDSA-N [(4r)-2,2-dimethyl-1,3-dioxolan-4-yl]methanol Chemical compound CC1(C)OC[C@@H](CO)O1 RNVYQYLELCKWAN-RXMQYKEDSA-N 0.000 description 1
- RSURRMKTAJYRAK-FQEVSTJZSA-N [(4s)-5-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]-2,2-dimethyl-4-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]pentyl] acetate Chemical compound FC1=CC=C2C=NC(NC(=O)OC[C@@H](N(C)C(=O)OC(C)(C)C)CC(C)(C)COC(C)=O)=CC2=C1 RSURRMKTAJYRAK-FQEVSTJZSA-N 0.000 description 1
- CGQVJQDUUJPIEZ-UHFFFAOYSA-N [2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-(2,3-dihydroxypropoxy)propyl] n-isoquinolin-3-ylcarbamate Chemical compound C=1C2=CC=CC=C2C=NC=1NC(=O)OCC(COCC(O)CO)N(C)C(=O)NCC1=CC=CC(F)=C1Cl CGQVJQDUUJPIEZ-UHFFFAOYSA-N 0.000 description 1
- SJDKLTPFPIYERZ-UHFFFAOYSA-N [2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-(2-hydroxy-3-phosphonooxypropoxy)propyl] n-isoquinolin-3-ylcarbamate Chemical compound C=1C2=CC=CC=C2C=NC=1NC(=O)OCC(COCC(O)COP(O)(O)=O)N(C)C(=O)NCC1=CC=CC(F)=C1Cl SJDKLTPFPIYERZ-UHFFFAOYSA-N 0.000 description 1
- MCVNSCLVBKAMJF-UHFFFAOYSA-N [2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-(3-diethoxyphosphoryloxy-2-hydroxypropoxy)propyl] n-isoquinolin-3-ylcarbamate Chemical compound C=1C2=CC=CC=C2C=NC=1NC(=O)OCC(COCC(O)COP(=O)(OCC)OCC)N(C)C(=O)NCC1=CC=CC(F)=C1Cl MCVNSCLVBKAMJF-UHFFFAOYSA-N 0.000 description 1
- UILNXSFBKLMMHZ-UHFFFAOYSA-N [2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(2-oxopiperazin-1-yl)pentyl] n-isoquinolin-3-ylcarbamate Chemical compound C=1C=CC(F)=C(Cl)C=1CNC(=O)N(C)C(COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCCN1CCNCC1=O UILNXSFBKLMMHZ-UHFFFAOYSA-N 0.000 description 1
- MWQAFBYGNSHPMQ-UHFFFAOYSA-N [2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(4-methylpiperazin-1-yl)pentyl] n-isoquinolin-3-ylcarbamate Chemical compound C=1C=CC(F)=C(Cl)C=1CNC(=O)N(C)C(COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCCN1CCN(C)CC1 MWQAFBYGNSHPMQ-UHFFFAOYSA-N 0.000 description 1
- JTQJOWQYNHDGHQ-UHFFFAOYSA-N [2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-hydroxypentyl] n-isoquinolin-3-ylcarbamate Chemical compound C=1C2=CC=CC=C2C=NC=1NC(=O)OCC(CCCO)N(C)C(=O)NCC1=CC=CC(F)=C1Cl JTQJOWQYNHDGHQ-UHFFFAOYSA-N 0.000 description 1
- ATKHMERIWLOEEN-NSHDSACASA-N [Si](C)(C)(C(C)(C)C)O[C@@H](CCC=C)NC Chemical compound [Si](C)(C)(C(C)(C)C)O[C@@H](CCC=C)NC ATKHMERIWLOEEN-NSHDSACASA-N 0.000 description 1
- ZBIKORITPGTTGI-UHFFFAOYSA-N [acetyloxy(phenyl)-$l^{3}-iodanyl] acetate Chemical compound CC(=O)OI(OC(C)=O)C1=CC=CC=C1 ZBIKORITPGTTGI-UHFFFAOYSA-N 0.000 description 1
- CVNMBKFJYRAHPO-UHFFFAOYSA-N [chloro(methyl)phosphoryl]methane Chemical compound CP(C)(Cl)=O CVNMBKFJYRAHPO-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000012042 active reagent Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 210000001742 aqueous humor Anatomy 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 239000005441 aurora Substances 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- NVXMGKXMLQLXLX-DEOSSOPVSA-N benzyl n-[(2s)-2-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-3-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]propyl]carbamate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)NC(=O)OCC1=CC=CC=C1 NVXMGKXMLQLXLX-DEOSSOPVSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000005510 but-1-en-2-yl group Chemical group 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- KWEDUNSJJZVRKR-UHFFFAOYSA-N carbononitridic azide Chemical compound [N-]=[N+]=NC#N KWEDUNSJJZVRKR-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000012059 conventional drug carrier Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 125000005432 dialkylcarboxamide group Chemical group 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 1
- WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- SLIKWVTWIGHFJE-UHFFFAOYSA-N diphenoxymethylidenecyanamide Chemical compound C=1C=CC=CC=1OC(=NC#N)OC1=CC=CC=C1 SLIKWVTWIGHFJE-UHFFFAOYSA-N 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- XNSDJVOOKNBCTG-TXEPZDRESA-L disodium;[(4s)-4-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-5-(isoquinolin-3-ylcarbamoyloxy)pentyl] phosphate Chemical compound [Na+].[Na+].CN([C@@H](CCCOP([O-])([O-])=O)COC(=O)NC=1N=CC2=CC=CC=C2C=1)C(=O)NCC1=CC=CC(F)=C1F XNSDJVOOKNBCTG-TXEPZDRESA-L 0.000 description 1
- FULYKNTUIATUHF-UHFFFAOYSA-L disodium;pentyl phosphate Chemical compound [Na+].[Na+].CCCCCOP([O-])([O-])=O FULYKNTUIATUHF-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- LBUJYIQSWHZSHZ-KRWDZBQOSA-N ditert-butyl [(4s)-4-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-5-hydroxypentyl] phosphate Chemical compound CC(C)(C)OP(=O)(OC(C)(C)C)OCCC[C@@H](CO)N(C)C(=O)NCC1=CC=CC(F)=C1F LBUJYIQSWHZSHZ-KRWDZBQOSA-N 0.000 description 1
- RRJHOMPUEYYASJ-UHFFFAOYSA-N ditert-butyl hydrogen phosphite Chemical compound CC(C)(C)OP(O)OC(C)(C)C RRJHOMPUEYYASJ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000002337 electrophoretic mobility shift assay Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940031124 ethanolamine oleate Drugs 0.000 description 1
- VLQLCEXNNGQELL-UHFFFAOYSA-N ethyl 1,3-benzothiazole-2-carboxylate Chemical compound C1=CC=C2SC(C(=O)OCC)=NC2=C1 VLQLCEXNNGQELL-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000002825 functional assay Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- DOUHZFSGSXMPIE-UHFFFAOYSA-N hydroxidooxidosulfur(.) Chemical compound [O]SO DOUHZFSGSXMPIE-UHFFFAOYSA-N 0.000 description 1
- 125000005113 hydroxyalkoxy group Chemical group 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000001286 intracranial vasospasm Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- VYCKDIRCVDCQAE-UHFFFAOYSA-N isoquinolin-3-amine Chemical compound C1=CC=C2C=NC(N)=CC2=C1 VYCKDIRCVDCQAE-UHFFFAOYSA-N 0.000 description 1
- 125000003971 isoxazolinyl group Chemical group 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 238000003367 kinetic assay Methods 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 201000005857 malignant hypertension Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- KBYVNPJJCABLLH-JTQLQIEISA-N methyl (4s)-4-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]pentanoate Chemical compound COC(=O)CC[C@H](C)N(C)C(=O)NCC1=CC=CC(F)=C1F KBYVNPJJCABLLH-JTQLQIEISA-N 0.000 description 1
- PHPZISAJUWINIY-IBGZPJMESA-N methyl (4s)-4-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]pentanoate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)CCC(=O)OC)C(=O)NCC1=CC=CC(F)=C1Cl PHPZISAJUWINIY-IBGZPJMESA-N 0.000 description 1
- HOCQFUJYQQPFMG-INIZCTEOSA-N methyl (4s)-5-[tert-butyl(dimethyl)silyl]oxy-4-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]pentanoate Chemical compound COC(=O)CC[C@@H](CO[Si](C)(C)C(C)(C)C)N(C)C(=O)NCC1=CC=CC(F)=C1F HOCQFUJYQQPFMG-INIZCTEOSA-N 0.000 description 1
- BTKLPINUUIACIA-ZDUSSCGKSA-N methyl (4s)-5-[tert-butyl(dimethyl)silyl]oxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate Chemical compound COC(=O)CC[C@@H](CO[Si](C)(C)C(C)(C)C)NC(=O)OC(C)(C)C BTKLPINUUIACIA-ZDUSSCGKSA-N 0.000 description 1
- ZNPRMSVWHUOCLH-FQEVSTJZSA-N methyl (5s)-5-[(2,3-difluorophenyl)methylcarbamoyl-methylamino]-6-(isoquinolin-3-ylcarbamoyloxy)hexanoate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCCC(=O)OC)C(=O)NCC1=CC=CC(F)=C1F ZNPRMSVWHUOCLH-FQEVSTJZSA-N 0.000 description 1
- LSBMJSAOIUOCKS-NRFANRHFSA-N methyl (5s)-5-[(2-chloro-4-fluorophenyl)methylcarbamoyl-methylamino]-6-(isoquinolin-3-ylcarbamoyloxy)hexanoate Chemical compound CN([C@H](COC(=O)NC=1N=CC2=CC=CC=C2C=1)CCCC(=O)OC)C(=O)NCC1=CC=C(F)C=C1Cl LSBMJSAOIUOCKS-NRFANRHFSA-N 0.000 description 1
- WZNONRZHWVMNCN-SFHVURJKSA-N methyl (5s)-6-(isoquinolin-3-ylcarbamoyloxy)-5-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]hexanoate Chemical compound C1=CC=C2C=NC(NC(=O)OC[C@H](CCCC(=O)OC)N(C)C(=O)OC(C)(C)C)=CC2=C1 WZNONRZHWVMNCN-SFHVURJKSA-N 0.000 description 1
- AOYBQZRYDWOHLC-UHFFFAOYSA-N methyl 3-(3-fluorophenyl)-1,2-oxazole-5-carboxylate Chemical compound O1C(C(=O)OC)=CC(C=2C=C(F)C=CC=2)=N1 AOYBQZRYDWOHLC-UHFFFAOYSA-N 0.000 description 1
- NIKQQXDOROMMBO-UHFFFAOYSA-N methyl 4-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(isoquinolin-3-ylcarbamoyloxy)pentanoate Chemical compound C=1C2=CC=CC=C2C=NC=1NC(=O)OCC(CCC(=O)OC)N(C)C(=O)NCC1=CC=CC(F)=C1Cl NIKQQXDOROMMBO-UHFFFAOYSA-N 0.000 description 1
- HNOCVVFHLPSDKT-UHFFFAOYSA-N methyl 5-[tert-butyl(dimethyl)silyl]oxy-4-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pentanoate Chemical compound COC(=O)CCC(CO[Si](C)(C)C(C)(C)C)N(C)C(=O)NCC1=CC=CC(F)=C1Cl HNOCVVFHLPSDKT-UHFFFAOYSA-N 0.000 description 1
- BTKLPINUUIACIA-UHFFFAOYSA-N methyl 5-[tert-butyl(dimethyl)silyl]oxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate Chemical compound COC(=O)CCC(CO[Si](C)(C)C(C)(C)C)NC(=O)OC(C)(C)C BTKLPINUUIACIA-UHFFFAOYSA-N 0.000 description 1
- GTCAXTIRRLKXRU-UHFFFAOYSA-N methyl carbamate Chemical compound COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- ZBCGBIZQNMVMPC-UHFFFAOYSA-N methyl isoquinoline-3-carboxylate Chemical compound C1=CC=C2C=NC(C(=O)OC)=CC2=C1 ZBCGBIZQNMVMPC-UHFFFAOYSA-N 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- XGEGHDBEHXKFPX-NJFSPNSNSA-N methylurea Chemical compound [14CH3]NC(N)=O XGEGHDBEHXKFPX-NJFSPNSNSA-N 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 125000004312 morpholin-2-yl group Chemical group [H]N1C([H])([H])C([H])([H])OC([H])(*)C1([H])[H] 0.000 description 1
- 125000004572 morpholin-3-yl group Chemical group N1C(COCC1)* 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 125000006203 morpholinoethyl group Chemical group [H]C([H])(*)C([H])([H])N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 description 1
- 125000001064 morpholinomethyl group Chemical group [H]C([H])(*)N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- DXASQZJWWGZNSF-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfur trioxide Chemical group CN(C)C.O=S(=O)=O DXASQZJWWGZNSF-UHFFFAOYSA-N 0.000 description 1
- OUQVKRKGTAUJQA-UHFFFAOYSA-N n-[(1-chloro-4-hydroxyisoquinolin-3-yl)carbonyl]glycine Chemical compound C1=CC=CC2=C(O)C(C(=O)NCC(=O)O)=NC(Cl)=C21 OUQVKRKGTAUJQA-UHFFFAOYSA-N 0.000 description 1
- YGFLCNPXEPDANQ-UHFFFAOYSA-N n-[bis[(2-methylpropan-2-yl)oxy]phosphanyl]-n-propan-2-ylpropan-2-amine Chemical compound CC(C)N(C(C)C)P(OC(C)(C)C)OC(C)(C)C YGFLCNPXEPDANQ-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 125000006574 non-aromatic ring group Chemical group 0.000 description 1
- UMRZSTCPUPJPOJ-KNVOCYPGSA-N norbornane Chemical group C1C[C@H]2CC[C@@H]1C2 UMRZSTCPUPJPOJ-KNVOCYPGSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 208000020629 overactive bladder Diseases 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 125000005968 oxazolinyl group Chemical group 0.000 description 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 239000006179 pH buffering agent Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 238000003566 phosphorylation assay Methods 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 125000006238 prop-1-en-1-yl group Chemical group [H]\C(*)=C(/[H])C([H])([H])[H] 0.000 description 1
- IVRIRQXJSNCSPQ-UHFFFAOYSA-N propan-2-yl carbonochloridate Chemical compound CC(C)OC(Cl)=O IVRIRQXJSNCSPQ-UHFFFAOYSA-N 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000004088 pulmonary circulation Effects 0.000 description 1
- 230000007575 pulmonary infarction Effects 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 1
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical class O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- ILJOYZVVZZFIKA-UHFFFAOYSA-M sodium;1,1-dioxo-1,2-benzothiazol-3-olate;hydrate Chemical compound O.[Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 ILJOYZVVZZFIKA-UHFFFAOYSA-M 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 125000006633 tert-butoxycarbonylamino group Chemical group 0.000 description 1
- OUTKFGFODNYEDD-ZDUSSCGKSA-N tert-butyl (5s)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-3,3-dimethyl-2-oxopyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1[C@H](CO[Si](C)(C)C(C)(C)C)CC(C)(C)C1=O OUTKFGFODNYEDD-ZDUSSCGKSA-N 0.000 description 1
- BLRCAPOBPCJSIX-UHFFFAOYSA-N tert-butyl 2-(2-tert-butylsilyloxypropan-2-yl)-5-oxopyrrolidine-1-carboxylate Chemical compound C(C)(C)(C)OC(=O)N1C(CCC1=O)C(O[SiH2]C(C)(C)C)(C)C BLRCAPOBPCJSIX-UHFFFAOYSA-N 0.000 description 1
- LTGXQXDOSTWGFP-QFIPXVFZSA-N tert-butyl 4-[(4s)-5-[tert-butyl(dimethyl)silyl]oxy-4-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]pentanoyl]piperazine-1-carboxylate Chemical compound C([C@H](N(C)C(=O)NCC=1C(=C(F)C=CC=1)Cl)CO[Si](C)(C)C(C)(C)C)CC(=O)N1CCN(C(=O)OC(C)(C)C)CC1 LTGXQXDOSTWGFP-QFIPXVFZSA-N 0.000 description 1
- JHBKBRLRYPYBLP-UHFFFAOYSA-N tert-butyl n-(1,3-dihydroxypropan-2-yl)carbamate Chemical compound CC(C)(C)OC(=O)NC(CO)CO JHBKBRLRYPYBLP-UHFFFAOYSA-N 0.000 description 1
- RHONTQZNLFIDCQ-UHFFFAOYSA-N tert-butyl n-(2-amino-2-oxoethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCC(N)=O RHONTQZNLFIDCQ-UHFFFAOYSA-N 0.000 description 1
- AOCSUUGBCMTKJH-UHFFFAOYSA-N tert-butyl n-(2-aminoethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCN AOCSUUGBCMTKJH-UHFFFAOYSA-N 0.000 description 1
- LNTVZTITILCTOG-AWEZNQCLSA-N tert-butyl n-[(2s)-1-[tert-butyl(dimethyl)silyl]oxy-5-hydroxypentan-2-yl]-n-methylcarbamate Chemical compound CC(C)(C)OC(=O)N(C)[C@@H](CCCO)CO[Si](C)(C)C(C)(C)C LNTVZTITILCTOG-AWEZNQCLSA-N 0.000 description 1
- FKSJNDJJJCNZJH-AWEZNQCLSA-N tert-butyl n-[(2s)-1-hydroxy-3-(phenylmethoxycarbonylamino)propan-2-yl]-n-methylcarbamate Chemical compound CC(C)(C)OC(=O)N(C)[C@H](CO)CNC(=O)OCC1=CC=CC=C1 FKSJNDJJJCNZJH-AWEZNQCLSA-N 0.000 description 1
- MSIDLARYVJJEQY-ZDUSSCGKSA-N tert-butyl n-[(2s)-1-hydroxy-3-phenylmethoxypropan-2-yl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@@H](CO)COCC1=CC=CC=C1 MSIDLARYVJJEQY-ZDUSSCGKSA-N 0.000 description 1
- CWZMYBITJHCPOZ-UHFFFAOYSA-N tert-butyl n-[1-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]-3-hydroxypropan-2-yl]-n-methylcarbamate Chemical compound CC(C)(C)OC(=O)N(C)C(CO)COCC1COC(C)(C)O1 CWZMYBITJHCPOZ-UHFFFAOYSA-N 0.000 description 1
- HVOOPSZIIGHILK-UHFFFAOYSA-N tert-butyl n-[1-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]-3-phenylmethoxypropan-2-yl]carbamate Chemical compound C=1C=CC=CC=1COCC(NC(=O)OC(C)(C)C)COCC1COC(C)(C)O1 HVOOPSZIIGHILK-UHFFFAOYSA-N 0.000 description 1
- CHKZKVLNEXTJJZ-QHCPKHFHSA-N tert-butyl n-[2-[[(4s)-4-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-[(6-fluoroisoquinolin-3-yl)carbamoyloxy]pentyl]amino]-2-oxoethyl]carbamate Chemical compound CN([C@@H](CCCNC(=O)CNC(=O)OC(C)(C)C)COC(=O)NC=1N=CC2=CC=C(F)C=C2C=1)C(=O)NCC1=CC=CC(F)=C1Cl CHKZKVLNEXTJJZ-QHCPKHFHSA-N 0.000 description 1
- FABHPMXEWHXPND-UHFFFAOYSA-N tert-butyl n-[2-[[4-[(2-chloro-3-fluorophenyl)methylcarbamoyl-methylamino]-5-(isoquinolin-3-ylcarbamoyloxy)pentyl]amino]ethyl]carbamate Chemical compound C=1C2=CC=CC=C2C=NC=1NC(=O)OCC(CCCNCCNC(=O)OC(C)(C)C)N(C)C(=O)NCC1=CC=CC(F)=C1Cl FABHPMXEWHXPND-UHFFFAOYSA-N 0.000 description 1
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000002769 thiazolinyl group Chemical group 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 150000003613 toluenes Chemical class 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229940117013 triethanolamine oleate Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Reproductive Health (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Ophthalmology & Optometry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pregnancy & Childbirth (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96502007P | 2007-08-15 | 2007-08-15 | |
| US60/965,020 | 2007-08-15 | ||
| PCT/US2008/009636 WO2009023193A1 (en) | 2007-08-15 | 2008-08-11 | Certain chemical entities, compositions, and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010536752A JP2010536752A (ja) | 2010-12-02 |
| JP2010536752A5 JP2010536752A5 (enExample) | 2014-01-09 |
| JP5670731B2 true JP5670731B2 (ja) | 2015-02-18 |
Family
ID=40350992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010521009A Expired - Fee Related JP5670731B2 (ja) | 2007-08-15 | 2008-08-11 | ある種の化学物質、組成物、および方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US8088793B2 (enExample) |
| EP (1) | EP2195328A4 (enExample) |
| JP (1) | JP5670731B2 (enExample) |
| KR (1) | KR20100044251A (enExample) |
| CN (1) | CN101821279A (enExample) |
| AR (1) | AR069364A1 (enExample) |
| AU (1) | AU2008287435B2 (enExample) |
| CA (1) | CA2696321A1 (enExample) |
| CL (1) | CL2008002411A1 (enExample) |
| MX (1) | MX2010001692A (enExample) |
| NZ (1) | NZ583351A (enExample) |
| PE (1) | PE20090958A1 (enExample) |
| TW (1) | TWI426908B (enExample) |
| WO (1) | WO2009023193A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8063082B2 (en) * | 2006-08-02 | 2011-11-22 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
| US8071625B2 (en) * | 2006-08-02 | 2011-12-06 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
| WO2009023193A1 (en) | 2007-08-15 | 2009-02-19 | Cytokinetics, Incorporated | Certain chemical entities, compositions, and methods |
| MX2013006101A (es) | 2010-12-17 | 2013-07-02 | Hoffmann La Roche | Compuestos heterociclicos nitrogenados sustituidos fusionados en posicion 6,6 y usos de los mismos. |
| WO2013138753A1 (en) * | 2012-03-16 | 2013-09-19 | Fox Chase Chemical Diversity Center, Inc. | Prodrugs of riluzole and their method of use |
| EP2834269A4 (en) * | 2012-04-02 | 2015-12-30 | Cytokinetics Inc | METHODS FOR IMPROVING DIAPHRAGM FUNCTION |
| CN107802623B (zh) | 2012-07-19 | 2020-10-30 | 开曼化学股份有限公司 | 用于ep4介导的骨相关疾病和病症的二氟内酰胺组合物 |
| US9914725B2 (en) | 2013-03-15 | 2018-03-13 | Cayman Chemical Company, Inc. | Methods of synthesizing a difluorolactam analog |
| AR108325A1 (es) | 2016-04-27 | 2018-08-08 | Samumed Llc | Isoquinolin-3-il carboxamidas y preparación y uso de las mismas |
| AR108326A1 (es) | 2016-04-27 | 2018-08-08 | Samumed Llc | Isoquinolin-3-il carboxamidas y preparación y uso de las mismas |
| TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Hdac抑制劑與pd-l1抑制劑之組合治療 |
| TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
| AU2018243770A1 (en) | 2017-03-30 | 2019-09-19 | F. Hoffmann-La Roche Ag | Isoquinolines as inhibitors of HPK1 |
| JP7154221B2 (ja) | 2017-03-30 | 2022-10-17 | エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | Hpk1の阻害剤としてのナフチリジン |
| JP7386841B2 (ja) | 2018-07-24 | 2023-11-27 | エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | イソキノリン化合物及びその使用 |
| JP7386842B2 (ja) | 2018-07-24 | 2023-11-27 | エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | ナフチリジン化合物およびその使用 |
| TW202024053A (zh) | 2018-10-02 | 2020-07-01 | 美商建南德克公司 | 異喹啉化合物及其用途 |
| US11612606B2 (en) | 2018-10-03 | 2023-03-28 | Genentech, Inc. | 8-aminoisoquinoline compounds and uses thereof |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3227709A (en) | 1961-11-28 | 1966-01-04 | Merck & Co Inc | Derivatives of cephalosporin c and process |
| GB1339764A (en) * | 1971-03-29 | 1973-12-05 | Ici Ltd | Pyridine derivatives |
| DE2851953A1 (de) * | 1978-12-01 | 1980-06-19 | Thomae Gmbh Dr K | Neue spectinomycylamine, verfahren zu ihrer herstellung und diese enthaltenden arzneimittel |
| JP2838148B2 (ja) | 1991-08-15 | 1998-12-16 | 富士写真フイルム株式会社 | ハロゲン化銀写真感光材料 |
| JPH07247274A (ja) | 1994-03-10 | 1995-09-26 | Wakamoto Pharmaceut Co Ltd | ピバル酸 テトラゾリルフェニルエステル誘導体、それらを有効成分として含有するエラスターゼ阻害剤及び肺障害治療剤 |
| EP1195372A1 (en) | 1994-04-18 | 2002-04-10 | Mitsubishi Pharma Corporation | N-heterocyclic substituted benzamide derivatives with antihypertensive activity |
| WO1998041510A1 (en) * | 1997-03-14 | 1998-09-24 | Shionogi & Co., Ltd. | Novel benzolactam derivatives and medicinal compositions comprising the same |
| NZ503782A (en) | 1997-11-18 | 2002-03-28 | Dupont Pharmaceuticals Res Lab | Cyclic amine derivatives and chemokine receptor antagonists that are effective in treating disease caused by infiltration of the tissue by blood leukocytes |
| US6107291A (en) * | 1997-12-19 | 2000-08-22 | Amgen Inc. | Azepine or larger medium ring derivatives and methods of use |
| GB9807833D0 (en) * | 1998-04-09 | 1998-06-10 | Boc Group Plc | Separation of air |
| US6420364B1 (en) | 1999-09-13 | 2002-07-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compound useful as reversible inhibitors of cysteine proteases |
| US6362177B1 (en) * | 2000-05-16 | 2002-03-26 | Teijin Limited | Cyclic amine derivatives and their use as drugs |
| CA2321348A1 (en) * | 2000-09-27 | 2002-03-27 | Blaise Magloire N'zemba | Aromatic derivatives with hiv integrase inhibitory properties |
| DE10063008A1 (de) * | 2000-12-16 | 2002-06-20 | Merck Patent Gmbh | Carbonsäureamidderivate |
| US7119083B2 (en) * | 2001-10-12 | 2006-10-10 | Azevan Pharmaceuticals, Inc. | β-Lactamyl vasopressin V1a Antagonists |
| AR038368A1 (es) | 2002-02-01 | 2005-01-12 | Novartis Ag | Compuestos n-pirimidin-2-il-aminas sustituidas como inhibidores de ige, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de un medicamento |
| EP1534693A2 (en) | 2002-09-06 | 2005-06-01 | Elan Pharmaceuticals, Inc. | 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| NZ540878A (en) * | 2003-01-14 | 2008-06-30 | Cytokinetics Inc | Compounds, compositions and methods |
| US7223788B2 (en) | 2003-02-14 | 2007-05-29 | Sanofi-Aventis Deutschland Gmbh | Substituted N-aryl heterocycles, process for their preparation and their use as medicaments |
| WO2004081005A1 (en) * | 2003-03-07 | 2004-09-23 | Neurocrine Biosciences, Inc. | Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| GB0319124D0 (en) | 2003-08-14 | 2003-09-17 | Smithkline Beecham Corp | Chemical compounds |
| WO2005016883A2 (en) * | 2003-08-14 | 2005-02-24 | Icos Corporation | Acrylamide derivatives as vla-1 integrin antagonists and uses thereof |
| JP4380508B2 (ja) * | 2003-11-28 | 2009-12-09 | 田辺三菱製薬株式会社 | 医薬組成物 |
| EP1711175A1 (en) * | 2004-02-04 | 2006-10-18 | Active Biotech AB | Diurea derivatives |
| CA2601709C (en) | 2005-03-22 | 2017-02-14 | Azevan Pharmaceuticals, Inc. | Beta-lactamylalkanoic acids |
| JPWO2006137350A1 (ja) * | 2005-06-22 | 2009-01-15 | キッセイ薬品工業株式会社 | 新規なフロピリジン誘導体、それを含有する医薬組成物およびそれらの用途 |
| WO2007056078A2 (en) | 2005-11-02 | 2007-05-18 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
| WO2007109615A2 (en) | 2006-03-21 | 2007-09-27 | Azevan Pharmaceuticals, Inc. | β -LACTAMYL VASOPRESSIN V2 ANTAGONISTS |
| CA2644910C (en) | 2006-03-31 | 2014-01-28 | Abbott Laboratories | Indazole compounds |
| US8017612B2 (en) | 2006-04-18 | 2011-09-13 | Japan Tobacco Inc. | Piperazine compound and use thereof as a HCV polymerase inhibitor |
| WO2007143822A1 (en) | 2006-06-14 | 2007-12-21 | Methylgene Inc. | Sulfamide and sulfamate derivatives as histone deacetylase inhibitors |
| US8071625B2 (en) | 2006-08-02 | 2011-12-06 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
| WO2008016676A2 (en) | 2006-08-02 | 2008-02-07 | Cytokinetics, Incorporated | Certain chemical entities, compositions, and methods |
| US8063082B2 (en) | 2006-08-02 | 2011-11-22 | Cytokinetics, Inc. | Certain chemical entities, compositions, and methods |
| WO2009023193A1 (en) | 2007-08-15 | 2009-02-19 | Cytokinetics, Incorporated | Certain chemical entities, compositions, and methods |
-
2008
- 2008-08-11 WO PCT/US2008/009636 patent/WO2009023193A1/en not_active Ceased
- 2008-08-11 NZ NZ583351A patent/NZ583351A/xx not_active IP Right Cessation
- 2008-08-11 AU AU2008287435A patent/AU2008287435B2/en not_active Ceased
- 2008-08-11 JP JP2010521009A patent/JP5670731B2/ja not_active Expired - Fee Related
- 2008-08-11 US US12/228,421 patent/US8088793B2/en not_active Expired - Fee Related
- 2008-08-11 EP EP08795242A patent/EP2195328A4/en not_active Withdrawn
- 2008-08-11 CA CA2696321A patent/CA2696321A1/en not_active Abandoned
- 2008-08-11 CN CN200880111558A patent/CN101821279A/zh active Pending
- 2008-08-11 KR KR1020107005370A patent/KR20100044251A/ko not_active Ceased
- 2008-08-11 MX MX2010001692A patent/MX2010001692A/es active IP Right Grant
- 2008-08-14 CL CL2008002411A patent/CL2008002411A1/es unknown
- 2008-08-14 PE PE2008001391A patent/PE20090958A1/es not_active Application Discontinuation
- 2008-08-14 TW TW097130926A patent/TWI426908B/zh not_active IP Right Cessation
- 2008-08-14 AR ARP080103556A patent/AR069364A1/es unknown
-
2011
- 2011-11-30 US US13/308,287 patent/US8759374B2/en active Active
-
2012
- 2012-09-12 US US13/612,713 patent/US8895582B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100044251A (ko) | 2010-04-29 |
| US8759374B2 (en) | 2014-06-24 |
| CA2696321A1 (en) | 2009-02-19 |
| CN101821279A (zh) | 2010-09-01 |
| US20090275537A1 (en) | 2009-11-05 |
| TW200922583A (en) | 2009-06-01 |
| US20120135964A1 (en) | 2012-05-31 |
| TWI426908B (zh) | 2014-02-21 |
| PE20090958A1 (es) | 2009-08-07 |
| US8895582B2 (en) | 2014-11-25 |
| AU2008287435B2 (en) | 2013-05-16 |
| AR069364A1 (es) | 2010-01-20 |
| EP2195328A1 (en) | 2010-06-16 |
| NZ583351A (en) | 2012-05-25 |
| AU2008287435A1 (en) | 2009-02-19 |
| WO2009023193A1 (en) | 2009-02-19 |
| EP2195328A4 (en) | 2011-06-15 |
| CL2008002411A1 (es) | 2009-07-17 |
| MX2010001692A (es) | 2010-04-22 |
| JP2010536752A (ja) | 2010-12-02 |
| US20130053348A1 (en) | 2013-02-28 |
| US8088793B2 (en) | 2012-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5670731B2 (ja) | ある種の化学物質、組成物、および方法 | |
| US10975034B2 (en) | Compounds, compositions and methods | |
| US8410108B2 (en) | Certain chemical entities, compositions and methods | |
| JP2003528076A (ja) | スルホンアミド置換架橋ビシクロアルキル誘導体 | |
| US20090192168A1 (en) | Compounds, Compositions and Methods | |
| US7910743B2 (en) | Compounds, compositions and methods | |
| EP1962852B1 (en) | Compounds, compositions and methods | |
| US20070208000A1 (en) | Certain chemical entities, compositions and methods | |
| HK1101060B (en) | Compounds, compositions and methods | |
| HK1209729B (en) | Compounds, compositions and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110810 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110810 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130725 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130806 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131101 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20131101 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140318 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140611 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141118 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141218 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5670731 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |